var title_f20_11_20656="Wedge two";
var content_f20_11_20656=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F54488&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F54488&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Larger superotemporal branch retinal vein occlusion with wedge-shaped pattern of intraretinal hemorrhages",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 369px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_11_20656=[""].join("\n");
var outline_f20_11_20656=null;
var title_f20_11_20657="Port placement for laparoscopic proctocolectomy";
var content_f20_11_20657=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F83861&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F83861&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 505px\">",
"   <div class=\"ttl\">",
"    Port placement for laparoscopic proctocolectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 485px; height: 601px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_11_20657=[""].join("\n");
var outline_f20_11_20657=null;
var title_f20_11_20658="Patient information: Bladder pain syndrome (interstitial cystitis) (The Basics)";
var content_f20_11_20658=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15918\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/28/27072\">",
"         Anatomy of the urinary tract",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?41/23/42353\">",
"         Patient information: Chronic pelvic pain in women (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?19/47/20210\">",
"         Patient information: Urinary tract infections in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?30/48/31490\">",
"         Patient information: Diagnosis of interstitial cystitis/bladder pain syndrome (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?17/22/17764\">",
"         Patient information: Treatment of interstitial cystitis/bladder pain syndrome (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Bladder pain syndrome (interstitial cystitis) (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/bladder-pain-syndrome-interstitial-cystitis-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H24555603\">",
"      <span class=\"h1\">",
"       What is bladder pain syndrome?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Bladder pain syndrome is a condition that causes people to have bladder pain and urinate often (",
"      <a class=\"graphic graphic_figure graphicRef79864 \" href=\"UTD.htm?26/28/27072\">",
"       figure 1",
"      </a>",
"      ). Bladder pain syndrome is often called &ldquo;BPS&rdquo; for short. It is also sometimes called &ldquo;painful bladder syndrome&rdquo; or &ldquo;interstitial cystitis.&rdquo;",
"     </p>",
"     <p>",
"      BPS can happen in both men and women, but it is more common in women. Doctors do not know what causes BPS, but some doctors suspect it might be caused by abnormal changes in the lining of the bladder. Sometimes, BPS happens on its own. Other times, it starts after a person has:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        An infection of the urinary tract, vagina, or prostate",
"       </li>",
"       <li>",
"        Surgery on the bladder, pelvis, or back",
"       </li>",
"       <li>",
"        An injury to the pelvic area or buttocks",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24555610\">",
"      <span class=\"h1\">",
"       What are the symptoms of BPS?",
"      </span>",
"      &nbsp;&mdash;&nbsp;All people with BPS have bladder pain that gets better after urinating. Other common symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Feeling the need to urinate often, during the day and night (even if you don&rsquo;t actually urinate)",
"       </li>",
"       <li>",
"        Urinating often, during the day and night",
"       </li>",
"       <li>",
"        Pain in the lower belly or around the area where urine leaves the body",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Symptoms of BPS are different from person to person and can be mild or severe. People might not have symptoms every day. But they can have &ldquo;flares,&rdquo; which are times when their symptoms get worse. Some people find that their symptoms get worse at certain times, such as:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        After they have certain foods or drinks",
"       </li>",
"       <li>",
"        During certain times of their monthly cycle (in women)",
"       </li>",
"       <li>",
"        After having sex or sitting for a long time",
"       </li>",
"       <li>",
"        During times of stress",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24555617\">",
"      <span class=\"h1\">",
"       Is there a test for BPS?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor or nurse will talk with you, do an exam, and probably do a urine test. Depending on the results, your doctor might do other tests.",
"     </p>",
"     <p>",
"      For example, some people have a test called &ldquo;cystoscopy.&rdquo; During cystoscopy, a doctor puts a thin tube with a camera on the end into the opening in the body where urine comes out (called the urethra). Then he or she advances the tube until it reaches the bladder. That way the doctor can look at the inside of the bladder to see if it is abnormal.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24555624\">",
"      <span class=\"h1\">",
"       How is BPS treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There are different treatments for BPS. Most people need more than 1 treatment. Different treatments can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Bladder training &mdash; You can train your bladder to urinate less often by holding your urine for longer periods of time. For example, if you feel the need to urinate every 30 minutes, try to wait and urinate every 45 minutes.",
"       </li>",
"       <li>",
"        Physical therapy &mdash; Many people with BPS have tight and painful muscles in the lower belly, groin, and buttocks. A physical therapist can teach you exercises to help relax these muscles.",
"       </li>",
"       <li>",
"        Medicines &mdash; Doctors can use different medicines to treat BPS. Some medicines help heal the bladder lining, and others can reduce pain. Some medicines come as pills. Others come as liquids and go into the bladder through a tube that is put up the urethra (",
"        <a class=\"graphic graphic_figure graphicRef79864 \" href=\"UTD.htm?26/28/27072\">",
"         figure 1",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        Surgery &mdash; A person might have surgery if he or she still has symptoms after trying all other treatments. During surgery, a doctor puts a small device in the lower back that connects to the nerve that goes to the bladder. The device sends electrical signals to the nerve that can stop it from feeling pain.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24555631\">",
"      <span class=\"h1\">",
"       Can BPS flares be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;To help prevent flares, you can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Avoid the foods and drinks that make your symptoms worse.",
"       </li>",
"       <li>",
"        Avoid activities that make your symptoms worse.",
"       </li>",
"       <li>",
"        Get treated quickly for bladder infections, which can make BPS symptoms worse.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24555638\">",
"      <span class=\"h1\">",
"       What if I have long-term pain?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have long-term pain, talk with your doctor or nurse about what you can do. Some people find it helpful to work with a mental health expert or join a support group for people with BPS.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H24555645\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?41/23/42353?source=see_link\">",
"       Patient information: Chronic pelvic pain in women (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/47/20210?source=see_link\">",
"       Patient information: Urinary tract infections in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?30/48/31490?source=see_link\">",
"       Patient information: Diagnosis of interstitial cystitis/bladder pain syndrome (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?17/22/17764?source=see_link\">",
"       Patient information: Treatment of interstitial cystitis/bladder pain syndrome (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?20/11/20658?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15918 Version 3.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-91.202.164.29-7B7E1375F2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_11_20658=[""].join("\n");
var outline_f20_11_20658=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24555603\">",
"      What is bladder pain syndrome?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24555610\">",
"      What are the symptoms of BPS?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24555617\">",
"      Is there a test for BPS?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24555624\">",
"      How is BPS treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24555631\">",
"      Can BPS flares be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24555638\">",
"      What if I have long-term pain?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24555645\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15918\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/28/27072\">",
"      Anatomy of the urinary tract",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/23/42353?source=related_link\">",
"      Patient information: Chronic pelvic pain in women (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/48/31490?source=related_link\">",
"      Patient information: Diagnosis of interstitial cystitis/bladder pain syndrome (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?17/22/17764?source=related_link\">",
"      Patient information: Treatment of interstitial cystitis/bladder pain syndrome (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/47/20210?source=related_link\">",
"      Patient information: Urinary tract infections in adults (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_11_20659="Esophageal foreign body sites";
var content_f20_11_20659=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F52252&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F52252&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 535px\">",
"   <div class=\"ttl\">",
"    Esophageal foreign body sites",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 515px; height: 305px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Common sites of esophageal impaction of smooth foreign bodies.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Schunk JE, Dudley NC. Management of esophageal foreign bodies. In: Textbook of Pediatric Emergency Procedures, 2nd ed, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_11_20659=[""].join("\n");
var outline_f20_11_20659=null;
var title_f20_11_20660="Omacetaxine: Patient drug information";
var content_f20_11_20660=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Omacetaxine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/13/13526?source=see_link\">",
"     see \"Omacetaxine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F15592818\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Synribo&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F15673352\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F15572848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691928",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat leukemia.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F15572847\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4022170",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to omacetaxine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F15572851\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take good care of your teeth. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2858939",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid driving and doing other tasks or actions that call for you to be alert until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697022",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man and have sex, protect your partner from pregnancy. Use birth control that you can trust.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F15572852\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698195",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Joint pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698113",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F15572853\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F15572850\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the fatty part of the skin.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F15572854\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 87039 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.234.146.186-EC60C7DA3C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_11_20660=[""].join("\n");
var outline_f20_11_20660=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15592818\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15673352\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15572848\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15572847\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15572851\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15572852\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15572853\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15572850\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15572854\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/13/13526?source=related_link\">",
"      Omacetaxine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_11_20661="Chlorpromazine: Patient drug information";
var content_f20_11_20661=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Chlorpromazine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/38/30312?source=see_link\">",
"     see \"Chlorpromazine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/35/21047?source=see_link\">",
"     see \"Chlorpromazine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F150514\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Chlorpromazine Hydrochloride Inj;",
"     </li>",
"     <li>",
"      Teva-Chlorpromazine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10018644\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700570",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a higher chance of death in older adults who take this drug for mental problems caused by dementia. Most of the deaths were linked to heart disease or infection. This drug is not approved to treat mental problems caused by dementia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10018646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691648",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop hiccups.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691747",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat problems with how one acts.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691807",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat dementia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691816",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat disabling involuntary movements in Huntington's chorea.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691951",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat mania.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691985",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat upset stomach and throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692053",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat schizophrenia. It may take 6 weeks to see the full effect.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692114",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat Tourette's syndrome.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10018645\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to chlorpromazine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10018650\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696822",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not spill the liquid on the skin. This may irritate the skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10018651\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in sex ability.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10018653\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699055",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shakiness, trouble moving around, or stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10018648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695322",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Long-acting products: Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696199",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use suppository rectally.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10018649\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10018654\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10018655\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12064 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-2A8E9B1E90-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_11_20661=[""].join("\n");
var outline_f20_11_20661=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F150514\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018644\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018646\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018645\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018650\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018651\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018653\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018648\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018649\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018654\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018655\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?29/38/30312?source=related_link\">",
"      Chlorpromazine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/35/21047?source=related_link\">",
"      Chlorpromazine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_11_20662="Stage II PBC - high power Masson";
var content_f20_11_20662=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F60916&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F60916&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Stage II PBC in a 32-year-old woman with the type of symptomatic PBC that is rarely seen today (high power, Masson trichrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 284px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEcAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDwbW72a8vPtKxCJWwVVDwPpXU6Sv8AxTv2mSKV7jf8yZzkeuOtcmdUiikKbcKvdABxWxopL+dqFtO6bBhRuxz6e9fVQer1O9Si3ozTvLy2nghYPIvltu8pCVA9xUOr69Pplwj2TqWZMkkZwT1qlIS16mCHiZdzKMYGajk0mXVHAiV3jjyHlUfKoqpSfQ0adtDp/h940u7fUxF5gV5ydyg/KT9D0NYHj7UtQHiu5klmkSUnIxwAKoW1k1heMRLmSLAUhcg10Gvaal1ZDUAS6SABnHOG6c+lXzOUb9Tn9k9bnVfDzWmk0sveEgqpUup649a5fWNa+06iS7SNaI53IhwGPrUGgxMkTwyuUiA+XaePrWXe+VAzr5m5c55HAFXOp7oQo2Z1VnrsWmyx7EWSHBfBx8/pn3qrrXiz+1Fkt/KjQsB80ZztribqdHsXjhILD+6eoqvpVvLLdW6W2XmaQcDsPc1kqspaIU3GE1pc9A0G0+2SW8k8rS228xuWY43AZGe9V/FSuskseVEbEjYvO0dua6m2OyyhsLWHe0c4mIQbiTjHOKNX02IWzyXFsxdvugjG160dNtGqqxi2jy2PTrye1T5NqI+4EcZH0rv/AA9crJNs+WSRU+70wB6VyWs36Wl2sG5mVBkiM42n0q3oVwmoweXJOYtuSGRRuPrn1rOE0pWQRgjeh1FY9XMN2XNvuCja2Sp9RXqegW9jeaXcR3dzcXSrl4Qg5PHRjXiKXsdtdmd5EcrwPMXIx68d67zwb4mt7i2usyImGAUfd8w9gK3i+aLVzlrQXOrnRalfPDcwokLLFaR7WbqxbHGR2NcZ4+nvrcW9xJb/ALrygo8sdF/pXTR2s8MVzPqhkSeWX5VBw3Az+IxVXxd4hzZ2iXUSS2yrsIVOEz6mtJRbVkZQkovmPCdX1CS7V4dvyKxYFjubP1qlZ2ryRCdlYorYJA4B7V7QvwoXxNGt/wCGLy28tsiRCduw46fjWJf/AA9vokWNo50aLImXbg8emOteZPDtydnqjaEoznzSMS1f/Ro5LhXZldQspJGVH8OO4roYtSsLrUJWhj8ofKEj2gBTjr7gmsLVtDubGzjIYrb5yMnJB9/Ss6DVrOytriGWHzJXwVdf4PxrRPk3O2UktTrJtPl1OOXdHJHFvPmL7Y/lVWy8CSXNyBsaNHIwccYrY+HN3DqmnG3ZpWlSQFsydRnsK7a7sL2VlYXSRWjSbFwcH8f5V1U4J6s5K81bQ5XwpBLoPieS0tC088SMS69c9K7/AMO67HfwXk92ArlzvR0y5Yf0rFNrb6fexzxpL5j4EkhPOR6e3vRc3CJdmWEK15uJdRgA9Dx7VvKKkcGpq6rq95cSNFYjZMmUMcWcn3rMt3ZXIv7RjNGf4CQS2P4qzdK8Q38evPNGhaZn8uMMOpPAGa7nXfBut6XeWt7ql3ARcPt3RcEP/Cp4qPaQptQbtfYJMxLSS8ubSODzyCXPmI7AH1wM9MVna1v07T7r7KWmujhguMgD1z61tajDqGj30seoWAT5cMSu4hscEMOxqt4c02PU7J47pXF0gLBA2OOxPrVKa5eZPQnfQ8t07w94w1ndcS3sltCGypdiD68AV3reHr7XNIGl317cspixJKxwAeoJ9fpXX6HpTXOkmXMokRcRscgCp73dBbRxXEql5BlET5i9T7RXcU9SGup5TongmPRZWjM0d1fvkIiHCkerVuzaAdHlhvLxIrafIK7EDRygclW9q9V0vw14ci8NtqccXn3kI81/PfDBvxqLX7nRb7Soo7o4uggbydvy+2DWUcYpS5Yxdk7Mn2TerOA1GBtYuGuI9J05HfG6OKQYfjriqs+vWHhK1D6jpjFlbajkEiEgccelc/f27QWc9/ckpJE5EUcb4AGcDmueu/G95aXBsdTVLyDA3RyjcuD0Ga6ZWUeXoXaW5vXmoWPjF4/Eek/bZNbsHUz2w+6656j04rO+K0f27XjewxPBbyoJxD1KMVGRXY/DTT/BXiGxmFhfzaLqL8vEVIQ/j3q34g8MPpjs95Os8Ui/JIykFx261g5Qk/Z9TTDQalzs8ls9Yl03TU3RB55TxJIxOAPatbUS+p6El0uMxkBm6ZrhvGcc/wDbkpw/k52oQOOOwr0LwroF3f8Ahfy7nKsyZVeh74/GppylK67HZ7SLdmZH/CZR6U6RwAsVG1nTHHHIqtcWUevYuoJdiOe/X34pt18OtZglLR2plj++rO2B+Vb3hjwjqURjbMbQpljhgC2fTNW1OatMypTjGTsc3p+h6ZYXKy382SDkDt9a0fE/i/SrnRLnSrTT43YsrRzkkMpU8/WrHiTS7uXUZI9ojRRtHTmqvh3wYWv2bUYgbcLnDdzUxTXupWLqRVrxMvwhoT+IZTvdLe38wlnPAT/Gt3xGZIJIrHTz5kcKiNSQSHXGDwa7S2t9Hto47Swi8h8Yb0DVJZabB/bOyRSsu0lDt4P41uoaWOfmcVdnDeFfCgS9jullJyQyIeNvtiu/+JOvxaFZaVFPAJWjcMybTyRzz61uafBHZwNM/wAk6OCVZBg5/u/pVPxtY23iC/tVvd0d03RsjkfTtRbVKJm5X3OR8PXmn33iO/8AEckszXEwHlwuM+WPaqV/4j1a31UvbCTy2OdoOAD6YrrbpNA0+COysVN1eAj5I1BAPue9X73TEtjYXD6evncjbtwCT0xVqSIdzjte8QTp4ckvJ9NEjBhuRwSCf7ze1cd4R1HWdV12KG1m+y25Ys6QDYgXvwP617O+ky3sjrNJbjemWj8slSPStyy+Hpist0c2mWqTYyYuuP8APas51oQknJ2G6ehneKrOD/hFLHUrOLyzLE0LSMfm3fwsPXmuRsPDt7qsQuFaaGUAbJDGf3jegI7nFdp4vWztks9JluEkigjOZOcKvrx3rH1DxLu8NWtnpUJMiTE/JLwcDjHelTcnBW1u/wACk7dT570jRrnxHezJp0SmRfnMe7nHfA74r1/SNLsdO8PrptrB9umA3h2i2gSnryetQXvgSz8FarLcabrkN5lsxtHwVU/TvXQ6H4llh1O3gu3a4QL8iyjIDVlThHlut2dEHOL52cfqPh23huVF1H5E2RlwpAP/ANasS/abRbgJaSj97nKhuCPQ17l4otEOnxz/ACb5fROn/wBavmXxXqEs2tTxgbFjO3C8Z96ibVro61XtG7NCS+lubgrLOAjMPlQAAH3roLKGUoYFJO0gGMsdrVX+H2jT65LCllZme6LFCMcN9a9ktvhRqtvC01wwjdVyBjv6VC5YfHJK43ioPY80kgmjle2jhVYyMnb0zXJ+JbOQQq8Cbogdx9/avUryye2klhlTy5oiVZhwee/P86wdShPli0aDbHEpbe/8RJ45rWdPQcasZpo8x0nTpb2/RIUcjeMnaQFHevafBHge61GC6aGAtaxcyOgG9/YGsuwgSxtpJk4LD7hwc4Hau++GHjG8a+s9IjjSOyaQGRY1IdvelKMqcHKC1OOcraJ6GdqthqVlNEPD9otg24JG8ihST3znvWh8StHvrPQ7Ga+lhmldA0whI2q3fpXufiXwzaa9ZmCZjFx8roBuX3HvXnXjLwNFJOIYjdmCOPJLZwxx61yUMwhWaT0f9dQikne+p8oa1os8eoSNBE0qud/y9h9K0dBtTp1ypmSMb4nJDt0BHb3rtY47SGWa11COZ54nKGMNgvjoD7Vxnia+hm1D/R4FiVBtManIGPfvW80os7qVrcyKY02a58ueCLzYl5Ydc/SshUuTeMXlMYhb5A/GPoK7+z1C30rw8LqcbSmCGHJbd2xUun6boHitBctI0M4GAy8bj6EVvGOllucdZqUrlJ/Gt4+l21peedKYlIEgwG9M7j7Vv+GjG9sZdRkiaF1OI2z81WbrRre101YY4oZ3YbcnGE+n1pInmtIVeK1SY2w29MJn0HvXQlYxtfcl0+ZIX/cyfY4Q3Kx5HFbFhrEfn5nd3RjgMxJJHpXkmoeLbm6u3zB5JL7fLx/Wu28PTi90Zi8QMmflUnvnrmpTUhfC9DrvFGiwalYzm0RSHUOcjoPUV8++INCu7O+lj2llU5BHpX0t4I1yHTw8euKDbOmVbGf8isL4r+HLW2vjOIl8i4QSRYbBPHHPvXHWScuRo6qclUXLI86+G1hd2tpd30qbY4YwyMSBk+lb/wAQtXnm8EMkLvDKJEkYqcbgeozXNeFLuaxnlgmtt8k6soVwSc9seleg6PoNt4j0KW2v2bzI12tAOo4znNbU7OOpnXXKrIm8LR6jbeF9M1AwR3reWCTI3YjrVTWh5k0kl3PBaSbPMkKjAI9FzVvSv7St9DSygBa1ifZEhIzx05rml8M674h15YxKkkUTFQsz/dz2razWrOTmsjp9DutI36XqVtPJNaW95G0m5PuAHnNdF+0D4lk8VWVjpHhKZriKKTz7maPIUY+6M0zS/B0HhyySx1G5RobnLOsa89PU+9cp4c8J+JtF8ZXGpzOJtFmDgMkgYFD0GOx6VzTp0qtSNW92tuxDlPW63Oj8Oa3Lb+FINL1KUS3bH5rqQlmK/U9RWtf6TpcUlncWd093H5WGKPsK+x9utZ9/BY6jpkFq6tFdL8zSqR8oB9DWG6WvlmRppZ3YFVXdhVAOBmtVTV7x08i4rQ7W51+a3t1itDClkqj931Yj1rOlilur1tQlRo441Ch9mQgPt2+tY624ljRbOeeI28QdiwypwO+eg9K67w5cebBq+m6gwZ51AikAAyMDgH8aiaVKLcVqUk29TmJb261K/t7Vj5NlGcs2f9Zg8kn0qh4y1tb3U47awZRbxpskK+vr9a0vE+my6LDGkTB5pF2MvXaO1ZNl4OvVxPLIvlsd74PzkY4wfWtYuDtNbDcWtCkbSO4t9lwrNC/ysuMMPTFZM3g3TbqNmuxJ5qtlZSD0rsJLaHTpvLiklEwUSeVOAeB159a6q1uItIjimtYhLHejL+YchQQB/Oic7LRXKUbnF6D4cGlRgWFoZi6hA4YNk+px0FenzabY6n4Yht9WuzPeQRFfkGBH6YPtXL6sE02J77SHEYkAWWJT8pYnnFVrjxCmn6fJ5qgPt+XfwCfauerGVVKSdrGsYpaHFan4Xtp7kSbWmy2WRP4cHrXeaPaw6Tp/mCye5G0yOBjMSj+LP9K4zTPFltb6ReyR7Jrwu2WJwY89vetHwJ4lfUXuraSeNfNjCnecAj39q0lqrIVW9rmt4k8a6b4eslvn0m7a2kIETk/LuPOSDV9taF/o0epWum2N1pzpvLBwsy8cjHcV5p8QrHUNU1rVIXdZIYlGbaNwQiqOtYevyhPCelpCsyXSfuvNQ4Tb16dzVrDppS/zOBVnd2PVNW1Cx1nS0ksbO2ZUwGEY+aP1FedeJ/EUWmXb2iJ5jrwWHAA9AKs/Dq7kg0u7YbJPnJiaX5WbA5PuM9K4P4hmX+3bmdcMJMEyIcjPpUVv3UbQPQwzvHmkdGNajuszQgCZDnaw5FdTpF7PqFgrSho2WQYkLgYBrxnw8WbXIIkc7HbDMT1WvefDGnWsWmb5rmO2cvwk3Vl9hV0J3jeRliJfym5bGSTRBLs+0XO4rCoxuGOpPtVfWdOTXLuCU7YWTajlSRk9yPStOxvokZBEu2NBuDKOQPSqOs69DpUUUtvszCCzLkFtxPp6VXvKWiOfmRz2tTDwbKYUtUkCZf5h8xOapWXxGfxLf2tnBayM6nKMQAEHfP8AjXU3+v2njDSo576zUkt5bhuuPwrmrjTNO0S3ubfSV8m6m+USHJO30PtTjd2c1qjRJvY6HcsaSme7SVkUltkmMD0z2rzWPxDr2v8AiOSJZJY7ESAIisdo/Gt7wbo1lrsD6ZaalbjUHO545HI83noPpXY6l4fsvDiQRRmPgElgOh9MUc8eZRvqVZyMfVZ1vGeGKZEbaI/MbnkDnNN0aOys7b7Q+JBvw6DqSPSluNLR0/0SbyJZcklkJU5qCbw2I7RrnUNZtYba3IaSOPOWHrk1o2loTZmJrlgsOmPc2M4V4myFf+Jfaq2kXMtzNFdXuI0jULuz1NZN5e+ZpdzG8gkknxsGOU9fpWYut/Y3FvN/q3UBwP51w+1tK57UqUUj2bVrppraygt5GY7Mh92RtP8AWvK/FGg2l3ch44tkxyGIBBJBq6NZkuII4LK7GxSNoBwcn61BdajcozHULtlkUk/IBz+NOo4vQinT0d0ehfAqGPRNWhknOIo0JKMRwT3rstW+LdtP4hudOS4jjRhs8tmxk+x7ZrwTw54ptLO7aF7hg0/ys7ngelUPGVhOmtwXdpGXjlC/vBzzmh0KVSSqSV+h5taPLflZ7f42xcS2+sW8P+jyJ5c6twY39fcVxl7umzEpDx/eBIwMexr0u11CA+CoY72KN2GFw/JJArz26ngmuYnuwqWe8qVUYwP/AK1bUk0nFrYzpzb1uVPscl0FiRQyxY2oDkn6mvQvBfgvWV0+TV7EpE+Pl24Lcdce9cZ4U8eeHPDmvjFo82HPzTDhl9q+n9L13S7zQhqthIhsdm8+WvI/Ad64swxVSgkoR0fX9C6bvLU+ZfiT8UvEOj+KLCz0rzLWaGIJKZOS5J56171omrXV74XtLydzKlzARIF5KP0/EV5zr0uhao2peItahhuprWQm0Rotssij29BW18NPiK2t3NtYDS2hWRtqZTaqJXPXpc1NOMNVuW4uM+bofPXxXmubPxBf29vKwYyYZj1HfrXG6bZzT6lBFHDLukI3KCWz6nNel/FTT7tviHqjXKcSyeZt2jGKNCgkgt5ZIbVUVsKHbjaPYnpXfCHtLSZUZWi23Yvaroel3fh24sjII5vK42ruKkHg15tpl1P4Tkj/AHkUwM4fIGcqOvXvXtWmWVwLd7V5rWGEPlpN2ZG9gK5Hxf4Rm1tFj0C3E91A/mED7xXuD710NJO63RyylzHSQ3Vrf6aby32vaXC5YY+ZGxwfaqurabeQadBfypIlqMDeikovsT0zVvwNZTaN4dbT9bsSiyRsrgHn2z6VqXGv38nhi20V4fMht8FlI+XaOmfem3K65V/wwuZpJyPKfGel2GnxxaiYpJnlkysKHCt6k45Fa2na7a2umQRR6fMjFR8u7CjNde2ly/ZlvLm2aFWG5JGIAx64PaqzyQSWxtbjTLeQk/LKvApryLTv7xb00RXcHzKxtmTKuuMj8Kz/ABiJptKhtHlM5j4Xe3zbe1XbaIQRB7RmhCsFKAhevf3qzd6RYbWlu7nZOfmKM/JpTSe5UJNPzPNNGt5tPvo3lWRwp6E5yPSvTtOmOmm2uLeV4XnU4xjaAR0x3rAlsYFmlmtngdE55bgCtawtZtWlihto4k2L97JOPpTUIxjrsTOpKbsO0/7Xd3XlWsRnRmLELwVPfiums0ktIzLPbGOZnO1iu3J7ZqjZeAHaZ4o9Rmi1BozIpUlfofpT521fTNQj0bxTcy3SHa0Lpj5h9axnVjOXLF/5ijTlDVjfFy79Jjnn3GWZiFOTww649qxpNWutI0mO3tb77RJK24RbchD9a9C8WW2mXVzpFvbs++OP5t5wqjr+ZrGn0hLy3ubi28uO4hJ+6OMeuPWopVouC5l/VynG7Me10SSe3S7mnXfOm5kDDgelZGrQW8Lx/apF2lP3YjPzY9MV1Ok6Tf22n3F6oi2RruO/1HavG/El/eTasL2W5/0mN8bABtC57Vqp3bV72KUUkemK1+0ItUUQxzqI/MlPDDGcVBd+M7Pw9a2cVzbh4wCpAGdxzyRWdd+IGk061s4bdlZk5lkYnr6elcr8QNFurmKzk02RWkijKFN2CVPcHvROOmw99TrtN1qw8U6mbh5y9uH+75mGXHQYr0CTTJ5B5ce9nCfLGjdV/wAa8S+E+gGG5mn1WGSOFoijEtjnjn2x616hZajcaQvlW94ZJHXcm45ORxgHvkYqZRk0lHcm/VktxJbuWzCpJQKzSfeB9M1Wgzcac8PmIJoiRGrPj6gVjFtT1OaZVjMbHJlBXB/Crdk3mWm8kkRH7zDmtOSyHGab0H3LTW9myzI4VwGUP2Ncl4zubyeytVjiUxA7TjqK6+8uZL2JVkWTyo3XLYwPpWTd6lpMsp0xJVmvZXztReFGOBn1os2jTmSep5Jb293aXFw0pBjfkxqMjPrWfo+q3Ol37SpLhjwV7YrrdQR4bxlnlMbICBj7oHpXneonOoSBtysWONvSuWb9m0bSScD3fwzpXh7xhbx3d5rh0nUAq7gw/d3CjsT1zV3xZ4i0rQNLFvBZWepQwufJluY8Ic8fKOp+teLeH7m4jMc0bfPCR+7A4eui8X382tNb/KxTy9vlgZyR0OKv2jkm22/Ixhg4p3XUxte8VXt5MNs0RgxtHlR7AvsB6Vd8OaaNUhmUSokQRnInP3iBnArL07w293GZ0ErRKRvOOAc4rZklTTYoINrkIMSMB19qxTbblI7YQ5VYn8P6TBZX5uGjVXH3Ex+tej3WmJJYWlxLcLAijcDMwJY9SQOuDXk+l+IobK4djJGvz8A85Ga7bT72HU5kvIpoXuU+VUlG5NvpXZQktkzgxkW17up6LpBtrxY4s4VsFGAwpOOa53xZaLLcXNtJbQlyAWdfvba3dO1JpmtRc2kUCKwAKHIH0rb1Z4bq4+0QrHJIpCshj5I6U3OUJ6o4o6rU4LRXj0yNUiWRVKfcdc811Fhpy6lpzieEgFC0JY8lvQCr8lno9ne27GyYYJYhyT71DqOrtq11aLYtDCYZCQc4VB9O9TKcqnwr5m0ZtaM8L17Rb3w/4ht9T0ySRXjm3lU6xODnp6V6LfXGqeOrHTtTmC2piIS52fLuIPX8RxWjH4de51F7lbnzyr7pFKdge9S6xq/2LSzZRyweS7/vdke0E/Wm0k01uaKHM79zPmuIYJVJMrQoSvkhsbhnkGqmu65p2qT7DaRxWqqAIXckDHsOtcrcazBHeRxylmti2HUjnis4askYbMaiEkgDrx25pupG9zoWGdtWc5c39zZT/wDHuUJG0M4yWrOurC7uZTKkD7CMnA4Ga9E1V9KvdOY3GxZlBUIoy3tXKXO+3sWjimkWTblg3RgfSuGpTl1O/mhLqc/HKLeQhievzDPatGe5luIwoDeWybV2nOfTNc9cYa4fLfL0Fauj+bHASobarB1OPSueNRt2ewoT5ny2M6GxuXvBFHA7yMcKAOte9eDopl8PxwXcKvIqBUcgFd2OnPeuY8Hqt1JNcMrBWXBO3JB61678JPCp8QLdXN5JJHp8Eu2JF6M+OT/SuyFSOHpuU9jz8TSjBpxZj6DqMb6XcRalD8wkL4HRcdK5/wAU26XuxbUBYvvkLxwa9T8efD5LMG80+doYCMN8uQpx1PtXlWkXcdx9oSZw8kY2HHTr1rrw9WnXjz02cDUqe/UyrfwVHexNK9xiOI56Diu+8Ha9eeG7UppBWfTVASWKaTD++O1RaPBZtBci6m/dGPAUAgnHrWEbSJhFJbBwoyzIegb3pyhCd4SWhdmkpHS60+j63ZSy6abq1usksj4PPtisfw/c3Gk31s13cOrICAdhXafT3ziuT1jxDb6LPGq5ad+WA7enSutfW7a/8C3Eb2oWeZlld93IweoPb6UnTUY2WqLVSU3yy3KfjK5m1DVZNSvGiRpsLtPRQPeufu7K11CKLydSD+Ud0sW7g+nHcVja/q7izJTa24bAme3rg158mtXkErGGQqN3QVhKvGm1HodE6aUPe3PorwtbWWmwwC4me4CqRJtbr3GPSq+s+KbPw1dfaI7jybl/4RzuU9K888OeNrqe0lEyxGUKEGR1zXGeLbq4udXkmbO3jGOQOKupVilzbmCpvlufTljGviPRP7R0udLt5v8AXqr42jvnnpUyWWlRaNC0d8WldMMiDcevOcnmvn34Xa5d6dfSKrubeQYdN2Ax9673xPeanc3dv/Z9lMlu4Ul1i3J79OlKK59VKy/rQOV2u0d/4h1yztNMgsLu3+2FgBC2Ogzxhc1hzabcXEMc1lbSyuzApGq9/oK6/wAKW+gWtgupeKpIEMChYhKu08d9vXmuH+Inx9itpJbHwdZpbLyGnUAMfp6Vg67pycKcfVvb+vQpK25n/EvwVrE9tHdHUEguyo/0BiVYe4A6VlaZY3mjaMk2tXSz3AU/ug+WUdh7iuX074hahdNJIUiFyimTeclnPuT1pwn1DU5DcStLmRd4GclvXHtVxqu1k7s6qWHjK02MvdcvJJCYCRGpOeOOfavSvg7c3OoTXawRiS/eIom88bscYrz8+HL14SweGPI3MkpIP1r0X4Q6ddfaoRp/lpdA7jISQpx2pe9yycn0Ctyq1j0u00jxiqNJrk9tC1nbMY5YwrGRR/CT2rzi78WDUNb04C2zDYjazSsdzMT6V33jDxlc6dPexaxFLavJb+QIx/q2H94HqK8X8OalHHrL397FFc+W+7B6N6E1nhIya5qiXlYymvdsj1XxRcLcI81sm3y1+VgepNeSWviK/sNXdpZ5Fdm2kMxII/wr0zV/LGjPfK2UuyPLgU8j61wWoWy3GVuIB6g4FddPSNkZOPU+gPBl9ZeJfB4VI0HnKd20/wAY9favMr/wTp81ytxJCWdpcFVPp296v/CzVbXQdTVb8mGzkh27tp2xt2z9a7nW2TTYY9VtWtZbAAPI7tuzk/w4rz9cPWlGO0tV/kawd42Z5zfaNZpIYnVrQR4ZVYdfar+uaFbtotm9jbq0khXJz0HrVjxJryeIpJXgsXijjQDf0OOxrH1RtRh06Bblbm2SIhll25DL2DYrsi5SUXLR9gfkP03TL2O3nFvaiWRTtKlsYQ9T74ri9dtr7SdQOoRB5ERtkYZssB6/SvQv+Ein1C0WC3EaeWArTIoOQeDzVC9eNwsNzbGdCMKQfmYe5rSDnf3kZzaaLnh7xdHqNjvvrPymACu6HB3etUdXmtlgf7IrsZWO3nBX6mufMi6PaSSxsTalyzK3dR2pun+IdPvdLF0IT5khO8N82w+1aRpRTujFz5dCDWdclttBaxtFZrs7mYbs81geA/B99d60l4JEa5B3IJyVErHqcDsK2be5TWIhBDbqba3fcZQu2U5PT3zXUtqtx4cuI530lFlKBokVtxkX1PpVTTivd3M1VU37xQv9LgkvZ7LVoorS6jGNqtuUt2wfSvM9f8DvBdSvbtvB+bJPGe4rqv8AhLbjxH4juVksv30rcqoxtx6Gu1i0pLbQY2lvLW7kcEvApDuvPfFYzpqSXPudVKuou3Q8KtdKlQoquAS3IU/dHv710cmsWmjooZ4ZRj58DkH0z3rrL7T1mmaaC0SFip2hRlSemcVwd/4W1CW8G/Tp5Y25IjGWX35rP2bhojsddONzV07Vorx1jtzHFYL8zpFkZ9C341jeK8wGdmKhZFJRscfhXTeA/A95NcyIkARZOo27nA/kK3tb0CTT0Npqtmstsw2ru7ehGOlKUbrl6hCunufPUjBVAC9epNbHh7XW08+X84B6EGt3VdEtoL90KxBV+71wT6GqsWiRyTGR8RptzsIz+ANc0I1IzViZUXZtM9D0PxC01nDHcTEITuAHGfxr0e91OOdbeSBzFsUZ8vqwHvXi1hJY2vlxmGVpABht2QTXaxX6S6XuUsQo5wOh7V6jcJ2fY4Vh6kW+Y62QprV6DfzXEZwAE3gFsdvpTpdNj06OS5WaJLRCAmXBkJ7jHrXj+teJbqG5zIMEAbCDz+FdB4Y1E3/kvdKobDOSWxk1F19llKhJu1ju9H1630tmit4LuWNwDJNNGSGOc5A6gVwPxB1NZ/7Ru7WUx4YYBXHJ/wBk9hXPeJPHd4urTwWMzQqo2725Ax2ArMstcOslvt2HLYjdFHDf7Q96wk43bW7Oymox9y5zwvruO/WQ3HmliMn1rYvLnFmxmiYuUzGU+79a2E8IR29yJAmxShdFcbsj/GpdatVhCkjgJtCL0IxyDWTTSOmnBrRs7vV18N39rPqNhslikQhHhABDf7Q7V59baLe6xM623zPDwyt1ZfUCvWbb4b+H9Ie7n0LWmnsZgQInG50rq/CPhrS9J0W81HUr14BFE3zgBQV7HJ9a0lXpqnzO55kHJWPn2HwnB9rjS9CNvH34un4jsa6ibwrBa2EUaxxyiU9mwVFK/imym8VLbtZo1tO21XR+OejAd/etPXLaeymSG3aAyFcvh+i9cD3qvYwSukdlOvd2uZ1gq6f5ttYOYoxwxxk+mAa9b8D+I9K8M6dbCa7mS1VW3Qqu7LHkua8Rt5U80yRFiyk5w/zg9/wrqNLuLGSPy7lHkReX2ZbIqZ0o1ocktjOvCLs2db8fvinaS+DP7P8ADU8zTXLBZJthAVcdB715h8JLc6rZMLpHZYSTJIBkla73xRpfhLWPCUUFvNOZUbzDJKQuB6KBzSfDXRbLT9J1GC0lZUxjdn72R1NRhqccPTfIml5nJU5ZzSWxgT+KNGh8Tvp1tcO+weW3mLxn2NblhbxahE8FmqLcgtnB4K9RXkU3ha9s/Fcy6huSF5jKkg5Egzng16poFwslm8dq0KSBf4uCR6V2RbcbkNanGaj4WfUdUEz3CR7W2yZX7o9q5D4jak4v/wCyrG4YWVmoAOceYx6mvddLiii07UViVZJJoiYhIe/1rzK58EyXc0cuohYo5TuAAzub0rOrdpxiaU4KTucD4VtLvVdUt7WHdcySsF2Enp9a7fxH8K/sksTvK2nySjPlS/vAfow616J8NtO8PeGhqmq3FuitFF5cKYzvJ4LZ/QVr3Mqa7BbqALeweQ7dzbsDHJJ6isI01zcsloupUqjSszzbRPhebW3huDci4jLfvAnBFWPEPhq2tZISUgN0RnhgSR7jpmu9meyuWFjp1z5MMQ+dYfl6d6ydcstOGpWRljnhuHQZY9D7ntXQorZomNRxeh5t/Y0NuiMs4D/M3kdC1btt42v9Mtvs6XCRxqpURjk10vjDTnkt08mBNsYDGXI59a4OXQVnupDaTDYdjTZBYKD1waxknHSJ6EGpK7MfWtev9SlcXMpMbDBUnOKwdL8JaprF/wDZ9PtzNIx47CvVrDwD9tBljl/0NBuNxPwAPQev4V6BZaOmk6YF0yGO6VoxtueUHbIyajlTfvsxrOLVkeRQ+A7XwnZRX/ii+W0nmO1IGjJz9MV6l4V8JjW9NtrnS7jTIrNxiNgf0OelZviXRoPGEK6fcxSy+Q++Ewtkx+o3HqK6HTPh1LZaDYQC/RFHzfZw/Cj1J9aqbVNWbSfpc5eea0jsGteGNE0zVD/aOtxXEhjH7qM5II9ap2WlPHHcXeh6m1tt+XakgDYPfBqtrXwYXUNfW+tdZEdjNtMkDP8AMvrz6Vq+ItD0jQo963LuissMIQ43nHXFFKtGSUOa79DGXNe7RyXiWG91kMmoXclxdJ8m+QEll7YrnvCvh+WGbyp2WKZn2oW55+leg2D6fcO32K+jlkBwVfIKt7H0NVZbW6/tMObdDPC5YwnAb8fWuiyWi0NIVb7lm8mWxgt4NUZJrOL90s0A4D+jCuU1JBLqCpb5KnGcA4x7etams6Xquv3ItbS2hsxkuedoIzyTk81qeH9CW3ZEe8ffAwZ2dMkn29BUKSjudL97Y8u8Ya/q9jMbC3tLm2hU5kmaMgv6HntXX+ANW1CbQDaaos32B5ElDzKVVsH5gvbuK9t8ZeHrLxDodld28tsbiBQJPnGCD2/A81xXjSItFYaWrzTxpGQxRQFXIwDgdK56OJVbS3XXysRyO97nnPiX4tyWeqTWNlZQNapJgF/416YHtXW+F/EkevRWshhmkt5fkktVGeAeefaucufh1pWqXAaaaS0nGA8YI5PcjPQVraPBFpYSx8MwSzzwL+8ud3yLzyT61tyqzQ/eT1ehs+JFsrOUzaZGlqZcBLcPkn6qOlZEV5cpqg3R+YAmPLHAX3ro9K01Gu2uJGeW9K5llIGF/DtXL6srJrLJbSlXmGGdhwuDzV02l7pM1pcv6wDrFkYGsl8mFQruoB3A+pFLofhe3eyu7OwXytifK23PJrS8N6hHaaeiQ4lMrYljfoT6il0mS4ttVkkt0lS3ldmmGQcY6KMdBihuSTUdLbHNLWxU1HR9G0fQDDYzE3yyH96eNz+/sKsaPazyxW90s0XnmMxMR8zY65waj1r7JqF/ex2qyLbxKGXeMKxPX3zUGkPFo+mXf2aF55SMrOCQI89etCvyefn5k8iTuinrvh6YeHdSXSIit80bFJI1wzHPOfTiuK+FOg61pd5cX16r28EkbIVlPL+pxWLr/ivXbjWV+xXNwih/kEeQzHtur13fcXfh9bhwVv5IlE7kYXA6496u0k9SbrZFfSLO7ur4QQplpDvhUnOAf6V1z6JOkTwMis8S5mlkbYv0z6VH4MNvpEq3yAmREPMp5xjpXAfFL4nvY6tNpywG4SRf3i+xHA+tc85VJ1Go6JG3NZF3XdIu57aW60u6LzkHbEJCiR4HXis/w2NX1fS5NGvL6MzRjzJ8ruYgngBvWuU+GmvTXWut5E0i3JY/6LMdwKnqBn+Vega1qNvZzF7kvAC2zyoYxgtn+I+mK6ld6LXsYysveeljnfFVvZ6RviuIg6ouVI689z6158+qwmdoIoUBPIfHJ9q9b+M+zUNL028tYltLVbRQPU+5/KvnY35jlzIPMbJw/qK4Z1XZNq1z1qM4qOrOxlaaVkaMtuxkIgxiuq8MyrbW0qXpVo2Upt5ye+fYiuY8LGZiJo1MysnykdQa6HUrYRpG93ut0kyxVjt//XWlNnTNJrQr6hpls+67Y+arOAm70/pVS2vYI/MiaN4kHACpu5HbNWLfU1WUm3iPknCpnnd64FWNY02yvhbPoUd3BdtnzkbODnrWiUdzGXMlocvrvh5bh0mEUkLyKGDHgP8A/XqLQ9KEUkZYhYwx3yZ4GK7U3sWm6ZFa30XnI+UQMMFSOuD2rjtc1M21qBFGcP8AuwGUYI+tYyUYPmNIxVuZo9J1jUIL6y/0OaN9sYVQBhgcY6+lctAZ4bd4kby4HIOJgGwe/vXFaVq91HcBWBwzAAj+VdDeJLNKso3DOA6kZxVKopalRTlsz0bxj440vRtbkht4pHDjKlFwAvY1l3/j6G80x4t88xcBWhfgY+hrE8a6Xba5rQfT5nE/MbxyjCgAcYrEbS202JGkmDtKCnyZJULWzfKtjz6dJzlpsaMesQ+d5Vpa2Vjt48xEy3/fR6VLJftdWWXlWSM5Usr/ADofXIrhNbklESrhlXJ3An+dZthdyQzAW+5Wzg4PUVxvESbszrcaVKXLY73RFvHuPs0ZjAc7i0pwSvoPeu41S41HT9NVdMSMDd+8ZB8yKR1+gri9PmF5aKgaOKUKNoIJYEdea30lZWiUyyoMYbnrXVSkpIjEUpR+HVFXQL6dblra8k+0FyWaRFGEU9wa9A0LWYrJfOeGOVWIBXP3wPX8KyJNNC6bc3C28cUpiwGXneO9ZNtYi40yOe2mZ7hFKk5wOO2K2qNNWZyUaV2dPrn9n6jcG/treVQUZigOQu3rg1w3hfxRNq/iEoypHASQwQcgA4rqtNtJX8PTEhlJYxOvQgMPvA1563hHXPDt291bBGjZeNrZ3A+1SvdslsRUi/meviY6cu8Rq/G1UYZ+hxWfrDCU5aMpP0eNZvUdQK5zwi+qJaCfV9zSrOCFkPKgdOnvWzZxs+k3lzcKUnkucDHLOc5H0pyVncuiuZMq6m11PeQWcbRw2iouxSMKze5q7bXloskdnYSiWUhvM8hs4YD7o7VFe28FzYos+SXTkGsrT9Mg0uZxbSneBvTA4X61e5k9NTkIfE5sNbnGoWzqVkKuQ5DYzjpXteg3dn4h8OQyxOt0ygxv/fRe1edaJqmg63q7ab410V7iRpNhu7Zts0f+IresdFfwd4naPw/fm70efHls/DKOwb1rBuUnyPdbMh+67oT4i6rJZ6GumSMw+YkzDqQOg9q5jwRJLe3cSRF2hb92w64+tVfiPrttDr0ltep5hJxMo5wPatr4W/2eEuJ7aN5YFVpWRDggBT1PbFRb3jsjUUYWHePYvEVlPGkUjSaZMP3XlONqY4KkdjWLP4wvfDOmW9pePLe3MiExxyMdsAPf3NegP4jt7TwzY6nJpqapatL5W4fLLA3bPqD710ep6Zo97aW17e6da3bXcPmQiZPmjHpx6UObWljF2l1Ob+Gni+DVdGkku7BYGgOGkhbDvnv703xzbXeq6aINO1htPukJyrMwDp2BI6Vom606Dy7fTLKWCXb95MBIz64rtPA2qW0XiyK0v2Rhd2uF80D7+en4iorS9nF1FEhrTlucb8ENBktIbiTWNWGouSCttBMXXPue1XfEOt2aeN4LW6shPYRN+88sZaPPGQPal121sPhr8V1k0csLTUojJLYn7iliQSv481LoumAQ3z6hCr3VzK0jM3VFPKr9KiDU37Z35Wlb+vI55pr3OqI9a8Ny+EtVSexjjm06QlwcDDg9vrTPEweewsrq0uFkus/u3PBkQ8bWPqK3LSCW8tbjS3ZyY8TQKTnB9K5bVo7jTriGxuE+QElR1CE9R+Na0m5NKT95fiio2jtsVJdNl0q4t5rp1YSDruJC8+tbmn3EbSSGW78pDjbtXcWJ9farCtC5sfsyrIx2qyOMhMHkEVa8U6NbXdvI9vGq3kjEloxhR9KJVE2lLqdlOzXula9tDIHDW6RMhLB1k2CTj26/SoZriwtdNSS08w32MOwb+L39a4b4gWuq2VjEY5WmjQ4ZVBx04NYXhTUtR+1m3kkVHZcKjAjefYH0pxgno2Xe3Q9m1WTQtXtVGtX1va6ukICbE+9xn5iO9aGmwaXP4ctrLR7VVd2MckrKc9OWz6GvKbu2gSeSW/ZZrgjIf6dq6HRfFttZaXHZwwXAcA7fnDAg+lZTwzslFvfboNPXU6u3tY/DovHuLkmOAhS5Aw+Rn864K4N7q+uytbW6mS5I2QoM+Wn9K2Ly21LVtOjbWZpbXTxl44gPmbAzk/8A1609GSHS9GurzKR3k1tsiycmNSMD/gR61UPcTk9ZbGNSV9FsYc1jBZ6Nb6heTCJkdh5ZPUg/yqlq14mh28N1bXkgWX95IYW43HoMVW8Ya7psFxFpseXjjjWFiBx75Pfmq+lpHdXqWNyCYYirEHhTnoK6oJtXkYSlZWR1UWl3s9rbTXE8Mt1NtkPOG57n86p+J5buysJbC1eOS7chAA2do9z0J9qtC1WzDXl488rg7VhjXcwBOAfTFbWh6fDYWtxe31n9s1K4cG3jTkQL7nsfWsZVeTV6/wBfoS05LlRytvYjw/oxgvZI31C4+WCbyhtQkdCfauh1aFrXQ9OtNgaQr+9K9Hx/FTNW0/WfENldWywRCRZRciMEKSR0Gfcdqy3uJbq9jh1gLFJHGHmUHAGO3HehPnd29VqyYQs7F8xTahZ/2bA7LcNIcPxhFUdRnrXJXk3h6bxKZ7zSX1Wa3TEskEbBiR/FxkV13heSK9g1IPEWXDJycAIe+fpXEeHPiVdeCdcbT9P0+0NtdSZkuZQTuXOMBvTFEua0lFXf3b+Zb0eotrqHgzU/G9lqOj6bc6ZfRNkbpQUkYd2GODXV2C23ihr6XVI7dLaBWuZgScLtJ4Pv9K5vUrG08Q/EGO9sILe306JRIWthkAg5JJ7mt2/8U6Df3k+gaTbT5lXM1w42+Ye4A9OKIxaSjFO7+dhTko/EZnjjydW8KhmcBmUxLDGxICAfKc9q+d5bSeF3ilt3Lg4HB4+lfT+heGr/AMSySWmnQxwWluwMrSvkKMdBjqaluvhx4esbuRNS1ObeieY4VcfUAd6yrypqXInqum510I8y1PEvDc0mjaGA6H7S7llRuAtYHirWruS9eKWZnzgkk5r2Lxn4XtdGuIpdNd7uwuo8BmGDE56A1weu+Ab25uWutN8uaVeWiboeO1Q7yS5Tvn/DtDocjomoSrdmCRi5cfI3901774GvI7jw3JqGoSRwRWgO6UKGZyOgx6149B4Sl0krd6nJCtwSQtsrcjjuf6Vs6NcXl/bR6fbyboSW3IBhQB/Ea6KcJWscvtXHc5nxp4knvtWl27hCHyiHjA96dFHHrGiq+yRpIyQQhGQe34UnivSQtwSFG9V5dDkH61a8GBtPmG4Eq7A5HOfaufkfM4yN4TlJ3+yY1pp0kdxEjk7g+AuM5P0rodQvDZxpDcgifq3GD9DjrXq4a0a1P2WztEmPziUqCeleaeIPDeo3N2Z7aJ7hQOQpwfw9ap0nBaHRCcVsVdItNQm1+eKa5dEjYtJLjd83tV3xDMLJonguHgiLAMW6scck55rpGuvtDRwW0SxlFLs8OAWI6jnvXEfETT7+E2lzcROYWXzFB6qCeN2O9VXbiZUbRptoq3E663JGheMHn96BwfrVW28PsmoMJHRkjcBjDzn3HtUXhGzuru+f7LCSjZD7h8oH1r0Oe40DTLaG21DUGjudvzfZ49yj2JpQpOauzP28H70tyHTobSxslVp2GSWXzUBJ9qn2KdOkeMBJt3yE9T/9am2ktnK8k+myx3yKAdxX7n1qxbvHfQNE0BilOQCo+8fXNawjYudZTXulvwbqWqXNpPp8+bhQu9CRkR4PPNMS5jtpHs4XiZ5j5hAU8fjV7w5arZaDqVgspW4uusoPIH19Ku+H/DWnG/ju7u982ONcbFwAD7+tbuyvc82LcdjY0TTri70m5igiO8RtLGM/fK9vxrzXSfHRlfUI9WAgaEkKgGcYOMc+9etw3c+kzSfYfKMTxlSy8svpXm3ivwNo2oeIFuLa/Nn9q+ZkkGdxPU+3NQubm8iJS8y1oOvLr0jRRQDcI2kEqsCTjrx2pk2qT2TW6yxsrjc6/Nnk8A1t+DvDUGjxasLO8ilZISnmY6L6D61y2r6/b/bEd4AI4m8vp6dj+VOUrs2oNpNs7W/ljkjtWgiRGMADp98Fu5H1q34NttKGsNJrUY+zPFnJPBOe9ZnhjxJZa0qxxognD/IBznPHFZ1zqksOr3VtKDb7MxsqE4HP+NKS91w2JsptNGT400Oym1iW906SOyKuRGoJywB7n3q1pMl/cact1N8qKdinPBNcLB4on0/xBJ/aswmt3Zkcbc7ecAj2rRt/Ek0UDQWzGX7ROBGc4RVz6euKIVVsglTjq2cz45SRfENz5mTIdu0n+LivYP2edGkn0/W5GjXy5oGgYY4AIwfxrmNW0q2up2jlhDyH5iue/wBa9Y8HaS1j4dikspY4oJhztOOR2rKqvdetrkyp6q2xyyaJqWiXMrW8H2mxgQK7RkbQuOCV6596ksVvbqCW/uJWSGdikYLEAbfQenNYfib4hS6Lrr2dvHukPFzngfT3r03TJdN1fwY1xqUxtIbdfMjymA2fTHX3q5VHBJy1Emm+VHJ6fbSRX7RIQzhSW2nftzim6nZTWeotqjeZK0bq6E5Xa6eg9KwrvU7mS4mOnypb7FLDa+Bt7ZPWtXTPGV5q9klvGP3tsmH3ruL57/StXzX0JaXU6/xPeaV4613SLyK7t4tRht1Xyi3J+bLV1GsacYdXZCXSJbdC20dDjrivDL3wnqM92dR0WGRlMq/uwf8AUOB1B64r23Sb+6eJ49SiZ7oWojmcdQ4/u+orz6tP2Kiqb0V9DJ6y16lFLm80+aCa1AdzmJZXwQ3Oef5VY8Rx/wBohZ5ItkzdMj7nriud1r+1n0FbKKNEe2mANwfvFeo4rqtMvpp9GittTMc0qcKyjnA//XRNcrVRLXb5FJaXMrUIVs7NNQhYC5R0d94wGHQ1ImqyTSzwQyxRu/8AqV7E+tN1S4lttLkDgyxRt5isV5K5/XFeaXDz6n4rby3dkHzRqmQfwrWnT9oryNYStseiazZD+wdxmVpYwWkQjGDnk14emn6vN4skvZyojgJaNW+Uuvop9a7fxZ42GjRW+najMwmIG5duSR6k1FbTaXesLoXsTKF+RlG9lyORjsa0pwaWpvJqT5bkENvJd2zSuoTHJD9vY1p6Po8kWlNqMsQ3vKFjIHFTWEHnFFklEdqx3Nn5Wf8ACup/tgNpCaRp9m89tG+fNK4RT9e9VOUlayJk7Gfq11M9nFayXZb5fnz0x6ZotoZbGONLxVlaT94UAJeR/wCHnoAPSrEmix2N5Hd6vdK8zKAkSdBn/CrGpQy29mXjLy3W8+ZKx+VUIONvvUc8dIxMkru7PECsh11ru53TQ+bv+X7wO7lMd69C01o9e1JZZbZYmDfek4KqKk8I2tnpU1/qk9r58yZSFZONrZ5YDvirelyaPPdMHDNDNlpW2/qK3btfQh67F/4na0dJtIpFCC3mVIdyuMkDsD/WvXPAttBN4LsTFYLbiWIEK/3m/wBonrk15KdN0DWbG1tN0ohWQPEXAySjA4A9+eK9kXxPpkdpGLYzTPgKsEcR3+nToK8LMeb2cKcIu9zSkrNtnjfxg1W90XXdF0m1UJJ5T3ErIPmbkgZPoK4+G+V3upZpd1xM2SMZZR9K9G8ZXUGua5eTXUQzbqIUKc/KOdu4deeteMX9jd2mryuq4iGZfMHIZfTP6V6uETjRXNuEbSnpse0fB61tbm616yuz5iyIFUE9iMHp9a5S30aDSvEV1ob6XbX9tbXG6I3GOA3OB6is/wCG/iZLPUZRZKY7goSASPm5711nioSXF89ysCRTHZHKd3zZI+8PzqVCUa8m37skvvRnUjfVdDlvHXxD/sjTEttI0qDS9RWRl2xpgDA9+tc/8PvC+t6tq8nibxHcFIAvmtKW+Zyc4UY4Fbev/wBktdyJqcAuvKICNI2Mcc81t6vq8+urY6XpcUENoAGVYiMKvoTWvs3BJU1buyVr8Wp13wcv4bcarpd1Lbq7DzoVL/vJAeT19OK8O+Muv3kvip7WUyskeUTaSpGT1qxrGq3mj+IGihuDHND8xuSoJHsPakvPFln4qgtZPEOmwXFxE+x7iPMbsP8AaI61ksPyVnUWvMdUNY8q3NbRNYhi8CXk2pSuyKm3zJOu8dPrXC2/i+Sa7AcyLuICvnH4EVpeOBNfW0dhpFsI7GIDy0hGQPc+prC0bwlPLcJd3m2LGD87ffI7gVuovmNJ1GklE7AR2FyD/aIMjkbijchT1psws4rBU09obONiGkfGAO5FatlaWtwY4QyyKUI9M/jWB4t8D6pqDRm2ceRHxth+bj3HrXTdRWhwTUpPXYdCtjO8iwXVvMi8NIFpIbe0tJ3do4zIclSv86gj05PBOkXkjES3YQHcy9z0GK42HxLqUV2wujDLFI/KcHGe4xWVWUd2dOHfLodW2sNAeAzlGO7jqO3Ndh4Tv4tReJJVHkudvJ5BPevJPFt3K1lGYZGMRPbjGKzvCOvXem6rCyyO0ZIBUnOOeorkVf3+VnoSkoWjbU6Lwzqkd9OtrJvV1Yuu5/lUH0ronkvNSP2G2hEzkbFB5D/QfrXMeBdDum1ZVhjikuGUkBzhVHcmvSPDkqaRrkKPgyRyKwnT7p9cVUPeIk5wp3Z1ng34c3Njo6Xl6kVvMsZZ1mGFRe5wO9ZEHg3wt41hubXTtTibVIN2VgGd4B7A9a9t17TJtS0sw32pLCmoL5UaoODuXoa4j4bfBSDwrqVzf3dzJuIITY2WUH0xXAsenCTqSs+n9dTjaaty6nAfDz4P6za6reRTwyxW7A7ZZAVzjoMd81TnVNH1Sa1uiyxrIUKBeR+Br6i1a/tPDuiF7m4k2RJtDH5m9K+ZL9k1LWbu58xp4JJfMZpR+8IrbL8RUxDk5K0VsXJ8i0B5rO1sJbiVcyjLqpXGV964221+7n1OB7rPlynJEeAIueBj+tdx/Y8upWt0wikltVDYYtj5R2qhoPhWGF1nRW+YEB5BuG3uBXpKWpnVjpfuWTe2QkV9HuVJBE08e4/KMYI561n/AG6x8RavZNaxSiXGwAH7xz6VYXw1puiSXzpJJM9zAywjshYd6x/Bvh/U9Kvnu5Y5gijcD5fA+lUpbHNyuzuX/EHiq98Hl7F9KjmeXO6RzjaoPQY6mq8GgJ4k8PB553ggcGWMRx5JyeSTjtUupw3XiG8e3lIK2z9XGcknOTXoUSwWfh44vYx5HyvHCMAn6ehqJ+7v1LpSv6HhEmnz6I4WxvHYFeWxtHXjGK1/Bovb/Upop41LyglZJWJGfrXoOv6Jaa7HbS6XbMobBbPykgcnj0rF1PTY7W4RrEmNIhmRj/e7gHvSSubRajscF8QNBN21vc6dGhkQbJkQ9W9RVjwdaXGj2vm3kGdmWMZAz+FdZ/aFgdSFuib5nX5mJwCw5xip4Jkkjt47mCNpJnZsseAOxJqI07TuuprJxab6mXFeXF5fWskiLbxzArHGRuP4ivT/AO3bbw/8OrZ7qDzLdJWjkO7aRz1rkdEsom3TsrSTq7eWSei9sCugu/Cep694CvIbUS3O6fC2wHLHqetKu4WTlpqQ01a5y2uaF4d8QtBrkMlw8k5BbHRcdmNWPCl/d6pAfD19D/xLt5UZGCMnqDWX4cg1Pw9o2p2OqWtxFYkFX8xcbGBHT3rpfhgsOsX1kZEcYYqhkBVtqnuPerk4xi29lqYRT3e5yfhnT7SX4o3miXDFbEzG1K56LjGc11WmaZBo2r3VpYNHNHFJ5YdzgSc9M1ma1o97pfxO1O+0+MmCW4LLLgfIcZ2mqmm6zep4l8u5jJt92+RgvykDk0oXklK/QctEz2DTLNbsSQ/ZUtW8sPJLbSblkPb6YrXuNNuIVK7dzxvhyG6qR1rz7wv8RvDX2prK1urldQkkyCygR5/ug+leuaROdRsEceVNDvO+YnbnHb3rysTKdJ8zWhEEpMpJZK9k7jCZ4Lt2rlrO40+E3cVpIzyOSFLH7xrM+K+v3EekSLof2hEDlZSDjd+PpXI/Cm/udRubu1mmBaJN43kZOewPrW9Ci/Zuc38i5OzUbHb/AGrTLlGN7efZ7iLosiEqo9AKqXNtYRot9AjzXhGY3h+RV+p/pW1YebBfxWZWAJMSGacA8jsT2zWFqNsl3qVzsiW0hgy8gRyFJHoK1g1zWvoEYtKxy3iDRdO1eaIX1p9qufug5xz9ayrTwzaeH2cRxPDI53Ek7uOwzXVvc2kchaBmLccucFfpQ1xZhVIBaVz8xb5sfnXXqXG3U2vB1joZnZrq1mv7vZwoYuM+w7Vq6lfvbTx28MZWE5NvabAgRu+4+grGtGOlWkM9kHN1M+cRYBUetRa7er9qtru+dmYIQuWJY59h3rkdLnqX3QSRk/FTVbnwtb2k1o32+SddxaROFPpj0rPstc/tnwnbfaJxp+Ljy5jySWAyAvt/KtPUNSbxJGlrqtqI7GEfLPIMMF/rXNeINftfDPh97DQ7ZX3NuieUBiG/vYrenFqKU90Z1NdYnRtZiPRbh7y5it0nfMU5fzCEHdh26Vy158StFsdQa30+0W6QEIz7dqkD0rnIItat0lm1+4kDX8GGhY8hD0Zh/CPSu1HgTw34X0N7zWIPtUxgE2JH27iwzgD0Aq5OyTbvczpO7tc1dM1Gy1iC1vrCKSKBCC8eMkBT1Hvk1v8AiLxbNcI9pYpLFFIy+eWkCttHQDHrXCaV4unuydM0uGPR9MhjDyW8Ccy9wxY8nNLpEV+tvJPcyo32qYZ5ywUdyO1L2KlaU1tsPmb2J/EHiCfRNQgsrdJUtXJO6Xk4PPWoW+zahHLO771c+WQBgEeuam1e3h1qaS1uVZJET93JtwBjoaw9csrzS/DkNhYHzD1eZWxwevFbJWRpe3wmzpOn2MF39rgULIp5RSCAg6Vr3l7OybxCH+0/eJ+8nbA9/euP8Fyt/bdlaqJDniUbflxjofWu+1q2mUIiyKkMWWdVA5U9qmVrpE25tTxXx5ql8l1Db3TpjnIOCevt7V0+iX0h8P2ptVcy8Zk6HI7AelVdR8Oxajftco6tGZPlD9QB3PtXQaXZG1UR7wFX+5xjPU1SumNU77GVqEQ1a0H9oxrHcREoJFbG8e49aNM8NG3gjbziY1OcDuc96t63YOmxLaMt5vIkjTeA2M5461562q6z4b1Zw9w2SNxySVcH1FRKcUzdQlFHe6ze2lnPtuAyqo+YoSuPpVGHVNNvZkRS4IwCrdST7+lcf4o1F75beZGQG6BYn+4emKzbGe5gnWzuJlYEhiU5J9s1lOq4s6IQjLQ9b1ZVstH+1tGERWC4Q/yrMj11LsKYL5o4l+UqpxJ9axPFOpXDaTFZmV/IhxIoU5Ck9B/OvNQ8xuWfLBs53A85rOeJcXY1lQhB6o9P8TPJd5tI7t7qOTG53+99DWTpPg03Eu9JBLt+Y5BGB7+9O0BdkMd1cFxLGA4cEHn396v6346ktbc6fp6OpkXE8gOHbPVc1XNz6sJwjSV0inqeho0PkJN5mDlsHvTtM8HQ2+J70G3Rl4Lc4PrRZavBeWcYsvKjdeGGzDEn1NZuoa3HGDb3T3BDEsyxuTt4461m+S9zZWspSNnw/dRzrKttLHbEx5kDAu3B7KOT9K1opZf+EghS42kxkLuXhWx7V5h4bNwuuQPahjOJMbc44+teoxSzwFLiVom2SZZNuMfjVUJptMxqNzpy0Pb/ABH49k06z0mOCdN3lgMu3nI7iut8G+JoLyJZb67ZZGGVWQ4Ary+48Otrum2upCMeVsDbUXO0e+e9d07yaTZ2ECWEQdoii7RncPeuLEYei4ezgtdTmUb7bGD8ZfEtu0ot7C+V42XZIqcktnoK4KK1WSBJlYxpJFh1YYK++az/ABXe/ZtYmJGycMSS/OPanC+ju4I47efAKkkFuemSK9LDUY0aahEyqJu7NEW5s7VkW9KQMw3KrEkj+VXluF/s5beEOcsdnJGB6mudguLW4Bt42SR40JdACoB9PqKn8YnUIvCdzJZOsRRFd1ThtvfnvW0kkrsxjJyZceKfUdYFkzLvjTO3cAEH+NdauuiysLSxa2UhUKE7ueOhzXkXwv8AGOtnV7Zbm3GoW+0puZOVHqW716tc20GpNBJAP+JkY2PlRjhQOnXrWVSza51oRzXTtueb2+utod1qmp+Wl1B5uDGc4I9DV/SPippcLzXp8MxxyqhQGOQuhP8AtCs65m1DwoDdSWEN1b3UjArKuQPYiptG+JljdafdaJH4M0sR3mQfJUhi3Y59addczVlf52Mqem+hv+HPHs/iTV5ba1021gili2F0BXZ3612Vl4OuLzX7aePyF0xotjLOMjBHzYA7+9Y2g+H9I8P2MTi5Ed1KpZoUAMe/sN3XI6Vd+Jbawnw/tNS0WKdWjfLsp6D8O1c1SVmo09L6XNlzO9zlfGfw3tdD1v8AtXSr55reUsFRxwjdOtS+BvD1rMiNrskjx+U0qlecqvb2FbfhTxBaeKdHt31p3MyhYnhiXG5geufU1e1jRG0m7ElohGmRxsP37gCMty+3HUe1OM5RXspvXuWrz96JxXiq7s/D2qbbfy3jcqVRW5wR2Ndt8O/EAfSjBD5iyvILiFXJHmdiAfavFPFl5bahq8Tw3KTFnyUH8HOAB+Fd54JnmW00+W2VhJa3OwgncuDwce1OSVSLgzrnBuPMdV8WNa1FYILW00VbuWZx5qKu4E/XvVrRL2Lw9a6beTaRJa3EoDbJDwCO2e1bWm63YReZM37u+tAfLdiXEvcnFZQ1xfHF/LHdjzUgUmGPG0qe/wBa54qSj7Nx91bnPK173LUJtPENzrS2ilkul8wYTd5TgHJz2rzjRtc0/wARWt3AsC29xawMsqgYEirkFgfWus8L6re+GdRuBLGkFncjazSDkY/u+/tXJeNvhleJcnxH4PnC6bcAyFM7WHPI29xmtYtUp8r+F2sRJu3mjzqz8MSaXrkF355EQbzEDpgkV9N2PjLw7o/gmynaMvcPCA0KnByeCa4nUdO1HxLYabHcWMjPZxhZGjTDOMd+1cZ8RWj0rUdM060jkdFXzHEq/NGOg49jV1KNOulCelnfRkRunzI9L0vxEt94cuDJaQrZxuUiWU53uxxsJ7nnrWdpPhebSPE8k+jWXlzE5SCQ5U8Z4NYvgTXo9P8ADMVpfBGDSSFN+ArNnhueteg3NzJDpVhdWtws1/b/AHOfkcYzgmomnSk1FaP+v+HLjqtSC707ULjSLnWNVQwXH2rLRbOFTGDj1xjNcvrupbtOhi2KJI2Zo5jx5ox/KvUj4h0/xb4QuHIENzGuZIGPzK+O1YeseEY4vCcFzEjSX8XzIdmQUAztYfSuahilH3ays72S7FvV+6fNPhubVNR8RQKJJXlklIkB+6q5716Dq8wN5LbWy4KjDsoHJHU1o6Qq3iOLSxS3kk5JWLG8j1NWda0e90+wMlxZ/Z7aQbt8sgDScc4FepzJNJvUmLsjAt3uFkgeJ3/ekAqrY4rqLWBRPKRtkmELGMSDd82efoMd68Wu/EevatqBtdFjlaFHKosKZYgHua6KC18aXaxQ6nEbK3cbd8h2tt/PNU2paXMZTfRHQDxTp73kOmwStLPGfLeTGVJJ6KO5Fdb4ki8J+DbCPWNaiuNU1NDvtLeZAiluoYqOoB9a1PAem+FvCWjpNYWsd1rDEhriVC23/aGelZHjPQm8c2UX+nWwu0kZvNkH3Yx2wK4Zz9rLld4xW/n/AMA0TaV76kXw98baP4ztNYXXLKK01G7IU3NtFukYjlcA56Y6Vg/FrX9R1Gzi0abeisTvuJIv3jAcBcL0+ldn4K8P6P4OliWxvIo8xM11fyDLvnoI1/Pmn/214eVtSuLK4kWaBTKZJY/MZ/wPAqYKKm5Ri/8ALp8vx9BRjZXbPI7bTdS8H+GJtV1W2lkNyois0nBBAHOSPT2rc+Dvh++8SS6hruq3OyxjH8TBfMc9gOwFamr+PLPxTp32HUbIOlvF8qn1J+8Kd4bFvZWqJZQyuqoRDFuO3PcuPTvXXaq6bT0f3g0r8xN4vl0uxu2nuLgyuFIEEZ4J7GsG08T6RdzBJbefaPlbzEwoX0x61594n0jVLPxmJy0rxzSiQtCSypk9M/41v+EkXUNS1D7dH9rjtpQXMZ5rWGi5WHNrzJns3hmK1stMkk0u0t2lmO1JCcvgnsOtZusade2k9yJrj7X9oIONmDCg7E1s+GZbJ9VnvpJR5NpB5kcITGwdgfeuD8beIpbnULiWItEkgGQG6gDpiuWnf2rtt1/yNVHmSuTNd2Vo8g+zyybF6qgK8c5NebeN/FEkt5IlvJ5UWwbQhxu+ornNR8X6q8oRZ3SBWwsX8P41d0nTn1RWYRDBUyEhc7fbNKpWctIHfQpIveE/HuraKkkds/mQk5Kv8wX3FXdelHiV4Wcwm7POyMYB78+9cdqlu9vbrEgCIZTlmPIPv7Ve8PC53qXY7GIUFh930P0pU3KWjKqOMdGbGp6RB/ZcFsqnPLjHHI7ZqvpHh2aMvO0TKI2y8jn9K6zQ9LlkuoIpMXSRA75GGAc+laTWRt7n97HNNYwTBjEgJCr2BrR0+ZlRnCKTMNPDN4umS6xLJbW2nxoQftL/AHh64/SuLbULOeV47KCLjo/r9a9D+Mc41vwbDcadcb47aYK8KADAI9BXlPgnRrzUtYjitbSSdsZKr3/Ouad1K1i3WfOopbnolnoNz/YkGoBlZG6IvQEdc1w+q6ZeNfOIYwytyO3Psa7e71S98NW8Ol3EbISclGw2OODXGtNNJc+bkMFY9Of0q5SSLcObct6PpE1kz/ao8tICSueBx1Fc1fWtwdUkZN8qscEgHJ9q73T7Lz7aMv5wlVtzOrZ49q6DTtHtbhEMl3JNBy2VjCvu96fs72sRKEXFRZwc80enyedZttaFRyq9T7mqumeJ7y61YS3gSZWwjbhgDnrgVqPaxxqy3CyC0mXjC8tzyAauaZ4Ssbgy3Wmy3PkwgMUkX8eSKIJ81zOvGbj7h9ZfBVQ/w8sZHhkj3l8rIM7lBOCPY1RvobrUNaP9mWDSQQKQrFiPKJ7gnj8Kp+HtWvLT4aaSumkxOkO3lAT161o+F/iLbPYxW2oq/wDaGDtCpzKB/EAK8p060ZzrRV7tnPRTjBHiPiS2EWvP/aCyqNx3ZbJLZ9TSWUVmwRbeNQxJy7cuP/rVvfErxdYWVzcSuttJNcRmRI3GcHsD71ieCNVt9U8NyajcNHBNFLtVI48CTIr3qcrxTa1MZyd+XuXPCfhKXVNWjs7T5HmYyud2Nq9zXYeOfAssPh+6triRd8kZRCrEkjH3s/0rySPxxq+g+O7e5tIH+STaV5zImemK998ceOra88KwR2FsJ7+7TBhzloCRzmubETxHtoKmrxZjHli2pHknw58Iz6FZzrqk8F1FvzCInPX0/wDrV6LFod1NdRahdSC33YYNjGEHGOOleT+OfG1x4djtrWNEefO4heinHTPrS+GPHF94ptJY7y+mingG5bUZ2yL659q2mpSdosSj5Hc+JNQtiJIJbKO4hBOQ/RznrUNtY+FYHtW0zTorS/KZnhDc5xwVzXO6hqrJFvmidcuPmPUrjt7Ux5rSdFm1Boow6lUGMnPbntVypqKVjWlTU3YzfHeo6rbaqYrSZra1U7kAj4Z/TpXVaHquo32kx2N+0oSRcmNSOR7D3rG0/VriyijDukyPkNFPGHH/AAEnmnaV4psheO8mnxsQcReWxUAilzJqzRpLDSi7noMHgi00PS2uLOSe4WMLJNGqFSuR1Jryj47eOZ7yxtNJ0svb6cg7H5nHuav+LPiHrGpW72kVy9tak7JI4jjd9T3rz+7j/tH9xcDzScYYg8CuS02r1HdrY2jQ07Hn9tM8dwjKTncOhr334U6+4QWghw65dDnk8d/pXnVj4SaS4CRWrHnDEggqfpXrnw18Ki2vAZJkieDMmWIHPYE/jVU04puWxLg6cdWee2Fzrr+MriOZrjyY2bdydhz3Fel+GtLnmsWubC5+zXceTGMcsM85ra1HTlhZ5HdYBz5rqwZAPXisbwD48tNK8VS6TqEIWIsVEkgxu9D7ZFbym/Ztw1ZyKMVL3tmdLpHjXTD4oTSr23JRbfBeeQFWkx39BU2r6lqmh6NosroqafNO0Elk5BMHPZv7pHNcBfaWt948uLfToQqzzB4zIh3Y7gZrt/Emg3dlpMtxf3QljjlXa7nfHg8bSo5DCsJUqanG736f16mc04N9TtdP1zRriVZdFkk2qjRyLJGTGdvX/wDXXDfELRE8S+J9Pub+ZYIZ0VFEIBTy+v3q6W0fSLSLT7aRJLG4cqvnZwH3Dkc9Aal1bSLDTdP/ALJ05pp5gWZHk5Azyxz0rkp8tKqmr38+3e5pG9rM8X+MWlJpOt2ttHNDFBFDujVT8uB6Y6mus+E3ivTrrSodPukaYxcSBlwwOeMetcf8TdObVL4RyS4ljXZEd2cE84wKp/DjRLiy1S1acyJGXyzEHOPX6Zr0OTnhyTYTjZcyR6XqFzZ6RePOqsBPLiJegI7jPrzXYeG9ZbXbbdHJPFa2REZUtkNxz9TXH+L7K+1qBbRHXy4X3wMpB3N7V0nhzwzd6XpYje6ltiyedcuoyucc/jXNiOR005P3unUSunYkv7eHSrELbXEAiDlnWUDK55HFc5bWur+P9SWGDEVjb/I0r9x6AfSlnezazlvLIm6+ccnc5yO5HpXR+DvEGk+HrBptQlS3Bf5nl+Utn2olz0qTnBXl00Hu0nsaehfCjSdKRRE3lt/G0I2s/wCPb8KreMvA85QDQo5HyhY7nHDD3PrXY6Z4w0PUpvLtL+F227hk4zXJ/Fzx/b6J4Tu10qUzahODDEYudhPevLo18a6yWt/NaGjULHKeDka6uLtZndorb93JFHy5bOCBS+LvEGh+GLqB47UwlMqy9ySP4j6+tc58Ho9V8PeFtV1S5k8i7vJQI0mU5zgkMaw/jLplzrHhmzu55k82N2djCMh2PXpXsOLnVbe234HLHVaFvVddl1KRHWeNX3bxGiDaw7DI7AdqzvEmn3UmjzagNojRT5flnh+eQ30rjPhXo17qOrPtkP2ZE+cOSPm7D617t41sbDSfDVjZXUkNtKq740Dbm3sOVx3zXU6sabjBLcpR502zxDwHcXM+rzWZmjSKfIE3lhiq9cAGvcbjRIP+EcMlzcTWMMqiMPaxjc4HHPpn0rzT7bofh6LdHZLHezccvkKe59q6Twl8RIprYaUkX7tixmfYHL+mPT8KmupyS5CoRSepT8SadFd6OuhaEbxGlfJuJVBLccgnPFQeGPDNho8kOm21wJVlKyXtypxj/ZB9qta/q3kMVtVNrdSvhMnchXGMn3rgNS0+/SGdPOnnlkPyGLcQT9BWqi7CaV7npE+prLd3A02ILpjXARpmblgDjBPpXMeI5dFA1CC6mlaWNme3eI4x6ZPpUnhmymGiwxam0qzW+XUYwoJHcdzWdDeWejy3E8iJc3F2pilXcCAD3x2qJrljY68PFykmcPc6XAoE8gyjruUkgfN6Gu70W6jsdGdbERx3Ekew7iGx7Bf61mXenteStNZwFbYBSFUh+R1wtRW9gbdkvGhUQ7juWThm7YxXMlZnpJJHQXGhWt9pqG4W3Z5AC4RMENjrn1p2l6Zaafp1xCq+XtzyBuJGOee1Z+jWoMvlR+YqqMpknjPYVtarHFa2wVlYpCgEqq33ia6aasrnJiUptJGNc+KLTT22WdusMXCqQxP5+/tXtPwH1DRL/Tpy7R/bi+9lmYZPuAa+bb/QtQvYXvIIhCsZ3JHnhs9xXafDPT7baY9fQR7Ru3LIVYH6+tctaLr05QbsKpS5bWO0+LK6FceLFbSrYwzvhZpIlG13z1K9CK4bXvFJ8NTvLDZ2iXs48kvCCMIB1HpXrej+FtB1zUgNIklZ7cq7tLLuKjByAO5ry74zeF7a38Qrb6e0xXGX4yVHuOwpU501FUY3ul1ClzxdkecvcS6tdTzNI0k6qWbD53D156UtlZDzFRJ5CSdxMa5I+o9K0tM0pUiaa83O7ArEfuYH9RWx4U017uZo4douQNq44z65NHJdndF2jdkOm200aHFszylsKWJwFPXiugiun0zSxhP30j/uDjqc8g+lWMFSYtQBSfdsRUzuJHtR/Yeo/Z5XnjMflkrhxnHp+NdMIGVSvCLscOLhooY0bGFbdHkZGfYVbm8ZXkqtZeVDGCu1xEAu8D1xU+r2li+waUJfMBP7zOVz6c9684nguE1PoTJv5A6k5rCz5tCa9TkjofZ3wr8W6Vq/hq20zUbP7LNBGIwNpxIPUYqfxodD0jT5tQ090ingiMa5Xt6AnmvDtD8b6ppWkvbQi1jnnKgiRPnXA7Gt6TXZvFXhWWDV4RBGhKiVOsrev0rP6g1V9pFtJ9LnBTq8miPIJJv7Z1q7vLz5reI75WlOVVc9Pc1r2vi/TxFDaWcZ+zq2RbBdi/h35rS8QeE7qXwncNpg3xebulBwGbHTArz7RvC+pT6hGjW7xKHG6SQYC/Wup81+WJNuVqbPRdP1WB9Wjkkso41YEgdSPxNdHZ6zbR2ss0TsJWyAcZLD04rFg8PJZ71kuozMoyGDZUjGeP8ACsGfVHtvtMFmFlVFwzL8u09a01irG0uWbuw8cxQ6vLbCL+Fcu3Od3qfSrPw80xLbUTHBMstxc7YQ55CZPrWVLK76cs+6RFJ5ZupHcVBZ+IrG21e3i0+SRIiRlm/hb1rGLtPXqXWUVTufSHirw7Z+bDo9onmb7cFiUyQ49PrXh3iiLWNG124/0US2cb7BEEJXHv6Gve/DeqNZ28d7YlLp5LYEGY5J9efrRp15Y2V1Np2qQ/bNW1RXuh5fKw4HCn3rGFWdJcslzW+/z+44NNJXseO6hpczWqMbWaKQoMR7shc88GsfT9J1KLeEt8iMZHHAFe3zOul6FaxX1hHPc3aNIsbHPlgdCcd6464MGppeqkipKqbmRCV8v6+tbRtO8ktDup4hu0ZHn11Al1A32WKWe5H+sjAxgnoRUllorq1ut27Q3SqWBHOKgkvJbKeaO1udzH5VwOc+1dj8M9Bg1rVYJdU1SFWXLbJHwTgdD6VPuq8nsjadXljc6LQ9MlksJbvUbkW8SKCm1fmnPpx0qxbRStp9kj6f5R8wBmVcyMGJxuFdtb3C32oCyIsraK3QAb3B8zH8Q7YxXnS3Mtvqgn0a7N/JNM+I424i2nkf4UUqjqN9HuedXqNK7N3SLrULUPZLaic+YVZXXaQufukEdarfEDwhZnxHBfW8e24ijWUbOcMOgb/GtvX9M1TU9OsrrUZzJCjC4laE4bd6ZFN1K+mNvC0VussLfJKQfnAP949qzhJuSnG3W4r3TT2GW11/a1/aXFvYmK9QF2ZiA8UgHX6VyGp3t/Jrr2+oajCbm3uPNlD/ACRzg45B9farnjdDYsniHw2Z41ijVLzdJ1btx3Fedax8RZrxpGksoX+dcB4wQR3APrW9GCvzL/gozr+/HU9C8Yy3+rlpftEkthC26LCgnkY+tdjp2ttp/wAPbJtcmEd1hlt1cZcJ7+5HSvNPFfjLUPCWuaFe6Sqtpl5ZBnt5Y/lz/FjPcVB4y1KXWLB7m2See4aPhM5CrjjArKVJVYpJWivvNKa975Gis1nrOoBJoHjIOQ8Rwx9Oa3oY47GSVY7S6KsnlwuvXPcn1rw7wRqmqxeIINkrtIkgHlkZzng19PaDplr5UM2sX0qsG8wQFNzD8R0FXVqqnDmZd+bRC/D3Sl+2WX2n5ggdijjgknjr6VJ4+8ZyQSyabZooTDxSE9M44rYvJdNl01xBqawXHLREjDAdcE14b4s1i4TVRYWkqTXbsGmfIbb/ALP1NcVCmsTW9rNbbIb9yJrad4ph8F6DqF00P2q8uPlVNvCD6VzuneELn4hWz6obua0wM/vB8gOeme1bPiG5ht4PPvo4SIVXe20bTxyOKnXxxfavoU9tpE0VpYRAYgSMJkeme9ejKMk26a1e7ZyuN3rsJdeFdI+HXh1tcmS51qQYQSJIRGH9OO3vVHwP4l1fxDOt6NN0rTNHhlVHYx7nkJOAqlv6V3XhrVlvPB8NpNpxdELLcyy48tPqD1pENhmPStFtVa7GJsSJ+7XHoormTldqpq191v0G1tyknie+S104WKqXmmY7iw+ZPwHtT9H8I6bdREanOPsgVSq5wC3eq+j2kST6lHqt2zX0m1mCHIjYZ+XNavhnSH1s3cN3u8vaURom2sp96ipL2dNpStbd/wCRrD3ncTS4/DWlXt7Np5i3RMVLMPlHHUDua868WXVjN4kGu6o/2uUj/RoG4VTj7xHoPSuj1nQdR8PSywTsk8AG6WT0QnuK8z8bGKGza7vZ4oY9xWI4yX+lbU4xS9qpc11ubQgp6PQ57xrbXd3atIsZaVMMEAByG/i/+tU/gTTX0y9j1PV1cRWoVyANqsvp7msXwf4vZdSkjuEEuSFjy5U4zjiu5+IS3l3pcq2LyTWg2spkbL5/iCgYzitabVT3kFVwUbnd6ZPpuu+KLa/1ICaw8g3JhRcDd/CntzXOa58WobLVpLK308W1ovDGCMbl56f/AF6b4LbWh4Yhk1S1+y2BzFBJIvlmYjoM9eM1Z8f/AAkuoNPsNVtrgB7hcSKwHyFugz3zUSVNSXM99EvQzTbWhzvxH8SG98L215pFwAjAjKj5uvJPvXjEE5N0jRSuZScsc4Fevaj4NOjeGTb3N1veRsgYIVSR0Jrn9N8AG6KjMIYjaFJIyfWorRk2lE6qVJvU1PAV7MGS5EJcMdm5xuHvj0r0/QPAV94mk8/5be1Lb239x64rnPDGhJpl5DZySRNLt2iOP5gK7bxLdarHGLDTN8D7AGlRtnH92m+dR5YPXzNasnsjU8QeC9M8N6FcaqLmOb7OoChPmLNmvnXV/GchvmjQKHkc73Izwf5V7uRNovw3ured/OupQyDBDhiT056EeteFy+CJb60uL60mjCAbnHUg55FZ03UUGpSvruTCEudWLel6sl4RFHG/ln7pLYHuD71bn1YW1yInAZTkBdnUGsvw7bx2zfZ5ZCAwJJ28g+uKZrEMkKxmeVpJ9xwwPBX+lVzNI71HudlY+JLOwhW4s7ue0v4ztJUYDL+H8qfeeNr4XYvZI4rtGXc0jRjcc8YNeTW5lZWU5WJWIGezHua6fQtLvLx2RZx5iBW3BeCPY9KSk5MShHsWNenhnMZd1MMhJ2K2RDzwB/hUnhu6twojhBLB2ZpI5ACw6YxWH4ntTazurIQrAthD8p9cVV8JWck+oL5MXKc5JxxSi3zFy0srH0L8GNNtNW8VPNqCpcfZoWaJZDnnIGcfSvXNR8OtME8gRokEhkjTAw2fWvnrwje3fhq9Gq2UgcW4CTD+8Cea9VuPi1A1ofKjSOQ8byc/iBXNjMPiJ1VOlqrfceRODjJ3R8o/D2LULvXVS2yVYnzGBJGPWvWI/Dl7azmVNEjleP5nkJHze4zVHQ/Dt9e6/b3/AId8u3i8zMkCjbuGeeK9d0z4paTaeLIPDeoW0PnlhFHNAuQpPGDXbWnKil7OPM/Uz9q4XTZ5hdWKarcrLqGnQK8OMIh+c+3ofSt3WLOW/i0uzsNPVJmGFigTHOa9W+KOlQxeEdRv7GOOCe3iaUFEAyffFfM+ifEbUovsazzAzMxCsf4Ae+eoowuJWKhzwVrE1LRd31O+vLVdMkkjlnMIjwsqYzhu4FVrSKGRJGZNyqcx7V+d/rWbL4kGpNcRtBGojXzDIiZJI9T3zXD6rrurXH+lC6ktFOFtraAYeTnG412JStruZyqJbHeLZokm+ZRIof54sAsc+1ef63o8j+IJ7TRIjFBMNzed/Ae4z/Su18Ipe2elzajrRLTsAIxIMMR7mtm2vgkrXUlrDACgOWI3MD1I96pq/QwVb5HAXPhxrbw0LaGNnnBJeXJOeOBjtXlUlhPbXhEyGN1PIYYr6PubwalK6aPpdxAsa5MsmWL/AFHTFWtM0TSPEUBOrRLBqtuNyxbQUkx1+lY1IxtzyRp7ZytA8w+Guo3t54ksIPPl8qMlVRieFx0Fev8A9pt/wldwL+BxDbRZjkhIycjp61zlrpMWn+MDe2cMG9RlY92FPt9K6W48Iwaj4ytNa0y/2xswaSMnCR/7OD071NSUU/e2syeRvYkuYpoo/tUatLHd8oSSwC+g7is7wv4L1I3l9q2nWxuoJlZGVn4OeoGP616L4j1Sw0LSrweHZ4EvlXaqyJxuJ7e+MkVxum+OX0qYrHGWn89ftL5wGB6kAd654Va1Wm3Tj9/9fibNqLSbPKPFmlpYao120csciMB5TnHsT+BpfCOu2mkalHK8aXMYz5quMBgevPr6V6Z8SvDf9q2kt/bFpLea4MqSbdwVSvI/OvBb97iyu0Dou2I/cx1Gexqoz5lzLrudd4yjaR9I6LHofiplk0KG7uJWUCSCWQJ5S9wPWov+FeeHLO8up31S4hLghYUwHQjqCK8h8O6zcaVdIbW6dZ5j8rI2BHkcfTFdRpF9ZTz3lrrmoxm+uAqOXfLSDPJznrTVGotVNpfezgq2Wm5q2Ev9i2mo2l1rFwscTiRINxYTg9ACOmPWt/QNQhu9Fubq+ujEJW8lIIwAz/jWd4h1jQrGKCxtnuwtnkQQtEG83PTL9eDV3wnBBe+H7+K6iaG7nP2iMsMgMOm33NObTp88k1qhQjJNI3NY0K2Phd7VoxKkykrhvvH3/DtXj+k+H7fwz4kinvbH7fogbMkTfeT3H0rtdQ1XVZrc6fqisFiOYWA2sfb3rGk1pbWJnuI2LSqfLLDOB05p0qcoxfO9zqUeaysWvijdWvi4WSWHkRWcKloW4G0Yx/kVT8CXa6hNb6Las0cwXY0pUFQueo9xWLbajYapdtbpqCJCSTJGkY6gdq6my0Sw8L6cL3Tb+a81KbKwwhNoGRk/j6VSiqcOSPyCrJyd0dNJ4b0fQb9bi0mS6vPm3SYHzH+9/wDWq5dak91dFbGYs8yFZERR+7AHzHPYV5vD441c69E2saIIrT7vlQwke273NXvGniGHS/D1yNFhuA94ph3vgFVYDd079RWKpSsubVmSlfY6fVLW31nw/eRaTeRuWhZRI0mfLdR/X1rw/wCHq6hN4rt0COIUkP2hnGQPU/hXT/DmXUtMlaG8jl/s+8AzsGSVHXPevY/CJ8OReIE09LNPMueQAPu5HOaqUnQi202KS57I8x+LFpFc6bPHpyRyQkqWMb4Y46kiuO+H+n65HKUWMPaSsAFdc7uegr65vvA3h27t3SfSLaZiuMtnP51ytx4c8F+H4Ps01/FbTHlIvtByPYDOa5KOaUpaJO/oU6Wm5j2Whx2kaxa7CzQ7fOFrbk7eP72KnfUtMkgD6FZw286/LuGS59hXQTWi6DbG70/Uh5E6bQlzhggPcNXml9qkItbk2kdxLcZIErHYGOeoA4xV0L4luTu/y+aJleGxtS6PfywRsk9ojlvNLPKBtbP8WevFX5NJ8RaXbyajbXMclsSHb7I+5lPc8dvavIviF4qsNQggsbyJrG78sBHVj83uateFfFB+GIsg9xLd3N9tZYxyjxk9euK3nTquOlr9mv1/4BCcU9DuNU1e6u7WTzJJLrzR5ZkVMMR7461yfjvwzLrunR6RcxRQ38S+bCzHbvXHA+orvPG3irT7CKwudMizd3gLSoUwEP0HfNY8++/0q2vZHlur9zycAAc/dop3lBe7ypnVGok9Xc+Y7LQdQt9VFtLbSpcJIAPl6EHrn0r6j0KwjtbOyGswpPajbIJlUbs45QVjX9nH9r23UaSvCm47SMoPQnvWXq3iuY+XHNqcKQxDZEhwCmOp+ta+z93ljt/WxLSTuVv2iPF82sXFnYaK5gs7dQBFnaf/AK1WvB2s3+o+F9Otb/UJ5bS2OAJHPlmTspPt6Vl+IdP8L+JLu2u01B9PuAgWcNH5qP6MOeD1rYvzbaJ4VisdDRry28wbZSOTn7zketRCEIRUEtv6+8qlTcpczMjx/qtxFcWUizCaOJuYnPDnofwrlf7fUXcgA8hcM6KJMoD/AHfXFX9VsUm042k0u6WKXejdXwegJ7DNc0fDtzbxspeMSnKOpQ8H0U0Tutjupp3O08M+M9Mvttjd2v2e4wSLiBiGU+vvXfR+JbpLSJdTt/NtIgSLuL70ox8uQe/uK+dbPQbuDWYvPysaSfMDkcf/AF69h8O6xaI1pHd25Fkt0Wzu+XZt+Vefes4yT+JFezlPfQZ4w8TEpayXyJa6fEMQQD7z5HLt6k1ztn4u0wWciWcbRyO53JuwAvrWB4/+2aw8lxGJHVJ3CDZgBAeM471zNrYXStHOYtqAhSG75qZVLaIqEXCVkju3uorqea4jjZZmQqGVuB74qlcaYbZEjljnmlcbkPb6/StPwnpLOl1Iz7XhiLCHbuD/AI/Sux1PQD/Zseo2B+0QlFVlQZKL9CapLS7OjrY8d1/bZ3sf2qaPbLHholHMZHZhXTeDL+/vdFezeWIW1uN0ZThiM8gYrkfGunz2muzzzo00TgMGHIx059K3vh5HNDZ3ezzVikAaPHDbhzgeoqIb6mEZv2rj0NjxE0N1LZurSfZ3HEbgDnvj1rJha5ilD23lRony7cdaRvOu3kba37tiduf9X7CtaFLzELzYKEAMdo49zVXuzoS03Nie9VtPCLHsv3+4qn7wxzmsSM3UkhE8b+YRgp16/Tt61dku0sYVkjhWWUvtRn6DPetbQIrbyZbi8uYGkydypy2B1P0rVO7JcE1dnZfAy/h/4SSa31D5YyhWMu2BnvmrXh34baefjJJc2WprdW9sftjAjJBJ4XPTrXnOns8N9I8UpOGJyucc+1ew/B6aK315t8jMblMKXGCCB096yxUJQjOtB/ZtY8Ocbtxl3PS/iAYx4M1dZgSjW7KQB6185W+haJaaG9/baa5upUVUUN8xbocV9DfEWZo/C1+GQeSY8M57fhXztb3OojSmWCRBMGKwFl2446/WsMlg/YyfmRiJctiq8NzplhLcNbNGyLuaFF3Z+tZnhy40AXP9oSXMcUjj5UwSyH0wa9A8JKum6Pct4huPtVwT8vctx+tee6zf3sepT3GgeG1kSMEmT7OW257mvY9pq0+hyuF4ps6fWJ75wo/tF5bIFSqbQAT7e1LfaV/xLUYSkpGdxiPJB9iO3tXPeE54tQtA2ptd2t8znBKDyx712CXy2dpJGmbqeF8K8QAUr6H1pt8qSiRGKe6GJq32jTooLu3UCIBmaFijlfp6V6DoXhiy1+2abS4xbw7MrMTksxrz2Ai+mNxIGa9jPyLHwsY9D2NXYZ9d8Px3VxBJ9ihuOH+ySjbu91IwD9K5cRTk42pPlkb05NPVXRfvNCGkXTaXJrdjPeBt6xBBvAPbd2+lQQW73MV3Yi5ijZFyHBxk1wGlaFcrrj6zqeqGaZm37ScnJ6ZrobQ31zfpeSZVtwV1PIA9celXGnJR96V36dRvTVLQ63STDquorHPKpeLb5s7jAXHTB9a3fEMOgXpuYTbM7SKMTKVRTjv6k1yks1/C4WC4tgrgkkqOV7Vei8Ma7FODez2k0E0QZVj6E9QA3euarCPOpOVuxSnbS1yxq3i+e00jTbHTvJQ20jJcWjgEzR9Bg1znjXQhqV5AkAs4Y9gaKNY+WB7Bq5zxt4qsNC1Q272xN2g3FZVJJ9AD6cV6l8F7mTxVpQl1qyj2wnfA6L8o56UVFDCw9tFevzJjJylytnkWteHLbwtrdjba7bbLWf5m2k7s9t1eceLNKjTxDLLoKTXFmTkNgjB9BX0X+0m+mQxWGqXE+0qrRBF5ZmB4GPz5rwq71PUdb0hbTQYN8IYzOkK4kBx0z1x7UUasq1NVOrO2Xs+XlZs+G9X1HTUtbXVf9IVSPlm5xnoN3Wvc08Qi106C9t9Ot7OVRtwM4HHUZr5++Guh61q+vRi4juHt0b52lBHlsPr3r2j4plv+EYmWzZVZYiGCnkHpmnV5ZOMZomnBS+HY8v8AEHxAdPEVwp1AXGX5k28Cqer3Fxqdo09tIjQCMnCHlSTXk9wAbkqf3eThmboK7rwRJdQwET3DeQ6lQsg+XB6Yqo1NLFwXNKweGdPuJruGGO1MdwZc71JAZfevQfiGNWtF05dJkSCJoFybeTLFhwSfQ1jW89hbXKSWsl09rkbdo53+3rV/Q4bOTW0m1QurZYCRmJXn+8vrWkZJ28gq4fkWhf8ACWp+I7aFrd9QS4t2YFDcIGbHcA9RXrXiXw34WGjJeTTCOQRKdoYYBPfH1qj4fksvshxaRRR2qmWb5ctIij+E9s15bpHjrWfFXivVo1tbQaWkbeXbsg2xqOmD6471zTUqlRKHu238zm5vZK/c9U0a9s005YYreCa3dQqzkbAD3685rmfF/ijR9D8R6bdtpkj21uwVrmGTLDnnOK5XQvFV3/athZSxWsiOxlgTG7YehFdnPpqa/qdxbqUV0iWQrMu0FvT6Vp7GNOTlN6a9TN1ZONkd14r8YRa/4VP/AAheoxz3k2MJHnftI/Svnl/COqWeoJd67cfZHMgZvtDfPnPT8a9e8PQw+GtJudSsYmiuiTm32ZSTaeQg9a4WfxivivU5LTxVYxGVvlgkVdjRAHNZYOj7GTjTV49+o5zc467mF8WPGeos+maMINot/wB4UiY5YYwCfQ12fgbTLrV5ba2TdIywedMkh2gDsuamufCngm6lg1G/1m/S6jQDeIwVHt71pWX2a5lFh4XlmivAwAluFIRxjkAetbe0SjJQTXqnZeZPI42b1OK8d/Dg69cu1ss6TxJhCuGRT3Vv8awfCnhW7m1S3HijLRaSm2LadwI7DPsa9xv/AAdeW1ut3d311JAgXzlhcr16n6Zrm7+4t4ZZra3lAXaANvL/AP16dGtGr8DuPlt8ehBYwtb2zeVJEZZCdolGSufc1b8MaXfXd7dWImEixqCdzDbn/CuaOq2MCG5nW4EtsHkWJ4irSNjGBmuY0P4k319qs0EitaE4ELAFiAD0f1racZyuo7snminc9B1cQ2Vzd2YiEUsA/fbeBnHBB718/eNLG6tNYn+0L5scnzxyYyuO1fSP9oadqOjRrdQx3Wo3TFbh1YBsjpiuOhs/LFzBdWqGKVdo3DIAzwAfwrNJzjZ6NfidNOV2r7HjPhuO7aJmfcFzhXJwM/Su80m6aPTZBFPMX8xd7b+dvfjoKt61pVrbeWY40tIWY7Nz4wQKy0mhsIFt44/LM+d5DbgfrWcFyvU9PltC0TSfT4bnU5tUsWlttOxtIJ+aVhyT70n9s3UlyiXIje3QnYJSPm9jWT4hnu4NMggDkxEnAjbIA67sj1rIs998scQm3OOTwdo9s+9aVKqeiMcPh5023Jmr4ivUhtRev87uOgPAI7VwZ16/ky6E+QDgL6e1d/HpFheWzR3om8qJireUcZOK54+F7aGWZbW8MdnI2A8i7mX2OPWuVwk5XOmrKTsonT+DtVju4ohNEx3IwJT5nC98juP1rqNO8L6NaQ295PrKyI+Q1sqncg7ZyOKj8OeH7bR7a1vkU5KYXC5LNjGB7Gp9RW5mltoIrZTM7kog6lT2PtW0YcxUp+zV5MUrFY+ZBpkbW9jMNryTHnPXOfek0nWpDZLp0yulpvyJ0P3U/uk+meavX3hi+0vRba61KRUDzBREBnj3zXmHibxhaC8u7OxSWSIkqQcKFPQ4x1onKNtCYVE3zNnRa/LYxSXsVjEk5MQWXHJZPQg/nkVyc12ZmaOzkkDAqI8cEKB0zVS2lkmtzdt+9Rk8vG7DYrW0rS5oreK8nTy1BKqRhjnjrWLbk9EdKs1cxNQvI7SAqFZpJOw65Bre8Pa5YXtvHagzibHzB+2PSuf1zT7mW5iuIZcylyBnCDHtTPD2l3Ta6ZFUgRt80O7kjv07U4NpmFSU+eyWh0EgmaOWOaZWUZAdhmtTRNTFx5dpBBAuRtkkZew/u1g65cCzlldow6ljgE9CexqHwrrMUmp+VJF5W8/KVPK+mKqMkppM0k7K19T0vRYm02CS8uHhEkaAkNggMexFev8Awj0+N9Ah1GwnW5uixaQOPlUsedvvivlrwba3ettdW8twyyXB6sc5Y+lfYPwh8Hz+DfDS2dzcLLJIRIQFxtOKzzSqoUN9Xsu/c8KMnJmV8Y/EFmfC0tlDdjz5ZljaMHDDHJzXzzaeKWvtat7W7g8yHzfLXH3gB3x0rf8Ajt4qhHjm6kQBrS3cQ4XqzAfMR/Kub8La/pN5fefa2vlXyNu2SfMCMYzmtsvhGlSjBbvX7ya8W3dHqFhe2ujX8LaoZJbDcSTjLKO1e1aPeaFd6DJc2fkx2Dr+93ALjjo1fN3xA8c2Gl2+l6TZ2gedov3sknTnrV5J7WyjtIbJppftMaSzPMcAe4Hc56VOJwf1tJ3cWjKNX2b1Om1S8/tiSaPw3ounWdlCzxRXMyjL5/iw1R/2FqEmmxCIpcSSuUYwLjp1wKzLuBpLK2tYLeYzRMXQy8Byev5daki8TXvgmKOPUr0SSSyeZFEBwnr9K2UJQjak9fPr8xc3vXkjpJ9PMdqkyWj2dtaoFMkykbmz27mvJPi74h1CzjtfsqsLQM2JVH327g5rY8UfEjUNdMuA0rRDKLu+RPcivPdWl1TXltYL8ySx7yY0jG4kn6VEOeK97c7VDmjdbB4c8XyFoxNFw5ww6jFdBf8AjN9EmlmgGbeXEZQNyB3H0qh/wgF1ZeHpdSGEnAIWJmw+fYV5y0FxeX9upkkkdyFcP2PpitVVdrWuZTo2Wp73a3GneMNI+06ZGbW7iXZtZyS+euBUel6B4j0nXbe+N5cmLaUi3yjylXHueK86tNdtvDerQfZ7d0ZeXHOG/Cvd9N1zw/4k0JZborAwXcYs/KMepPaqnNpaK6+85fZK9pPU4LxL4FtfEIW5l1YvrKLunT7yHns1dn4G8VXHgfR2iCx3diHXbaxsN6jHLZ9far914q8NWeoW1jp8OkSvdx7CYZNm3joc968b1XWNRsvE8sVpZRWcJk+XeCVPvms4QWJi4VY6MUnyL3Hqj1L4j+ANc+IsMt/prRrDKyyw27sFaPI6GuW8M/A3xLokM97qU9rbIo+752ScfSu20b4rXum6AsRt7Wa4j4JXPH19arXHig+LNtzda1NZx9GhRf3YI7VzQhioStoor5ux0pwkveNGz03VPDlslwJFuoZvlURtuaM9yV9Peqv9nyzWmqrLcbZEkBZQwI2sOV/rXW+C7zS9Ot2kmkwhQqs5+ZX/AMK4vxpqUGm2E+pzRLKEJkmeLADnPyj8qI1JSnJSXz7nTSSWx5Lqmg6Hptw4u5o5DKd0QEZyg+p6itjw9o1rdxTRSp9riwPmUlfKB61xV14lPiLxB52qW7JG5Cx+Wfur6V6Not9pmpXQskvYLGaNfKjiBwxHqx7n2reEbps2liIQszB8ReDtShu0Fi5ms4suvlNgJ9c/zrN8LrqBlu0vbaTyj0dyMpj+desxeDdVkgEx1IsmNjPHD5hCds49a5vVNE+wymJbuKWUNu2yRmNh/wABNKCjze6xyrqSvax03gieUpsuVeUSRGJwvUowx0qDTPDnh7wxbXOBKrSON7O2ZZGPREA7Vp+GLSc6nFJFtztAdiCFX3xWk9xHo9xqF6Lm2kNsha2ym5mkPAI+nWlUlabtvY4ZxutCo3g/QdEWC9TTJJbjf5ywPc7ZFB5JCdap3l/Jc6vDcJaraRohTft5cZ4GD3rzrS9P8R/21ca1I0t/LM5EkpZgYye4/DpXRS2t7JqVtPZ3Dbm2h0lkzjPUk+ta06bWs3dmLTasjJ13X9UQTvLiaaOcmOEbi6g9Tx0o0TWYLnUlu9atv30uY0IYHB9SMV6RpOn6feyXVpqggtWkLKLl+WcjsMd65q+8DR2epzSvDdzmIAhpSdpT2IGKtV4XcHp/XQFS05kSW8d3dTIljYb1icMrZ+XdnoB616Q1xq+m+DftFxZxWVy8+d0Sh3TPf2PauG0HXLuyvHh0+Bm0m3fMTSkDDkc5I5610qeLrm00u7ikJuZJmEhZlyqj0XPWuTFQqTaSimky6UlfmdzO1/x3q9poAhuDHFFIf+PuVSSRj0rkNM8VaHoMdzfzzw6heBP3Hqjnq3vXXaz4jtJdElk1XT45rJB8hchCzEdBjrXlviW40LVrU+foL2DSqAl1bZAI9SOhrSlTSg4KFr72YTS5ua52fh3xja+Oz9huIjezJnEUjImc993bFUZ/Cstt9rmtokVYZvs8i43bfcNXKfDnwlLputrqz3CSWkeQNrYaTPAJBr6G+GuqWjXWpaXd7BcvKJ41cf6xSO2epHFTXqywsXOCul0+YKPMvfONsNE1DTUaZNPty0I3hkOd3fn3qPVbyPXbbThb28MU0twyydipxyD6DNe6zWNtKQXhUtzggYrwb4iSTaJL4hSwgDvaH7WkiDO3IwQf51yYTGrFT1VmjRxUFoeZ/ELRdQn8r7LEckmJSPnyQfTtXPW2g61FpiR3wa2dJDIY3Q5fA6A9q6f4fa5f6pdyW26UMITP5jdM56j0B6Yq14mu763Hmz3bEOhREU5616E4Le52YeakcnBClrMwF7+6lAIh2E4J6jB6V1HhTw1BqDNPFMvlKhbYnAyPWvMr3VbiC8KbpMAdW42mu1+HfiOeC6ihjjiEbnaxY/KQfU1hTknsdt0iXUbRTIyTSNFGG5wflPNXrVtHkOya6hRc8IRgZHT61P49sn02f7RbwKYtu5AvzDn09a8gvpp4rsx4ZssCUxyR/StG0nqZTm4q6R9FG5fT7JPMkSSAAbVVefbBFWdI1TT47GW4vittaxyKWlxucD+6p9c15v4d1TUY9PtlIkaHiN267QTwPrivR7Lw/a6pot5o96JYobti6uvVCBx+pzVSa5XcyrXkk0UfGHjjRfEoitNMuHEkLh5BINrYAwCB3rxTxF4N1SDVGkhEU6yqZA8ZwVBPcetdnqnw31aJ44y9o0EDYS7U4LKe+OoNdHbyvZm2ikbzpFTY0wTLMOlL2UHBRj0M6Kf/AC8RwekeGPs+nRLKWM+/cZEPBGfu46V2WjWK20k7yQgxKD5fOQePSrkzI9q8bRuSCGQsAMA9c4rmNZ8RWnh+XyDPILifGB5f3B3qoU+XU6KmIjBWQut20cNrESiu4JkRTHymT/KsnR9RjlmLs0UUrZB24VueMZ9K9Gg+H2rTeFhqV00zLNFvB3D5V6g4614ZqNjPa36xfvDKpIIAyrD1B/Gp92TvHUj6xKyR0Grae140kYkCEnKqwzlh2NYK6fdWepw3FwEKbgCB0z6V32j6ektpErsTNGoYAc7j6VZutMsVdl1CBNikNncQB/8AXqPZtu6OluNryO4+EfgS70jxGkeo27edG3R0xsx0Ne1/EnxOvhXwxPdIN97L+5tYx1eQ9PwHWpbPWrO1tZbvVr6zWXGSQQAB9a8h+IWsp4p8TW8tlIZbG0iYRhRkNIe4rzOWeOrpzjaMd+x5cIJPlR5D460K8lsIZb1wl1LKXRzwcnk7h9e9ct4csLiy1TzrhU83O0oOmPWofF/iDV38RXZku5Stu5iVXxkKD6V2HhzUv9AtLq8thMSmIxKcYPf6ivWheUrlyVO9uxXvtPHizxDboJhHHaJhtqEkjrXqbwxTXVnI8SeXBEkUURGd5A71x/gw2NteXM9kswmV97K3Pvj3FdjKQ9xBco5DE7hkZ2muq1jjlBSdyn4l8WW2h3M80yPPd/LsiQ4CYHavHPFPiS+8V600jIFU4yo7Cuq8faXNcasrPI6zSPhCnzBsiq9l4fXSxMxkeS4AGcJnGe31rJ+RpGlrrsULCGSMpFbxl2YAFMHLex9a9K0nQiNKubzSlEF1bRE88Et6D3rH+GdvdXOq3FrIgZXGcsvMYHevRGMrJLb6aHWFX2NN0GR7jvUv3dOprKpfSPQ8Y8O+JvFja8yJYM8uSG8yIkD3JNat7dXetXDiDwzG8sbfvLuOEptJ9T/WvT9DvbuzleG+mFt5hwsww24jt0qygttKv5LC9lZ7Kd96SI+N5PY+tDqWdrXZg6bSvc8gvfhxLqMkU/8AaQeQJlolXcFA7ZFbdlpVlbaJcWM5YxiPZgHBB9a9U1HwGup6Jez6O8y3aqXSJG27jjoDXzt5niOx1CS2u7W5ikRjuWaM7vyp0cRTqtqL/wAyZQ5dbXKl/o1wdVj2TwyIhJSRjsK/hXremeIYpLSxNzpkN3GiENLLHu3N0yP8a8u1a4hSOK+SYNfk8xqfugdyK9D8D6xa3mnNcTvMFERyqKMZwcfhW8ox5X1MVJ86ujo9V0TRtZ06x1Kxjgsrx+JraB92ApxnA9a7q28KaBqtlDCLy3iiQKZIIWCE49e+a+a/Bj3lp49vorV5D5iOQhORWiNXiTxGYrZZpHQkybHOK45Yac4qMZtHR7Wyd0e0yaRpUtwZdNurmLTrObZ5Q5WUn+dcV8SlSW2l0+aZFimbBhj5wuO1a0V7qOm6RbytD5EtwhMVu7DIT+8V7H61yc+qDV4Qt9LHHLGxw+PmyeOtEKbT1ldHRSaavYpfC34Z22q6y815qDRabAC4LKAcgZH1rcfwH4Y/4Sg3R1OS6uFYSFohmI4HBH+FaNvqVt4Q060/tXULdftQ3ravEWZlwQWYg965jxFejSLOO9SRYbGSXeqxsD5gPTB604Rk5NqXu9Dmcot2aOh1Pxb4h067jttDmeOwHGEwCR3JNdv8P7zT/Hvhi5g8RLFcapYysI52X94FP3SD39K868Lav4d1+yKajczQMnyPJj5I89Ca9M0XxD4V8OWDLpc8WqXMQ+dbRMnnuWPaubGQVrU4vmvo0v1LjNb30Oc1aLUjePo0TiKSAhzcLx8grifGuoa6w8nQLVjbhdm5kBz6sa9Dn16y1rUlvrXP2pw8fklgQvoKbZ6tFIjrewTIA24pb4J3dxmuiDnGKbjr+oSlB6XODhvr+PwhcLaTs99NEY2HIWJu7Y9fSo/gPoDRX+oX3iSaQbFxHauSTK3qc9q6W9njtSYtNtwHuZQWIBZol6DPv7VX1GeVtTkS8UW0ECgCVeJGPvW8o+0TS0ucbm0010LF41w1/dxaejKZ5sRMpysX/wBf6VqW82q3lvB4dN7NcrD8/X5yACcce/rVZ5oYdPje1cCzK7mkLfOWz1+teaxeNE0nxJayae0sd0kxeSYvvz2walw51srra/c0UeV829zqbgTLN9nmyihi8gUbWY+/uKsXHirQrwW+habcs20dMfMG7jPSrXi6/s1WLVbh1iFzBvlCg9T6V5n4bk0LTNdl1DT1vLpmcKCRjyyTz161cVzpSZrP3HZHd+Io9NPxF07QLqZjYRyQLcR7+FDAbsH0zXuXiLwro0egXDpaBYraBn8tBneqqTt/HFfNXj21+1axdXunXC3UrRLIzqNu04xgn1FV/B/xe8VeHZvsFwDeRy/J5V0SwUdOK4MThq01CVOVmvxF7VKTuWPhRrc2s+Kru0FvEkDE+Sn8ManoK2/GvhG7n8RfbNJ1aSO8iVDsXcVX6EGsLUIpPBmiHxBDZgyX9wdoRdqqOufYUj+ODPp0WqXfm28ch2iKI/M7DuPp1rus273ErW5ZHTan8XfEnhSyXR7wNNfFTiaQdF9R3rI+EXirU9Q8WXg1eNrrTtSgeOZmGdykHIXPesW4W18aW9zq9hczQvCdsq3Me5TkY4b1Nd14W0ODTLTRndf9HhQKY8nMpznefas5UacYyskr9uoa9GP8O+FINJnuP7GeaafGESZclEz93P41m6vFFc28lm1uJJkJyjcMjA9K6/SC9t9qu9xjSK4ZcxSbS45wefT0ryzxfrD6WtxelSXkLGKJsls/3ie9Jy3vsdlDdWOd17w88zbrgSQSMeNyenatXwr4aVJYxPepGNv8QwR6Ee9eet4p1yS9F3NfSSbuoY5GD1GK7fTbyRTPK7uhWL92jcgkisYSi9jug+e52Gp6xbXEJ03Cyx2ihBISSx+mayofBQ1S9VrD95cXHTcdpU+ma523trm5EcUETJIzAly3Lj0r1LR7WJNGtrlYJVNvlZ5D1C5xkVrbmQpTUHZnJR2dno9xJBfylGtn2yKORuHqasJ8TbXTwwaRo5GJQyxruP4D0qHxY0KS3SCVZopH4cjaZBjsfWvL/E2nTi3injAdxkPsGdo7Z96zqSlFbDkk4OSPWLHxKNXtWuLC7F1IX2FWUqV7859qsLqNp5MUs0xSWJ9pjjXLEV4/4TM1kZLiVSYmUKVJIz7g11V7fiHSI1h3+ahLLKp5cnrmqVWyux0oc0Vc9AGsWM0twIoHRmAV5MjtyKx/HHglfFT21zo0kaX8cOXWY7RMmex/vD0ryk6jfxyJPFdZEnzDaf0r1vwJ4mv7WOFbuAywqAUEi5yT2BqlV51bqc1Sip7bHf2ut6rB4L020vLlYNkQgmYE5KAevQ5HFccrWbaq1zbQxGyQfMHToPY+ue1Sar46uJpJliijjjhbawVPlDd+vpVXw/fWmrC4u7y9UeUWHkseD6EU6fJC6ta44UZq1jcSytTHM8FsnmybSixrjJPQVnfEL4ZeIb3RVlQRxXEjq7Rl9uPb+tEIumsIb+G6aK4839zGvQEHjjua6h/iRLNAE16MM6Y810TGT26VNR1E0qdrdR1YSlvscJqTy3kKRQo1w8aGRlJLCIdetc1ofjnT9H1QBJ55IZDsnXb8hz6emPWtD7a9mLqH7YtvMUILKpwSf4W9MivL/wCyLs3z2qMGXdkP2xV1arcrLYxVBwV0tT034g6FpF1eSappkS+U8QkTaCyu3fP/ANeuW0W91CZltZVEsR/ujBQD0/Cu88ETTW2mvp8+14TEVGV61pafbQPZxwG3gidQf3qgZwfU1pTgr3Qqt+ujNLwnpNvBayXsUmRuIG5eWwKeJ/J1G3t1k5uFZpiUzsX1qOFTEtvAjS4DE4UjaQa6HQ001bi8a+LRmaHyVk+8dvcCnUbinLc512MkyWiaVJaKkM+TiK4AG4jPapY4ITYrAlv85BALIcknu1PFrD9olW0iwA2Y1IwAPX2NZlzqQ02Ui4lSMckR7iWNCSvoa87S1Nfw5pcVjp938yvLP8r7SQQewFdH4amsbGOKHUFIDLuORwTWJoep2V5axyWspZN25tgJwfeulns/7StFkjX7O6gugkHD/wCArlxD+zPZk0vIwPGk+nWMgngTMLfMAp43H0HavOda1FdWjhWzlH2iP7tuSRz2wfWvRoLd1NxHqQP2bb8jIA6k9/wrIuNN02+hRJYVsp3bdbzR/KJMdRnsa3pSUEo72CcXJaHLeEbjxh/aO6K91K0VF+dihbaB/Sug8XLqB0KXU9S1WS5m2kKjR4k575ro4PE8mk6NPaXduJLplKxuWwdvvWLrdyNX0CPTLSNT8w33LnDoPT3qfec78tvPyCEFFbnzhpYSPXB/aUUssDP8y5wSM9a+m/7K0dfCtlFoS/Z7p1BBRcLg/wB6uMtNI8MaHcqviO9hn3MP3R5kI+vaut8V6xaWXh26NgsKxkK0csZOAOgXJ9KbvdKNzFRs3c5/Uvh7f2bDxVaahE8Qibzo485RvQ+xrzvTdTkspZ768ZJriWYFFC4LKOSPpXatrc0Ph82UspL3ybWBJG4HuBWRpfhJ7G6e5vriOfy7ZniGePp9a0jzQvd3HyKo0c5d/E3Wrq7vp0W2KXKlWDJuMY6ADPTiqlpqkcDRSLMAkqhiCSdpzTj4PknWbUEimgsTl/MYfKSOq1zOoQTNdqvlsqn7uBnNcib5rHZyunC7PU/FumprcdhM0pE0SKUlT5gVPXNUtV8Nzw3kUMt3GLe3iVd27dsyOwq1o8OsQeH7AWkPnSDCmNjyFPbFX9WurHTtSXTJIZH1GYDzSeBEx7fgK9FWWh5k1eVyhe+GrUaItnpzBLeXnzN2ZN3qwHauLhe/0KSeK0mdHf5JJB0Az0/GvbXWC6ijg0K2gggAX7TfStjzCBjav/1qteHfCmg6xrT/ANqQ27GOTIhiLAuMevT8KynUjGLnJWsL4pcqZzXgTSZLK3j1S7mREusEbuWUDq+PSuh1PVLO10x7hHk+xwknCnbu5659fal8YHdrcYmiW202EiBYUAQhewOOprmfHerWSeHrPR7SJY2iDNOc9STx+NTKTcVN9SqKcpuI3wz8U00zWTPY2O1XGxGlbfn0zVnxh42uRfXo1GGAX86BmjUAbR2wDXlOiaUbjVrcIxMOfX8a9DHgC51rXL+8ElknkIHJuZ8kDHasouF/aSWu1zqlh5WLbZ1DS47uzn86PKl0b5d5HXj2Nc/D4Qurq+kuLj91bCTzMqmdoPvW1a2Vh4e0+OFdQW5uZH3sy8bTnpg9q6HTIm+3RqVAtseZcQu+6Nh2LDqDW795cxPNGl7skWprezuPD0seoKJbNI9sCyHDuo7gVd8DfDnS7+0+2i1MnmqXWBZzlD6sff0rzbxXrmp2figXDITYPIqrGqBkxxjHqK+kPhv4t0i7i/s5rRNK1AKGMTgIJgR95f8ACuLG1atGlzU1r+Qk4ylZnIW3h0SXH2dNOeFATE7mPIDds+tWfFvwztLCyi1K0hSd4/8AXIy469/YV7KUG7I71g+Pb60tPDN4l47qtwhhGz72W44ry4ZnWqVIqH3dy/ZQPnHxbr9rHALWVYpbcOESJnyqADkn154rCuLHR/EPh20tdzWl4JTsaFeD6jHpWf8AE/wzfWWpQQFRGchk9ww4BFX/AAFa2ujaS134l1JbS3aULDuBZ9w6nA6CvoouKj5HLO9zO06DVvDUtxpEkRm0q5IKKQc5z14717DaaR5PhmzvLKPUElRd0kkoyhXODj6ZqHwtq1lfRW9y0lprdtBIYwAwjYLnjIPPpWvr+u6g+i6wt9cJBA7D7PZRrgqp6ZPp3rmq1JtqMV1NKcIvVHJeMdR+1SWumabGx0+05mmH/LWTHtXD+IDDexLbbROU4H9+I/Tutc74/wBeu7T7NZ2MpQElmdO5+tTeCtYutQeWz1OVJJrdcxuUG4g9RuFVG3wI7YtQ06lU+DEjMl0jIqbvlV8ms3WZbnTmC3G4liDHg44Hf6V3NreXtt4hudPmVzaugPmyJlQDWb488PTTxxXdq4e5QBXB+UBfQVFaioq8TahW5k4rcv8Aw/1yPWrtLSa3jWbpuz09yK9P0S/OnyXOj3tuLW4KsgZjlXyOh96+ffDhfRr4SXB2yOSPNjY5B7V6jpl3cTec9xdi4uGwfm+8fQ5qoe/GzM6kZNofqtjGllPBeAqiH/R5CAdpzyGFQ6R4PlvbfdczbLQ8r5eF3D1b2rqtSSC78KS6hcvFB5Z8uct0zjjPvXMaJDJrEf2OzuVkcL5ZKS7R7Ef4VU3dN9jXDtc3KzntY1SGOOTRkm06AWg3OgUAy46AN61ObK11OwR4gLS6EHmDjKOuOQe4PvXlPizRb7RtYvLXUoZRcJIfnPII7HNJpet3cJWNnkdcbPvEEVx+01szWGItLlmrHWw+H7JyfIEksmN464X6D610mnwT2nh6KIR+Sk04YSl+cjPQdqwkvLqxuI5pG2iQBSq8BR34qzqOsxyWrrbz+ZcRSZVf4dv07GtItI6EraIo+LRumk2NIY3dRI7NgA4wcj39awvDpmTV4o7HMiM+1kdtufWttHGoTvIUwduJ4m5BHtU8OjyWD7DHGI5BuR8fNtNStXcJU7tSTNO81a70tGtiUnigYy2w5Hzd8n1rjm1vUrvUbm785omONwzxj3HSug1Czj2kMplUA4O4/wAqwU0wx/vJpX8sD5lC5Oe2RVX1FVjJ2tsXdP1CTV4ilxGpuM5aVyfmA7YrtbXRtOjsB9qJF0gEgmD5Xb2x+FVvDei/2GwcRrdXkxIhhRdxyeMmvZ/APwqa4Zb7xXApLYcW+cY9AQKqpUp4ePPVf+Z50q0lotWcl4F0HUNSjkuYbJ5Ld/ljZl+Uj+8a6HXPAV1pFg9zujEjAbhGcDJPSvR/EWsDwnFa22madGbboUjGNgrjfFfji3tbAeYqs1w2dzHcUPpjsK56WKxFaSlCNosxsvtnBrZXMkDw2dx5swOZVkXbtP8A9elnTULW0lv5yqW9oNvl9Mken41ZM0km27iLQXRUrNjnfzkHHpzSyCF9LddUMkvmFiIm+Vnz3x6CvTcmTyqxgeEdd1HxJrT3DR+VAuQ4BwG9Mms7xxpv27VU1IPNiLKeUvQH39q7LTNGg024tmt1b+zXx5qqe3/1qxPHWthvGssOlRoLSONYyqpwwPUn3qb3kkkSlyrUw/C89xpEzNcyeTbScGMHJPua9FTxSLOxxO88dsxBWRiCGx2x2BrzHX/LscbC8rSZ2Io4x7muM8Wy3M7pNHLI0IACoHzjHXP41nUknpJHR7GybifTkeomXwpfXumRpdiPnaj49+cVyznUbnw8L2eyi8wufKjx8pz1P1rgfhBrupaVcMYf3lrKNrW8v3WyORiu7uNZt9SUW2mi7iIkL+QwBC+yn0zShFxk+XZmav8AbG2VxNcQSLqVqCqqFWMHLZ9jXMaTqFnqN4bcQyWSMdpbfk5zjOK7SwvbSyuIvMgLTnklu3bkVyktjFLrN69kiHbLuc8DGTk/gK3T1egpLRalXXfB3m36TQxNfRD5RkhfxrK8Qveab4Smsbq5LBOAijgHPHNejPq8Vnbm5mcEqmNhGduP4h9a811dl8SXcVlFHIA7eaWbPJ7DiiKZNVx+ZVS3kml0Z7i4VQkKlt3YZJ5rofGqyXehtc6eSfJQOGi6Fe+a4XXNC1pL0vrF7DbWPmBd7PwB6ADrx2r1fwzJpC+HltLe7Mttt8rzUG4P3IYHkUN80XYiD5ZJM8R0nXtTlms7GSeaSyaQf6Mp+UZPOB612Ou2j6VNbx6eBHNcOfmkwSgHXFbWtaVpuh3CXunWMaPncWUe/YdjXoXg3QtL19Dc6kG81FzEh4EQIycn+dYO1KPPI25n8F9zkPAlm2qaYbi9uGLQyjypC2C5rBuYbeLx5q17qaPJbxtsGDksT2B712Wp3lnca5Dp+jRieC0kJYL8iufY1g+NIY0DJd4w3JjjbG0Hqc+tdUNXdnFU1Tijq7VtL1fSWl0Cy/dxRjcXfoB1+hq5p8l1pFu92WYSRR7gwVdgJ6KPf615n4L8N3UGrrNp2oyS6WvzvCSQW9AQOMe9d2jxxWzJvcSuT5hILAZPHBqZR05WTCN2ZWkxalq8Wr6jrBSS9DhoU3gdTyfyrlvGXh7UIEMspL2cjYWYD5geoBHpV/UoLrSr83wmZFlXYMsBj2/+tV7wMusO7y6zqf8AxLCDsyN5b2A9amaurdDpor2L1W5xlhpUkGnXVxEjiZVBVf74zzWWdUu47iVoJWiOdpjYZJHvXtNvZW0t9dC2aBLYICjSj5ye/WuU8U+Bo7W5k1TzoUTIzDnk+4rGa5WrHZTl7RWMTUJkv7GxlckOihZZEUE5HRvesebxZc6ZcmCGSOcOQzuQQZPY1T1q88m5jtraRoI5OpQ847ZqKw0E61rMcKzvI5j8xpCuNo9/anCclsZYmMZ6dj1rw3qyapoUCNpUl5Irs7JEMmEDHJFXJZ9OknhutUuNStdUtnH2WRI9yhc5AYdcVzMFs+h2drYWU5+2NuLzo3UdhnvzXYPA91bWL3EjyXflg7FQDJ9T1rolGL36nnNzWlzU8WfG+/tvLXQNHluQi4lugCUfHoO341q+GfEGpeOX07WtXe302yiyhtWI+duzYPPWuastG1vU57gWdoixoPKaNnVCuOpAqXS0022JsIria81SPK7jIAlv7nHXHrXE8JQgmqS9772rjhUmmnI6nxjp9u91caxe+TcQzIIcSfwhejr75rzO+1aHWPDOo6Dc6dtuppQscoh4HoQa6TU4bq8tEgklIt0PLo3D/WpPC2lae9wGkdmt4ZQxHpjtntWtOnGlT97W39I6W3N9it8O/DEHg3wVM0s0N1qGqsuJXHyW6KevPfNZWtatJbmR1VZyrbAxP+sJPBx3FdT4vuludZBtN8dnFxFEpG1vY/U5rzfxdezfZZYPkEjZKADCrj/Cpp+7Hne7/r8joo00zntftP7RieHVoDBN5hZPJUM2fQitfwno1tpgLRKJZnjIz0OD3+oqt4TluJ1lmklaTYy7fMHzMMc4Ndro3lAySQqMBcBZF+bJPJoitbndyp7nPaitxpfiUT3Mby6Zfw7X7hT0/MEV0ECu6yxxxRy2ZXBLR79uB19a1dDMb3MDXdutwsjGEiQgIz84PtWV4ka50fw7r1zpqKjQKUO7ORk84+graVT3WmcFKly1jzm/ubX7Yr26O9vHkBXGMAHBXHY1r2Xiy1tYoljt1DAbVkzyPrXlya3cm6RpSsij/lmRwR9a6C3KzlBImQw+RvukVxOUuh6dKcKj0PQRrcusXMcIwAW3+XjKucYBI71q3fhMeEpLG/t5BPczHzZ1TO3npj0xXm2rSXmixRTWqeaqOrh8H5AK7Pwz4yvdXEkW1mBI3l0GFHTvXVTbmlfocWIcadT3dzodW1LQ/EkNvbaraykspDxxAlseua8sk8BJDfSA33l2qtlPNhKsRnjNdV8Vb3Vba7stP8PRPFI4PmSQDlj2GR0rjrDXtUX7Tp+tzySyRttdHb5gO496iUIXH7aU5WmjW1kQOGSWEpBCoAaM53HjB59a89vr65gup/JdosnDAcZ+teqeGLG2vraaTUc+XKhjRAx4/CodU8C6TqFhNPaNc2l3E4QhvmV65qkHLVHdOMpwtF2Zxvhm8eRo2iEiXGfmK8hj1rqb6aa4eMSSDdKQSoHTFaemeEFsbeFLeSSFoY2aeZ8Ae5qje+YtxGLaCQpGuUkYf60+taQVlqUlJRSe5vW+hNLpUkt0HgdQTFICOnofrXLajcWOnSAlPtVyQN5duFP0HtXRQaybzSb+11b93NHGDEU6D2NcNNBHKzh2YsSPmC9efWqm10Gr6Hqusanb+EdCa/8ADLSXOqsgXzZIzmIng4H0rZ+A/ibxVPcT3PiK8d7BjvxMcOzev0roPH1w0OjR3MaRCdRgPsHP1qD4RyHUtVae7CsVQ4Tb8vHfFFXlqUJVJLoeDOmlUUTsfG2sST6VcRxQRm4ZcK+ccGvOLiysplt7iRY7xlQhoGJXawHt1Nbnjy9mudYRXIC9AFGMVwurl7LV90EsgKDPJ69Bg+oowdKMKSt11Nqj5WdTa28QkjZZB5nlF2UjhQCMCr1zp0jStMzo6hAzhn+7nsPY46U3w1cG+1mKS4jiYtZuSNvHFWdWs49Oiju7cvv37QjNlRu6nFVKo1LlLjZq5lGJ51iEQYhozhc7cHPX3rOXw3aT37y3LNburEFic7sDPPviup1+2isLmyeBclQhG4kjLHBrL8eztFfS2MSqluZwSFzk/LnrTVZyaS6hyK5574q0yK5EskEnlyRDbGpIBdT6eleaT3P9k/urlFBc8qRuyK9F8WubeK3miADlWBPrXlXiZ2uNRSaQ/vCBkj61lVeuh1TXJDmO+8JXdne2zSwsUlix+65xj19q7yys4IVM5nVIWy5BBJU+ma8x+FS/6TqXJwIs49cV1niu7mtvCLmFguYz29//AK9dVPSNzjnPmszvP7R0fV7GBYNpu5RhZIXGRjvivL9S0fxFpniPEAUwyNvExb5XT/armPhw8k+ruryyAICy7TjB9q980jGqamtleqJIFiEmO5PuaL8i5kZL96rSF8EaFd6ppc88Vikkx4N1Odsa/Qd6zrPwl5N5eXnmJM8ORO0LbUXnsfWt74jTvY22m2difs1tJtDRxEgHj0rPtV8y2e3LMIFVU8tThTjucdT71jTnOS9pfRmqtfl7HnnjXRrjxY9omnTeVDbyEZmI2898+tZxvLbwRG2nWpW+uZHEjyZ+QH1ra+Jdy9ksFpahY4XPO0c9a4DxYgWysiMkyQ4Ynqea157PQJUlbm6nbaF4jbWJ1guoNtwJA2F5B/PtXofhvVLK6Oo2NlOFkeArIvfJ649MV5J8PtqxTzuiySIpKlxnGBTvh9fz/wDCSRtuHzSnI7EHqKdlUTTMp3gkzqtA8OnRr68V7t5xLFu8zH+rXPAB9c1Tu9L1C/1OC2SNpASVZj84216JotrDeNd3N0gkaBDsQ8J+IFcjpXjrWZfF8VhG1vBbBtuIogDgH1p+1d3GO5zuMYu7NV9Ij8NaXFJbvPDMq5ycDp7elZun63Y6mzL9uaWZiQyMMKfXHrR8YbiVfDWqSq7B5JQGIJ6E8j6V5T4aQf8ACRafboSkeC3y9ScVdN3Xvbk1PdleJ1OvT/adeZrNTcWcAIUYJDyeoHoOma9G8G+F5L7Q4dSKXFxOXKiHAREx35rkNHsorXXZfLLlIyCiMcqCc54r6M+GqJc+GLeaVQXfOfT8q5cfiHh6alE68PFOTlLU4k+FrfUrWOS00+5tbsptkcSAgjnPy+lcNqtk9nO1jcFzGp4DHJCnivpaK3hDBfLXb6Yrxn4nKLrx+tk/yQJAuAnBPfrXFgMbKtUdN7WubV3GPvRWqPKbfwtbG5me9j81UBwAuWYdgAaoeI9XtvCSW39naSQtwCrSzc5x1Xj616To1jHdav5LySqNwQMrcgfjXaNoOnTXUOmXNsk9kxyYpACMjv7H6Yr0alaNHZHNKMqr1ehwnhCCDWbGw1JbRVxER5B9TzgdxV0LfIs8a2EkVrdH5pLaTO3HYv1Wuomhi03VY9PsIkt7cxP9wc9OmaorENL8CMLVmAupHWbdzvwe9ZPEc2tt7EKkk+XsclrvizRLK5tbWaKRIIkBWOA7i+euWPWo7XxBZz3CyW2jS6dZu4Vwq5aVfc9fes7XLKC7tXkmjXzI1DowGCp9q3DN9u0vTvtEaF1ATeuQ2OPeutQirf5mLvFs9Iu38Kvp2YLmNCUyEU8jgcY7Vx2j2dt/ZGofZZgVdi4Vhy+e1OltorhvLkX93nG0dO1aJgS4itojmNY5TCDH8p2HtXFGHsVZSbv3OtTlJXfQ5HcJW2KqyzQxnEZbv6+9eKfEWK8Gt4nDxxsMxgn5QvfH417VrcC6b4vigtWdY0jPBOc89T71L4p0izv7K7luIwxAGBgYzjr0rat7yTR04dc8XF9zwjRdc8uzW1uGlfHyI4+XaOxJru9D1FnNs0rGRCoDgNgv9D61zSWMC6ra2hQNbzrl0YD9PTpWlJI1pLJFBhY4mIRcDArnpyaO2MNLM7xNVt7e3S2KOymTMe8jcB1GferrXBinvBJAklleJhlHzBsjB4PevMrW8kGoyzEKzhgg3ZIANdhaXEvktEWyoRiM9iO9dUJKas0c1eHI+ZHFal4BtDfEaRqQeIAv5VzEY2B9Ae4rS0rR47df+JjLtCEGOOFdxYjsK7/wvjXozFqaiXbtVXxhlHsaxvFdrHpEt4bbLGNgF8w5xSjShexiq8o7Lc19D8GvqHnrqslvArqN8Nw6gqhHGa0vCvg+2tL7yLC0byHYl1QZ8wA9j6VyPgZBfSLcTljNIp3Nn/Gu/wDGWs3vh3VvB2m6XL5ds8RaTIyz5JByazqucXyxe/4aE8+nNIz/AIleL9G0yOXTNP06H7REB59wMAhv7o96+e9cZZ9QknwPMkbr0J/D1r1XxNZQ32oalcXILPneB2Bz1xXC65YQfZLdsNudjk55rLl5Eoo74UvccmaPgvXpisdtcxqGTmOQAHJ967zwzDqWravst7R5lfKlVT5U46t6VzXwo0Ky1HWIVu1d1D4xnjGK7GTxHqPh74i3NlpcixWxjUshGQ2D3rZtxTUd7GHtpW1Mbx3cSaUk1rfKV8hTM8aHh8ds9cV4xf8Ai2/uZ8t+6ty24RITtFfRH7QG288RWazIm02bAhRjORn+dfMZgXzSmTtDdK4/aucIy2ui5ynyqUXY6633Xttu80AzLlgeowOPxrQ0ay2yK4bzDgjbnjH496wElYZVcKFG0YHQYqo2oXcNxIkVzIgVSwIPOapTV0dbmoq7P//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There are no normal bile ducts in this portal triad; rather, there are clusters of bile duct-like structures with no lumens.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_11_20662=[""].join("\n");
var outline_f20_11_20662=null;
var title_f20_11_20663="Lidocaine (systemic): Pediatric drug information";
var content_f20_11_20663=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Lidocaine (systemic): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?13/54/14184?source=see_link\">",
"    see \"Lidocaine (systemic): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?35/58/36772?source=see_link\">",
"    see \"Lidocaine (systemic): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8768558\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Xylocaine&reg;;",
"     </li>",
"     <li>",
"      Xylocaine&reg; Dental;",
"     </li>",
"     <li>",
"      Xylocaine&reg; MPF",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8768559\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Xylocard&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F10529691\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antiarrhythmic Agent, Class I-B",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Local Anesthetic, Injectable",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F12675239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Antiarrhythmic: Ventricular tachycardia, ventricular fibrillation : I.V., I.O.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loading dose: 1 mg/kg/dose; follow with continuous infusion; may repeat bolus;",
"     <b>",
"      Note:",
"     </b>",
"     Neonates with reduced hepatic function or decreased hepatic blood flow (eg, CHF or postcardiac surgery) should receive",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     the usual loading dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Continuous I.V. infusion: 20-50 mcg/kg/minute; use lower dose for neonates with shock, hepatic disease, cardiac arrest, or CHF",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F10529764\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/54/14184?source=see_link\">",
"      see \"Lidocaine (systemic): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Antiarrhythmic:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Infants, Children, and Adolescents (PALS, 2010):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     I.V., I.O.: (",
"     <b>",
"      Note:",
"     </b>",
"     Use if amiodarone is not available, for pulseless VT or VF; give after defibrillation attempts, CPR, and epinephrine):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Loading dose: 1 mg/kg/dose; follow with continuous I.V. infusion (PALS, 2010); may administer second bolus of 0.5-1 mg/kg/dose if delay between bolus and start of infusion is &gt;15 minutes (PALS, 2010);",
"     <b>",
"      Note:",
"     </b>",
"     Patients with reduced hepatic function or decreased hepatic blood flow (eg, CHF or postcardiac surgery) should receive",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     the usual loading dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Continuous I.V. infusion: 20-50 mcg/kg/minute. Per manufacturer, use a maximum of 20 mcg/kg/minute in patients with shock, hepatic disease, cardiac arrest, or CHF",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     E.T.: 2-3 mg/kg/dose; flush with 5 mL of NS and follow with 5 assisted manual ventilations",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adults (ACLS, 2010):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     VF or pulseless VT (after defibrillation attempts, CPR, and vasopressor administration) if amiodarone is not available:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     I.V., I.O.: Initial: 1-1.5 mg/kg. If refractory VF or pulseless VT, repeat 0.5-0.75 mg/kg bolus every 5-10 minutes (maximum cumulative dose: 3 mg/kg). Follow with continuous infusion (1-4 mg/minute) after return of perfusion. Reappearance of arrhythmia during constant infusion: 0.5 mg/kg bolus and reassessment of infusion (Zipes, 1999)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     E.T. (loading dose only): 2-3.75 mg/kg (2-2.5 times the recommended I.V. dose); dilute in 5-10 mL NS or sterile water.",
"     <b>",
"      Note:",
"     </b>",
"     Absorption is greater with sterile water and results in less impairment of PaO",
"     <sub>",
"      2",
"     </sub>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Hemodynamically stable monomorphic VT: I.V.: 1-1.5 mg/kg; repeat with 0.5-0.75 mg/kg every 5-10 minutes as necessary (maximum cumulative dose: 3 mg/kg). Follow with continuous infusion of 1-4 mg/minute or 30-50 mcg/kg/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Dose reduction (eg, of maintenance infusion) necessary in patients with CHF, shock, or hepatic disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Anesthesia, local injectable:",
"     </b>",
"     Children and Adults: Dose varies with procedure, degree of anesthesia needed, vascularity of tissue, duration of anesthesia required, and physical condition of patient; maximum dose: 4.5 mg/kg not to exceed 300 mg.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F8768838\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed in D",
"     <sub>",
"      5",
"     </sub>",
"     W, as hydrochloride: 0.4% [4 mg/mL] (250 mL, 500 mL); 0.8% [8 mg/mL] (250 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride: 1% [10 mg/mL] (2 mL, 10 mL, 20 mL, 30 mL, 50 mL); 2% [20 mg/mL] (2 mL, 5 mL, 20 mL, 50 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xylocaine&reg;: 0.5% [5 mg/mL] (50 mL); 1% [10 mg/mL] (10 mL, 20 mL, 50 mL); 2% [20 mg/mL] (10 mL, 20 mL, 50 mL) [contains methylparaben]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride [preservative free]: 0.5% [5 mg/mL] (50 mL); 1% [10 mg/mL] (2 mL, 5 mL, 30 mL); 1.5% [15 mg/mL] (20 mL); 2% [20 mg/mL] (2 mL, 5 mL, 10 mL); 4% [40 mg/mL] (5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xylocaine&reg;: 2% [20 mg/mL] (5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xylocaine&reg; MPF: 0.5% [5 mg/mL] (50 mL); 1% [10 mg/mL] (2 mL, 5 mL, 10 mL, 30 mL); 1.5% [15 mg/mL] (10 mL, 20 mL); 2% [20 mg/mL] (2 mL, 5 mL, 10 mL); 4% [40 mg/mL] (5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride [for dental use]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xylocaine&reg; Dental: 2% [20 mg/mL] (1.8 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, premixed in D",
"     <sub>",
"      7.5",
"     </sub>",
"     W, as hydrochloride [preservative free]: 5% [50 mg/mL] (2 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F8768599\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F10529784\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endotracheal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: Flush with 5 mL of NS after E.T. administration; follow with 5 assisted manual ventilations",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: Dilute in NS or sterile water prior to E.T. administration. Absorption is greater with sterile water and results in less impairment of PaO",
"     <sub>",
"      2",
"     </sub>",
"     (H&auml;hnel, 1990). Flush with 5 mL of NS and follow immediately with several quick insufflations and continue chest compressions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral: I.V.: Solutions of 40-200 mg/mL must be diluted for I.V. use; final concentration not to exceed 20 mg/mL for I.V. push or 8 mg/mL for I.V. infusion. The manufacturer recommends that when given I.V. push, the rate of administration should not exceed 0.7 mg/kg/minute or 50 mg/minute, whichever is less; however, during acute situations (eg, pulseless VT or VF), administration by rapid I.V. push has been used by some clinicians in practice. I.V. continuous infusion must be administered with a calibrated infusion device.",
"    </p>",
"   </div>",
"   <div class=\"block uicp drugH1Div\" id=\"F14472684\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Usual Infusion Concentrations: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Premixed solutions available",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      I.V. infusion:",
"     </b>",
"     8000",
"     <b>",
"      mcg",
"     </b>",
"     /mL",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F8768696\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     LR, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, LR,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     NS, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acetaminophen, alteplase, amiodarone, argatroban, bivalirudin, caffeine citrate, cefazolin, ciprofloxacin, cisatracurium, daptomycin, dexmedetomidine, diltiazem, dobutamine, dobutamine with dopamine, dobutamine with nitroglycerin, dobutamine with nitroprusside, dopamine, dopamine with nitroglycerin, dopamine with nitroprusside, enalaprilat, eptifibatide, etomidate, famotidine, fenoldopam, haloperidol, heparin, heparin with hydrocortisone sodium succinate, hetastarch in lactated electrolyte injection (Hextend&reg;), inamrinone, labetalol, levofloxacin, linezolid, meperidine, micafungin, morphine, nicardipine, nitroglycerin, nitroglycerin with nitroprusside, nitroprusside, palonosetron, potassium chloride, remifentanil, streptokinase, theophylline, tigecycline, tirofiban, vasopressin, vitamin B complex with C, warfarin.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Amphotericin B cholesteryl sulfate complex, metoprolol, pantoprazole.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Nesiritide, propofol, tenecteplase, thiopental.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Amikacin, caffeine citrate, clonidine, clonidine with fentanyl, cloxacillin, edentate calcium disodium, glycopyrrolate, heparin, hydroxyzine, ketamine, ketamine with morphine, morphine, metoclopramide, milrinone, nalbuphine, penicillin G sodium, vasopressin.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Cefazolin, pantoprazole.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Ampicillin, ceftriaxone, diazepam, epinephrine, fentanyl, insulin (regular), sodium bicarbonate.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F10529708\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at room temperature. Stability of parenteral admixture at room temperature (25&deg;C): Use the expiration date on premixed bag; once out of overwrap, stability is 30 days.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F10529692\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of ventricular arrhythmias (FDA approved in adults); local or regional anesthetic [FDA approved in pediatric patients (age not specified) and adults]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PALS guidelines recommend lidocaine when amiodarone is not available for cardiac arrest with pulseless VT or VF (unresponsive to defibrillation, CPR, and epinephrine administration); consider in patients with cocaine overdose to prevent arrhythmias secondary to MI",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACLS guidelines recommend lidocaine when amiodarone is not available for cardiac arrest with pulseless VT or VF (unresponsive to defibrillation, CPR, and vasopressor administration); it is not considered to be the drug of choice but may be considered for stable monomorphic VT (in patients with preserved ventricular function) and for polymorphic VT (with normal baseline or prolonged QT interval).",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F8768552\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication (epidural administration; I.V. formulation) among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Lidosen [Italy] may be confused with Lincocin brand name for lincomycin [U.S., Canada, and multiple international markets]; Lodosyn brand name for carbidopa [U.S.]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F8768666\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Effects vary with route of administration. Many effects are dose related.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Arrhythmia, bradycardia, arterial spasms, cardiovascular collapse, defibrillator threshold increased, edema, flushing, heart block, hypotension, sinus node supression, vascular insufficiency (periarticular injections)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation, anxiety, apprehension, coma, confusion, disorientation, dizziness, drowsiness, euphoria, hallucinations, headache, hyperesthesia, hypoesthesia, lethargy, lightheadedness, nervousness, psychosis, seizure, slurred speech, somnolence, unconsciousness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Metallic taste, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Thrombophlebitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Intradermal system: Application site reactions: Bruising/burning/contusion/hemorrhage/pain, edema, erythema, petechiae, pruritus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Paresthesia, transient radicular pain (subarachnoid administration), tremor, twitching, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchospasm, dyspnea, respiratory depression or arrest",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions, anaphylactic reaction, anaphylactoid reaction, sensitivity to temperature extremes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Following spinal anesthesia: Cauda equina syndrome, double vision, hypotension, nausea, peripheral nerve symptoms, positional headache, respiratory inadequacy, shivering",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Asystole, confusion, disorientation, flushing, headache, hyper-/hypoesthesia, hypersensitivity, methemoglobinemia, nervousness, skin reaction, weakness",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10529704\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to lidocaine, amide-type local anesthetics, or any component; patients with Adams-Stokes syndrome, Wolff-Parkinson-White syndrome, or with severe degree of S-A, A-V or intraventricular heart block (without a pacemaker)",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F10529706\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with hepatic disease, heart failure, marked hypoxia, severe respiratory depression, hypovolemia, or shock; incomplete heart block or bradycardia, atrial fibrillation; pseudocholinesterase deficiency",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F10529705\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Decrease dose in patients with decreased cardiac output or hepatic disease; do not use lidocaine solutions containing epinephrine for treatment of arrhythmias; do not use preservative-containing solution for epidural, spinal, or I.V. administration.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Chondrolysis (necrosis and destruction of cartilage) has been reported following continuous intra-articular infusion of local anesthetics for extended periods of time (48-72 hours); patients presented as early as 2 months following the infusion with joint pain, stiffness, and loss of motion; more than 50% of patients required additional surgery, including arthroscopy or joint replacement; intra-articular administration of local anesthetics is not an FDA-approved route of administration.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Premixed infusions containing dextrose may cause hypersensitivity reactions in patients allergic to corn or corn products; some products contain benzyl alcohol or bisulfites (consult specific product information) which may cause allergic reactions in susceptible individuals; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (\"gasping syndrome\") in neonates; the \"gasping syndrome\" consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse; avoid use of lidocaine products containing benzyl alcohol in neonates;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate, a metabolite of benzyl alcohol, displaces bilirubin from protein-binding sites.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F8768686\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (major), CYP2A6 (minor), CYP2B6 (minor), CYP2C9 (minor), CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F8768687\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amiodarone: May increase the serum concentration of Lidocaine (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: May increase the serum concentration of Lidocaine (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inducers (Strong): May increase the metabolism of CYP1A2 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Moderate): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Strong): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproterone: May decrease the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Darunavir: May increase the serum concentration of Lidocaine (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disopyramide: May enhance the arrhythmogenic effect of Lidocaine (Systemic). Disopyramide may increase the serum concentration of Lidocaine (Systemic). Specifically, the unbound/free fraction of lidocaine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Etravirine: May decrease the serum concentration of Lidocaine (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: May enhance the adverse/toxic effect of Local Anesthetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prilocaine: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Prilocaine. Combinations of these agents may increase the likelihood of significant methemoglobinemia.  Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when prilocaine is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine in infants receiving such agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saquinavir: May enhance the arrhythmogenic effect of Lidocaine (Systemic). Saquinavir may increase the serum concentration of Lidocaine (Systemic).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: May enhance the adverse/toxic effect of Lidocaine (Systemic). Telaprevir may increase the serum concentration of Lidocaine (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F8768620\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F8768621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal studies with lidocaine have not shown teratogenic effects. Lidocaine and the MEGX metabolite cross the placenta. Use is not contraindicated during labor and delivery. Topical lidocaine is used locally to provide analgesia prior to episiotomy and during repair of obstetric lacerations. Administration by the perineal route may result in greater absorption than administration by the epidural route. Adverse events have been reported in the infant following maternal administration, however, when used in appropriate doses, the risk to the fetus is low. Cumulative exposure from all routes of administration should be considered.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F10529785\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor ECG continuously; serum concentrations with continuous infusion; I.V. site (local thrombophlebitis may occur with prolonged infusions)",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F10529786\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Therapeutic: 1.5-5 mcg/mL (SI: 6-21 micromoles/L)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potentially toxic: &gt;6 mcg/mL (SI: &gt;26 micromoles/L)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Toxic: &gt;9 mcg/mL (SI: &gt;38 micromoles/L)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F10529709\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Class IB antiarrhythmic; suppresses automaticity of conduction tissue by increasing electrical stimulation threshold of ventricle, His-Purkinje system, and spontaneous depolarization of the ventricles during diastole by a direct action on the tissues; blocks both the initiation and conduction of nerve impulses by decreasing the neuronal membrane's permeability to sodium ions, which results in inhibition of depolarization with resultant blockade of conduction",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F10529724\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Antiarrhythmic effect:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset of action (single I.V. bolus dose): 45-90 seconds",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Duration: 10-20 minutes",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F10529725\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: Crosses blood-brain and placental barriers; distributes into breast milk; breast milk to plasma ratio: 0.4",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     V",
"     <sub>",
"      d",
"     </sub>",
"     : 1.5 &plusmn; 0.6 L/kg; range: 0.7-2.7 L/kg; V",
"     <sub>",
"      d",
"     </sub>",
"     alterable by many patient factors; decreased in CHF and liver disease",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: 60% to 80%; binds to alpha",
"     <sub>",
"      1",
"     </sub>",
"     -acid glycoprotein",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: 90% in the liver; active metabolites monoethylglycinexylidide (MEGX) and glycinexylidide (GX) can accumulate and may cause CNS toxicity",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life, biphasic:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Alpha: 7-30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Beta, terminal: Infants, premature: 3.2 hours; Adults: 1.5-2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     CHF, liver disease, shock, severe renal disease: Prolonged half-life",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Elimination: &lt;10% excreted unchanged in urine; ~90% as metabolite",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dialysis: Dialyzable (0% to 5%)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F10529787\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?35/58/36772?source=see_link\">",
"      see \"Lidocaine (systemic): Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dental/local anesthesia: Avoid eating or drinking for 1 hour after use because some numbness of the tongue and throat may occur. Begin with small sips of water to ensure swallowing without difficulty. Immediately report swelling of face, lips, or tongue.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.V. infusions: Report dizziness, numbness, double vision, nausea, pain or burning at infusion site, or respiratory difficulty immediately to your healthcare provider.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Field JM, Hazinski MF, Sayre MR, et al, \"Part 1: Executive Summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2010, 122(18 Suppl 3):640-56.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?20/11/20663/abstract-text/20956217/pubmed\" id=\"20956217\" target=\"_blank\">",
"        20956217",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      \"Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 10: Pediatric Advanced Life Support. The American Heart Association in Collaboration With the International Liaison Committee on Resuscitation,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2000, 102(8 Suppl):291-342.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?20/11/20663/abstract-text/10966679/pubmed\" id=\"10966679\" target=\"_blank\">",
"        10966679",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      H&auml;hnel JH, Lindner KH, Sch&uuml;rmann C, et al, \"Plasma Lidocaine Levels and PaO",
"      <sub>",
"       2",
"      </sub>",
"      With Endobronchial Administration: Dilution With Normal Saline or Distilled Water?\"",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 1990, 19(11):1314-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?20/11/20663/abstract-text/2240730/pubmed\" id=\"2240730\" target=\"_blank\">",
"        2240730",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kleinman ME, Chameides L, Schexnayder SM, et al, \"Part 14: Pediatric Advanced Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2010, 122(18 Suppl 3):876-908.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?20/11/20663/abstract-text/20956230/pubmed\" id=\"20956230\" target=\"_blank\">",
"        20956230",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Neumar RW, Otto CW, Link MS, et al, \"Part 8: Adult Advanced Cardiovascular Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2010, 122(18 Suppl 3):729-67.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?20/11/20663/abstract-text/20956224/pubmed\" id=\"20956224\" target=\"_blank\">",
"        20956224",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Phillips MS, \"Standardizing I.V. Infusion Concentrations: National Survey Results,\"",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2011, 68(22):2176-82.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?20/11/20663/abstract-text/22058104/pubmed\" id=\"22058104\" target=\"_blank\">",
"        22058104",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zipes DP and Jalife J, \"Lidocaine,\"",
"      <i>",
"       Cardiac Electrophysiology: From Cell to Bedside",
"      </i>",
"      , 3rd ed, Philadelphia, PA: WB Saunders Co, 1999, 896.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16016 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-3C5F28D7A6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_11_20663=[""].join("\n");
var outline_f20_11_20663=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768558\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768559\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529691\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12675239\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529764\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768838\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768599\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529784\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14472684\">",
"      Usual Infusion Concentrations: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768696\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529708\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529692\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768552\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768666\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529704\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529706\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529705\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768686\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768687\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768620\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8768621\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529785\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529786\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529709\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529724\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529725\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10529787\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/16016\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/16016|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?4/30/4579?source=related_link\">",
"      Lidocaine (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?12/39/12915?source=related_link\">",
"      Lidocaine (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/59/30642?source=related_link\">",
"      Lidocaine (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/54/14184?source=related_link\">",
"      Lidocaine (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?35/58/36772?source=related_link\">",
"      Lidocaine (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?20/3/20535?source=related_link\">",
"      Lidocaine (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?28/46/29413?source=related_link\">",
"      Lidocaine (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?32/50/33574?source=related_link\">",
"      Lidocaine (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_11_20664="Malignant gastric ulcer Endosc";
var content_f20_11_20664=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F58136%7EGAST%2F71672&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F58136%7EGAST%2F71672&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Malignant and benign gastric ulcer: Endoscopic appearance",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 353px; height: 486px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopy showing the differences between the endoscopic appearance of malignant and benign gastric ulcers.",
"    <br/>",
"    (A) Retroflexed views were required on endoscopy to detect this malignant gastric ulcer of the cardia. Note the absence of folds radiating to the base and the exophytic appearance. Biopsies confirmed the presence of adenocarcinoma.",
"    <br/>",
"    (B) Benign gastric ulcer in the prepyloric region. The ulcer is well-circumscribed with folds radiating to the ulcer base.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul C Schroy III, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endoscopic appearances of gastric cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 345px; height: 468px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopy shows different appearances of a gastric adenocarcinoma. Upper panel: Adenocarcinoma in the antrum manifested by a friable, ulcerated, and circumferential mass. Lower panel: Adenocarcinoma of the cardia. This large, lobulated, ulcerated mass was seen only by retroflexed views of the gastroesophageal junction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul C Schroy III, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_11_20664=[""].join("\n");
var outline_f20_11_20664=null;
var title_f20_11_20665="Overview of palpitations in adults";
var content_f20_11_20665=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of palpitations in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/11/20665/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/11/20665/contributors\">",
"     Peter J Zimetbaum, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/11/20665/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/11/20665/contributors\">",
"     Robert H Fletcher, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/11/20665/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/11/20665/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?20/11/20665/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Palpitations are one of the most common problems of outpatients who present to internists and cardiologists, accounting for 16 percent of complaints in one study of 500 medical outpatients [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/1\">",
"     1",
"    </a>",
"    ]. Although the cause is usually benign, palpitations are occasionally a manifestation of potentially life-threatening arrhythmia. As a result, the concern about missing a treatable condition may lead to the inappropriate use of expensive tests with little diagnostic and therapeutic value.",
"   </p>",
"   <p>",
"    The common presentations of palpitations in adults and a guide to rational diagnostic testing and therapy are reviewed here. The approach to palpitations in children and the management of documented arrhythmias are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/38/9832?source=see_link\">",
"     \"Approach to the child with tachycardia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/28/33223?source=see_link\">",
"     \"Arrhythmia management for the primary care clinician\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Palpitations are a sensory symptom. They are defined as an unpleasant awareness of the forceful, rapid, or irregular beating of the heart. Patients may at times describe the sensation as a rapid fluttering in the chest, flip-flopping in the chest, or a pounding sensation in the chest or neck, and these descriptions may help elucidate the cause of the palpitations [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Description'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of palpitations is extensive (",
"    <a class=\"graphic graphic_table graphicRef64306 \" href=\"UTD.htm?41/41/42652\">",
"     table 1",
"    </a>",
"    ), and the etiology varies depending upon the population studied. In a study of 190 patients presenting with a chief complaint of palpitations to a university medical center, an etiology was determined in 84 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/3\">",
"     3",
"    </a>",
"    ]. The cause was cardiac in 43 percent, psychiatric in 31 percent, and miscellaneous (eg, medication-induced, thyrotoxicosis, caffeine, cocaine, anemia, amphetamine, mastocytosis) in 10 percent. A cardiac etiology was more common in patients presenting to the emergency department than to the medical clinic (47 versus 21 percent), while psychiatric etiologies were more common in the medical clinic (45 versus 27 percent). Cardiac etiologies may also be more common among patients who present to a specialist [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Psychiatric disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Palpitations may be a feature of several psychiatric disorders, including panic attacks, generalized anxiety disorder, somatization, and depression [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/0/32776?source=see_link\">",
"     \"Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link\">",
"     \"Clinical manifestations and diagnosis of depression\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/8/7305?source=see_link\">",
"     \"Pharmacotherapy for panic disorder\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Palpitations are a symptom and can occur in the absence of a cardiac arrhythmia [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/7\">",
"     7",
"    </a>",
"    ]. When palpitations are associated with anxiety or panic, it is frequently difficult for the patient to discern whether the feeling of anxiety or panic preceded or resulted from the palpitations.",
"   </p>",
"   <p>",
"    Psychiatric illness may coexist in patients with another etiology of palpitations [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/3,8\">",
"     3,8",
"    </a>",
"    ]. As an example, in the university study cited above, 24 of the 190 patients (13 percent) were assigned more than one etiology for palpitations; 21 were coexisting psychiatric illnesses [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/3\">",
"     3",
"    </a>",
"    ]. A second report of 107 patients with electrophysiologically documented reentrant supraventricular tachycardia found that there was a median duration of 3.3 years between the initial presentation to a physician and the definitive diagnosis of supraventricular tachycardia; 67 percent of the patients also met the criteria for panic disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/9\">",
"     9",
"    </a>",
"    ]. Supraventricular tachycardia was not diagnosed during an initial medical evaluation in 59 patients and 32 received a diagnosis of panic, stress, or anxiety disorder; 65 percent of these individuals were women. These findings suggest that although there is good evidence that psychiatric disorders are a common cause of palpitations, this diagnosis should not be accepted until arrhythmic etiologies have been excluded.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Cardiac disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned, cardiac disorders are a common cause of palpitations, and their possible presence generates the most concern among physicians evaluating patients with this complaint. The spectrum of cardiac etiologies ranges from arrhythmias (virtually any new deviation from normal sinus rhythm or a significant change in the rate of a stable arrhythmia, such as atrial fibrillation, can cause palpitations) to valvular heart disease (eg, mitral or aortic insufficiency, mitral valve prolapse), the pacemaker syndrome, cardiomyopathy, and atrial myxoma (",
"    <a class=\"graphic graphic_table graphicRef64306 \" href=\"UTD.htm?41/41/42652\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Most patients with palpitations who undergo ambulatory monitoring are found to have benign supraventricular or ventricular ectopy or normal sinus rhythm [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]; normal sinus rhythm is found in up to one-third. Ventricular premature contractions and nonsustained ventricular tachycardia are also found in a substantial proportion of patients with palpitations; they are not associated with increased mortality in patients with structurally normal hearts [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/6/9320?source=see_link\">",
"     \"Prevalence and evaluation of ventricular premature beats\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/27/441?source=see_link\">",
"     \"Supraventricular premature beats\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the university study cited above, four variables were independent predictors of a cardiac etiology of palpitations [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Male sex",
"     </li>",
"     <li>",
"      Description of an irregular heart beat",
"     </li>",
"     <li>",
"      History of heart disease",
"     </li>",
"     <li>",
"      Event duration &gt;5 minutes",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    None of the patients with zero predictors had a cardiac etiology, compared with 26, 48, and 71 percent of patients with 1, 2, and 3 predictors, respectively.",
"   </p>",
"   <p>",
"    Despite the relatively high prevalence of cardiac disorders in this study, the short-term prognosis was excellent; mortality during one year of follow-up was documented in only three women, all over age 70, and none of the deaths was sudden or directly related to the original etiology of palpitations [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/3\">",
"     3",
"    </a>",
"    ]. The one-year stroke rate was also low (1.1 percent).",
"   </p>",
"   <p>",
"    A second outcome study reported similar findings. In this retrospective cohort study of 109 patients with palpitations evaluated in a primary care setting, there was no difference in morbidity or mortality compared with age and sex matched controls over a mean 42 month follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/14\">",
"     14",
"    </a>",
"    ]. Ventricular tachycardia was responsible for palpitations in only four patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Arrhythmias during catecholamine excess",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of sustained supraventricular and ventricular tachyarrhythmias may be provoked by sympathetic stimulation and catecholamine excess, as occurs during exercise or at times of stress. Studies in which exercise testing was performed revealed that nonsustained supraventricular and ventricular premature beats are more common than sustained arrhythmias, and the incidence of any arrhythmia is increased in patients with underlying heart disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/36/36424?source=see_link&amp;anchor=H8#H8\">",
"     \"Clinical significance and treatment of ventricular premature beats\", section on 'Exercise-induced'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29129?source=see_link&amp;anchor=H7#H7\">",
"     \"Exercise ECG testing to determine prognosis of coronary heart disease\", section on 'Ventricular arrhythmias'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29129?source=see_link&amp;anchor=H8#H8\">",
"     \"Exercise ECG testing to determine prognosis of coronary heart disease\", section on 'Atrial arrhythmias'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On the other hand, idiopathic ventricular tachycardia (VT), especially when it arises from the right ventricular outflow tract, can occur during exercise in patients with structurally normal hearts; this arrhythmia most often presents during the second and third decades of life as palpitations, dizziness, or syncope [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/14/26858?source=see_link\">",
"     \"Monomorphic ventricular tachycardia in the absence of apparent structural heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Supraventricular tachyarrhythmias, including atrial fibrillation (AF), can be induced during exercise or at the termination of exercise when the withdrawal of catecholamines is coupled with a surge in vagal tone [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/16\">",
"     16",
"    </a>",
"    ]. AF occurring during this relative increase in vagal tone is particularly common in athletic men in the third to sixth decade of life [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/41/31384?source=see_link&amp;anchor=H5#H5\">",
"     \"Paroxysmal atrial fibrillation\", section on 'Autonomic dysfunction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Catecholamine excess resulting in arrhythmia may also occur during emotionally startling experiences. As an example, patients with the long QT syndrome, especially congenital type 1 or 2 (an inherited abnormality of myocardial repolarization), characteristically present with palpitations during periods of vigorous exercise or emotional stress; the mechanism is often a polymorphic VT known as torsades de pointes [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link\">",
"     \"Clinical features of congenital long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Inappropriate sinus tachycardia is a rare disorder that manifests as palpitations during minimal exertion or with emotional stress. This arrhythmia is characterized by an inappropriate increase in the sinus rate and is most frequently seen in young women; it may result from a hypersensitivity to beta-adrenergic stimulation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/25/14742?source=see_link&amp;anchor=H6#H6\">",
"     \"Sinus tachycardia\", section on 'Inappropriate sinus tachycardia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the vast majority of outpatients with palpitations, the cause of the palpitations is benign, and extensive and costly investigation is not warranted. Attention to characteristics that identify patients at high risk for serious causes of palpitations will help define the much smaller percentage of patients with palpitations who require more extensive diagnostic testing and management of their condition.",
"   </p>",
"   <p>",
"    The diagnostic evaluation of all patients with palpitations should include a detailed history, physical examination, and 12-lead electrocardiography. This, plus some limited laboratory testing, is sufficient to make a definitive diagnosis in more than one-third of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/3\">",
"     3",
"    </a>",
"    ]. Ambulatory monitoring is helpful in the remainder, and rare patients need more specialized testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history should include information on the characteristic presentation of the palpitations, associated sensations, and the patient's age at the onset of palpitations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Age of onset",
"    </span>",
"    &nbsp;&mdash;&nbsp;Age does not appear to be an independent predictor of the presence or absence of a cardiac etiology of palpitations [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/3\">",
"     3",
"    </a>",
"    ]. On the other hand, age may help narrow the differential diagnosis of certain arrhythmias. As an example, a patient who has had rapid palpitations since childhood is most likely to have a supraventricular tachycardia, particularly one that uses a bypass tract, although atrioventricular nodal reentrant tachycardia (AVNRT) is also possible. Other types of paroxysmal supraventricular tachycardia, such as atrial tachycardia or AF, are more likely to occur as the subject ages. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/22/361?source=see_link\">",
"     \"Overview of atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Serious ventricular arrhythmias typically occur in older patients with structural heart disease. However, idiopathic VT occasionally occurs in adolescence and many cases of torsades de pointes due to congenital long QT syndrome occur before the age of 20. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/14/26858?source=see_link\">",
"     \"Monomorphic ventricular tachycardia in the absence of apparent structural heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link\">",
"     \"Clinical features of congenital long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Description",
"    </span>",
"    &nbsp;&mdash;&nbsp;Palpitations are described in many ways, but some specific sensations are common and useful for narrowing the differential diagnosis. Thus, it is critical that the patient give a detailed description of the sensation associated with the symptom of palpitation. In particular, it is important to establish the rate and degree of regularity of the palpitations; it may be helpful to have the patient tap out the rhythm with the fingers. It may also be useful for the physician to provide examples of rapid and regular rhythms, rapid and irregular rhythms, slow and regular rhythms, and slow and irregular rhythms. Rapid and regular rhythms are suggestive of paroxysmal supraventricular tachycardia or VT. Rapid and irregular rhythms suggest atrial fibrillation, atrial flutter, or tachycardia with variable block.",
"   </p>",
"   <p>",
"    Other descriptions can also provide helpful information:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Flip-flopping in the chest &mdash; In some cases the palpitations are sensed as the heart seeming to stop and then start again, producing a pounding or flip-flopping sensation. This type of palpitation is generally caused by supraventricular or ventricular premature contractions. The sensation that the heart has stopped results from the pause following the premature contraction, and the pounding or flipping sensation results from the forceful contraction following the pause (ie, post extrasystolic potentiation of ventricular inotropy). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/27/441?source=see_link\">",
"       \"Supraventricular premature beats\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/6/9320?source=see_link\">",
"       \"Prevalence and evaluation of ventricular premature beats\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Rapid fluttering in the chest &mdash; A feeling of rapid fluttering in the chest often results from a sustained ventricular or supraventricular arrhythmia, including sinus tachycardia. The regularity or irregularity of the palpitation may indicate the probable arrhythmic etiology; as examples, atrial fibrillation is irregular while sinus tachycardia and AVNRT are regular.",
"     </li>",
"     <li>",
"      Pounding in the neck &mdash; An irregular pounding feeling in the neck is caused by atrioventricular dissociation, with independent contraction of the atria and ventricles, resulting in occasional atrial contraction against a closed tricuspid and mitral valve. This produces cannon A waves, which are intermittent increases in the \"A\" wave of the jugular venous pulse. Cannon A waves may be seen with ventricular premature contractions, third degree or complete heart block, or ventricular tachycardia (VT). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/59/33719?source=see_link\">",
"       \"Examination of the jugular venous pulse\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Rapid and regular neck pulsations, which are due to prominent and regular A waves, may be seen as a bulging in the neck, sometimes termed a \"frog sign\" [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/19\">",
"     19",
"    </a>",
"    ]. The sensation of rapid and regular pounding in the neck is most typical of reentrant supraventricular arrhythmias, particularly AVNRT or atrioventricular reentrant tachycardia due to a preexcitation syndrome. AVNRT is the most common form of paroxysmal supraventricular tachycardia and is three times as common in women as in men [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/20\">",
"     20",
"    </a>",
"    ]. In the typical form of atrioventricular nodal tachycardia, the atria and ventricles are activated simultaneously at an average rate of",
"    <strong>",
"     160 to 180",
"    </strong>",
"    beats per minute; as a result of simultaneous atrial and ventricular contraction, the atria are always contracting against a closed or partially closed mitral and tricuspid valve. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24793?source=see_link\">",
"     \"Atrioventricular nodal reentrant tachycardia (junctional reciprocating tachycardia)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24311?source=see_link\">",
"     \"Atrioventricular reentrant tachycardia (AVRT) associated with an accessory pathway\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Onset and offset",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mode of onset and termination of the palpitations sometimes indicates their cause. Palpitations that occur randomly and episodically and last for an instant are generally due to premature beats, while a gradual onset and offset suggests a sinus tachycardia. Palpitations described as abrupt in onset and termination may be caused by supraventricular or ventricular tachycardias.",
"   </p>",
"   <p>",
"    Patients often become adept at terminating their own palpitations with carotid sinus massage or other vagal maneuvers, such as the Valsalva maneuver. This mode of termination is suggestive of supraventricular tachycardias, particularly atrioventricular nodal tachycardia or those using a bypass tract. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24793?source=see_link\">",
"     \"Atrioventricular nodal reentrant tachycardia (junctional reciprocating tachycardia)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24311?source=see_link\">",
"     \"Atrioventricular reentrant tachycardia (AVRT) associated with an accessory pathway\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Positional palpitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have a history of AVNRT frequently experience the arrhythmia upon standing up straight after bending over; the arrhythmia may end when lying down.",
"   </p>",
"   <p>",
"    Often a patient notes an intermittent pounding sensation while lying in bed, particularly in the supine or left lateral decubitus position. This symptom is commonly the result of supraventricular or ventricular premature beats, which occur more frequently at slow heart rates, as when a person is resting in bed. In the left lateral decubitus position, the apex of the heart is closer to the chest wall, which may account for the greater awareness of palpitations in this position.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Palpitations associated with syncope or presyncope",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dizziness, presyncope, or syncope may accompany palpitations and should prompt a search for a hemodynamically significant and potentially serious arrhythmia, most importantly VT. Short runs of nonsustained VT can cause syncope as well as a sensation of palpitations.",
"   </p>",
"   <p>",
"    Occasionally syncope is associated with a supraventricular tachycardia, particularly at the beginning of the tachycardia. This type of syncope is believed to result from acute vasodilation, rapid heart rate with low cardiac output, or both [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/9/5272?source=see_link\">",
"     \"Pathogenesis and etiology of syncope\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Psychiatric illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no optimal screening tool for psychiatric causes of arrhythmia. In one study of 125 outpatients referred for ambulatory electrocardiographic monitoring to evaluate a complaint of palpitations, patients with psychiatric disorders were significantly younger and more disabled, somatized more, and had more hypochondriacal concerns about their health [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/23\">",
"     23",
"    </a>",
"    ]. Their palpitations were more likely to last longer than 15 minutes, were accompanied by more ancillary symptoms, were described as more intense, and were associated with more emergency department visits.",
"   </p>",
"   <p>",
"    Diagnostic criteria for the major psychiatric disorders associated with palpitations (panic attacks, generalized anxiety disorder, somatization, depression) have been established (",
"    <a class=\"graphic graphic_table graphicRef73966 \" href=\"UTD.htm?37/9/38044\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef55612 \" href=\"UTD.htm?28/54/29547\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/0/32776?source=see_link\">",
"     \"Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link\">",
"     \"Clinical manifestations and diagnosis of depression\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/8/7305?source=see_link\">",
"     \"Pharmacotherapy for panic disorder\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Medications and habits",
"    </span>",
"    &nbsp;&mdash;&nbsp;A history of all medications, including over-the-counter medications, should be obtained. In particular, palpitations may occur with the use of sympathomimetic agents, vasodilators, anticholinergic drugs, or during withdrawal from beta blockers.",
"   </p>",
"   <p>",
"    Illicit drug use (eg, cocaine or amphetamines) and nicotine use should also be established. Any temporal relationship between palpitations and excessive caffeine intake should also be sought.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Other medical disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;A history of or symptoms consistent with any of the medical disorders that can be associated with palpitations (eg, hypoglycemia, thyrotoxicosis, pheochromocytoma) should be determined. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/39/24184?source=see_link\">",
"     \"Hypoglycemia in adults without diabetes mellitus: Diagnostic approach\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/60/14279?source=see_link\">",
"     \"Overview of the clinical manifestations of hyperthyroidism in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=see_link\">",
"     \"Clinical presentation and diagnosis of pheochromocytoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some studies suggest that palpitations can occur more frequently in pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14362?source=see_link\">",
"     \"Supraventricular arrhythmias during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physician rarely has an opportunity to examine a patient during an episode of palpitations, but the physical examination is still useful in defining potential cardiovascular abnormalities that could serve as a substrate for arrhythmias and in identifying some other medical disorders that may be associated with palpitations. A notable example is the midsystolic click and occasionally murmur associated with mitral valve prolapse. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13705?source=see_link\">",
"     \"Definition and diagnosis of mitral valve prolapse\"",
"    </a>",
"    .) Virtually every type of supraventricular arrhythmia, as well as ventricular premature depolarizations and nonsustained ventricular tachycardia, has been described with mitral valve prolapse, and palpitations are nearly ubiquitous in the subset of patients with mitral valve prolapse who have the mitral valve prolapse syndrome, even in patients who do not have an identifiable arrhythmia [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17719?source=see_link\">",
"     \"Arrhythmic complications of mitral valve prolapse\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3476?source=see_link&amp;anchor=H7#H7\">",
"     \"Mitral valve prolapse syndrome\", section on 'Palpitations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A harsh holosystolic murmur heard along the left sternal border that increases when the Valsalva maneuver is performed suggests hypertrophic obstructive cardiomyopathy. Atrial fibrillation is a common cause of palpitations in this disorder, but it is also associated with ventricular tachycardia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinical evidence of a dilated cardiomyopathy and heart failure raise the possibility of ventricular tachycardia as well as atrial fibrillation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/17/14615?source=see_link\">",
"     \"Pathogenesis of ventricular arrhythmias in heart failure and cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The physical examination can be very useful for evaluating patients with chronic atrial fibrillation and palpitations. Although palpitations may not be present at rest, when the ventricular response is slow, a brisk walk down the corridor, which results in sympathetic activation and an increase in catecholamines, will enhance atrioventricular nodal conduction and may unmask a poorly controlled ventricular response and resultant palpitations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/22/361?source=see_link\">",
"     \"Overview of atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Twelve-lead ECG",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of palpitations should be clear in the few patients in whom an arrhythmia correlating with palpitations is captured on a 12-lead electrocardiogram (ECG). If the arrhythmia is documented on ECG (eg, atrial fibrillation or ventricular tachycardia), the patient should be managed according to the underlying arrhythmia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/28/33223?source=see_link\">",
"     \"Arrhythmia management for the primary care clinician\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, most patients are in sinus rhythm when the ECG is obtained; in this situation the 12-lead electrocardiography (ECG) may help narrow the differential diagnosis of palpitations&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The electrocardiogram should be scrutinized for the presence of a short PR interval and delta waves (the Wolff-Parkinson-White syndrome), which confirms the presence of ventricular preexcitation and suggests it as the cause of supraventricular tachycardia (",
"      <a class=\"graphic graphic_waveform graphicRef75578 \" href=\"UTD.htm?34/55/35706\">",
"       waveform 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Marked left ventricular hypertrophy with deep septal Q waves in I, aVL, and V4 through V6 suggests the presence of hypertrophic obstructive cardiomyopathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy\"",
"      </a>",
"      .) Left ventricular hypertrophy with evidence of left atrial abnormality (as indicated by a terminal P-wave force in V1 more negative than 0.04 msec and notched in lead II) suggests a likely substrate for atrial fibrillation.",
"     </li>",
"     <li>",
"      The presence of Q waves characteristic of a prior myocardial infarction warrants a more extensive search for nonsustained or sustained ventricular tachycardia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/0/36868?source=see_link\">",
"       \"Pathogenesis and diagnosis of Q waves on the electrocardiogram\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Isolated supraventricular",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ventricular ectopy may occasionally be seen on the 12-lead ECG. The morphology of the ventricular premature beats, particularly in patients with normal hearts, may suggest that an idiopathic ventricular tachycardia is the cause of the palpitations.",
"     </li>",
"     <li>",
"      Prolongation of the QT interval and abnormal T wave morphology may suggest the presence of the long QT syndrome (",
"      <a class=\"graphic graphic_waveform graphicRef77018 \" href=\"UTD.htm?26/24/27008\">",
"       waveform 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=see_link\">",
"       \"Clinical features of congenital long QT syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A bradycardia of any etiology can be accompanied by ventricular premature depolarizations and associated palpitations. In particular, complete heart block can be associated with ventricular premature depolarizations or a prolonged QT interval and torsades de pointes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no evidence-based guidelines to direct the laboratory work-up of patients with palpitations. Limited laboratory testing to rule out anemia and hyperthyroidism is reasonable, in addition to testing for specific disorders that may be suggested by the history and physical examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Further diagnostic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;While most patients with palpitations do not have a life-threatening condition, the majority have recurrent symptoms that can adversely effect quality of life [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/3\">",
"     3",
"    </a>",
"    ]. Thus, when the history, physical examination, electrocardiogram, and laboratory testing do not establish a definitive diagnosis, additional testing can serve several purposes: to rule out a serious condition; to possible identify a treatable cardiac dysrhythmia (eg, atrial fibrillation); and to reassure the patient.",
"   </p>",
"   <p>",
"    Diagnostic testing is recommended for three groups of patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Those in whom the initial diagnostic evaluation (history, physical examination, and electrocardiogram) suggests an arrhythmic cause. Testing is particularly important in patients who experience syncope or presyncope in association with palpitations.",
"     </li>",
"     <li>",
"      Those who are at high risk for an arrhythmia. Patients are considered at high risk if they have organic heart disease or any myocardial abnormality that can lead to serious arrhythmias, including scar formation from myocardial infarction, idiopathic dilated cardiomyopathy, clinically significant valvular regurgitant or stenotic lesions, and hypertrophic cardiomyopathy. These disorders have all been shown to be associated with the development of ventricular tachycardia [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/25\">",
"       25",
"      </a>",
"      ]. Other high-risk patients are those with a family history of arrhythmia, syncope, or sudden death from cardiac causes, such as from a cardiomyopathy or the long QT syndrome. Low-risk patients are those without a potential substrate for arrhythmias.",
"     </li>",
"     <li>",
"      Those who remain anxious to have a specific explanation for their symptoms.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In low-risk patients, we use ambulatory monitoring only if the history or ECG is suggestive of a sustained arrhythmia or the patient needs the reassurance of a documented benign cause for the palpitations. Additional diagnostic procedures in high-risk patients include ambulatory or transtelephonic monitoring devices, and ultimately invasive electrophysiologic testing if clinically significant arrhythmias are recognized or are suspected but not recorded by ambulatory monitoring devices.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Ambulatory monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ambulatory ECG monitoring devices are the most important tools for the diagnosis of unexplained recurrent palpitations [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/32/36361?source=see_link\">",
"     \"Ambulatory monitoring in the assessment of cardiac arrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Holter monitor is a 24-hour monitoring system that records and saves data continuously. The device is worn for one or two days while the patient keeps a diary recording the time and characteristics of symptoms.",
"     </li>",
"     <li>",
"      Continuous loop event recorders continuously record data, but save the data for the preceding and subsequent two minutes (or for other periods, as programmed) only when the patient manually activates the monitor. These recording devices are capable of direct transmission of the ECG as an audio signal via the telephone [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The implantable loop recorder (ILR) is a subcutaneous monitoring device for the detection of cardiac arrhythmias [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/28\">",
"       28",
"      </a>",
"      ]. Such a device is typically implanted in the left pectoral region and stores events when the device is activated automatically according to programmed criteria or manually with magnet application. The ILR is most often used for patients with unexplained syncope, but it may have a role for those in whom other methods have failed to document the cause of palpitations. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=see_link&amp;anchor=H30#H30\">",
"       \"Evaluation of syncope in adults\", section on 'Electrocardiographic monitoring'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Holter monitors are inherently limited by the short duration of time available for monitoring. In addition, arrhythmias may be identified on a Holter recording that are unrelated to the palpitations. This was illustrated in a study of 1454 elderly patients aged 60 to 94 years, 8.3 percent of whom complained of palpitations [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/29\">",
"     29",
"    </a>",
"    ]. Arrhythmias, predominantly conduction abnormalities and sinus bradycardia, were found in 12.6 percent. However, the prevalence of palpitations was similar in those with and without arrhythmias. In another study of 518 patients who had 24-hour electrocardiographic recordings, 34 percent had their typical symptoms at a time when the electrocardiogram was normal [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Continuous loop recorders can be used for longer periods than Holter monitors and, since most patients with palpitations do not have them every day, are more likely to record data during palpitations. Furthermore, symptoms can be directly correlated with the cardiac rhythm since the patient activates the monitor.",
"   </p>",
"   <p>",
"    A review of four prospective and two retrospective studies of patients with palpitations found that the diagnostic yield was 66 to 83 percent for continuous loop devices, compared with 33 to 35 percent for Holter monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/30\">",
"     30",
"    </a>",
"    ]. In addition, continuous loop recorders have proved more cost effective than Holter monitors for the evaluation of palpitations [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/10,31\">",
"     10,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two weeks of transtelephonic monitoring is sufficient to make a diagnosis in the vast majority of patients with palpitations and is less costly than the standard monitoring period of one month. As an example, in a retrospective analysis of 5,052 patients who had undergone event recording with a continuous loop monitor, 87 percent had an initial transmission corresponding to palpitations in the first two weeks of monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/32\">",
"     32",
"    </a>",
"    ]. An additional 9 percent of initial transmissions occurred by four weeks of monitoring. In a second report of 105 outpatients referred for placement of a transtelephonic monitor for the evaluation of palpitations, the diagnostic yield was 1.04 diagnoses per patient in week one, 0.15 in week two, and 0.01 diagnoses per patient in week three and beyond [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/11\">",
"     11",
"    </a>",
"    ]. The cost-effectiveness ratio increased from $98 per new diagnosis in week one, to $576 and $5832 in weeks two and three, respectively.",
"   </p>",
"   <p>",
"    Thus, the data support two weeks of continuous loop event recording in patients with palpitations. A 24-hour Holter monitor can be used in patients with daily palpitations, particularly if the patient is likely to have trouble activating the loop recorder. An implantable event recorder can be used in selected patients with infrequent but symptomatic palpitations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Electrophysiologic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Invasive cardiac electrophysiology is an established technique for the diagnosis of a suspected arrhythmia and is important for the therapy of certain rhythm abnormalities (eg, supraventricular tachycardia). It permits a detailed analysis of the mechanism underlying the cardiac arrhythmia and precise location of the site of origin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/2/12326?source=see_link\">",
"     \"Overview of invasive cardiac electrophysiology studies\"",
"    </a>",
"    .) Electrophysiologic testing is indicated in patients with a high pretest likelihood of a serious arrhythmia (eg, patients with structural heart disease).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Diagnostic recommendations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of patients with palpitations should begin with a history, physical examination, 12-lead ECG, and in some cases limited laboratory testing.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If there is no evidence of heart disease and the palpitations are unsustained and well tolerated, ambulatory monitoring or reassurance is recommended. Two weeks of transtelephonic monitoring is the optimal ambulatory monitoring technique in most cases.",
"     </li>",
"     <li>",
"      If the initial evaluation suggests heart disease and the palpitations are unsustained, ambulatory monitoring is again recommended.",
"     </li>",
"     <li>",
"      Regardless of the presence or absence of heart disease, if the palpitations are sustained or poorly tolerated, an electrophysiologic study, with or without prior ambulatory monitoring, is indicated. A Task Force of the",
"      <span class=\"nowrap\">",
"       ACC/AHA",
"      </span>",
"      has published recommendations for electrophysiologic studies in patients with palpitations [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of most sustained supraventricular or ventricular arrhythmias causing palpitations involves referral to a specialist trained in the pharmacologic and invasive electrophysiologic management of arrhythmias. Most types of regular supraventricular tachycardias and some types of ventricular tachycardias are now curable with radiofrequency ablation [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/25/19866?source=see_link\">",
"     \"Catheter ablation of cardiac arrhythmias: Overview and technical aspects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most challenging cases of palpitations are those due to benign supraventricular or ventricular ectopy or associated with normal sinus rhythm. I attempt to reassure patients with these benign diagnoses that these rhythms are not life-threatening. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/6/9320?source=see_link\">",
"     \"Prevalence and evaluation of ventricular premature beats\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/27/441?source=see_link\">",
"     \"Supraventricular premature beats\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the rare cases in which the supraventricular or ventricular ectopy proves incapacitating, treatment with beta-blocking medications can be initiated (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/31/39417?source=see_link\">",
"     metoprolol",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/46/30440?source=see_link\">",
"     atenolol",
"    </a>",
"    50 mg daily). The beta blocker may not suppress the arrhythmia, but it can eliminate the associated symptoms and make the patient more comfortable. Antiarrhythmic medications are not recommended, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/48/777?source=see_link\">",
"     quinidine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/30/30182?source=see_link\">",
"     flecainide",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/13/21721?source=see_link\">",
"     sotalol",
"    </a>",
"    because of the associated risks of proarrhythmia.",
"   </p>",
"   <p>",
"    In general, radiofrequency ablation of isolated ventricular ectopy is not recommended. However, on rare occasions, ventricular bigeminy can produce palpitations with fatigue and near-syncope on exertion because of a slow effective heart rate and low cardiac output. Radiofrequency ablation may be considered in this circumstance, if the ventricular ectopy has uniform morphologic features and occurs incessantly. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27097?source=see_link&amp;anchor=H14#H14\">",
"     \"Tachycardia-mediated cardiomyopathy\", section on 'Frequent ventricular ectopy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/36/36424?source=see_link&amp;anchor=H15#H15\">",
"     \"Clinical significance and treatment of ventricular premature beats\", section on 'Radiofrequency ablation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of inappropriate sinus tachycardia deserves special mention. The diagnosis of inappropriate sinus tachycardia can be made after secondary causes, such as hyperthyroidism or anemia, have been excluded and the patient has undergone electrophysiologic testing to rule out other forms of supraventricular tachycardia that may mimic sinus tachycardia, such as right atrial tachycardia and sinus node reentry [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/35\">",
"     35",
"    </a>",
"    ]. The first line of therapy is pharmacologic treatment with beta blockers or calcium channel blockers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/25/14742?source=see_link&amp;anchor=H6#H6\">",
"     \"Sinus tachycardia\", section on 'Inappropriate sinus tachycardia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If this strategy fails, radiofrequency ablation or modification of the sinus node can be attempted. However, these treatments are often unrewarding and may result in serious complications, such as complete destruction of the sinus node, requiring permanent pacing, or paralysis of the phrenic nerve [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20665/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/41/33431?source=see_link&amp;anchor=H6#H6\">",
"     \"Catheter ablation of atrial tachycardia\", section on 'Inappropriate sinus tachycardia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Palpitations are defined as an unpleasant awareness of the forceful, rapid, or irregular beating of the heart. The differential diagnosis of palpitations is extensive, but is most commonly due to cardiac and psychiatric illness (",
"      <a class=\"graphic graphic_table graphicRef64306 \" href=\"UTD.htm?41/41/42652\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the majority of patients, the cause of palpitations is benign, and costly investigation is not warranted. Attention to characteristics that identify patients at high risk for serious causes of palpitations (eg, structural heart disease) will help identify the small percentage of patients who require more extensive diagnostic testing. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnostic evaluation of all patients with palpitations should include a detailed history, physical examination, and 12-lead ECG. Limited laboratory testing to rule out anemia and hyperthyroidism is also reasonable. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with bothersome and recurrent symptoms, ambulatory monitoring is helpful if the palpitations are unsustained and well tolerated. For most patients, two weeks of transtelephonic monitoring is the optimal ambulatory monitoring technique. A 24-hour Holter monitor can be considered in patients who have daily symptoms. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Ambulatory monitoring'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the palpitations are sustained or poorly tolerated, an electrophysiologic study is indicated. Electrophysiologic testing is also useful in patients with a high pretest likelihood of a serious arrhythmia (eg, patients with structural heart disease). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/2/12326?source=see_link\">",
"       \"Overview of invasive cardiac electrophysiology studies\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The management of most sustained supraventricular or ventricular arrhythmias causing palpitations should be managed by a cardiologist trained in the pharmacologic and invasive electrophysiologic management of arrhythmias. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/1\">",
"      Kroenke K, Arrington ME, Mangelsdorff AD. The prevalence of symptoms in medical outpatients and the adequacy of therapy. Arch Intern Med 1990; 150:1685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/2\">",
"      Zimetbaum P, Josephson ME. Evaluation of patients with palpitations. N Engl J Med 1998; 338:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/3\">",
"      Weber BE, Kapoor WN. Evaluation and outcomes of patients with palpitations. Am J Med 1996; 100:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/4\">",
"      Mayou R, Sprigings D, Birkhead J, Price J. Characteristics of patients presenting to a cardiac clinic with palpitation. QJM 2003; 96:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/5\">",
"      Barsky AJ, Cleary PD, Coeytaux RR, Ruskin JN. Psychiatric disorders in medical outpatients complaining of palpitations. J Gen Intern Med 1994; 9:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/6\">",
"      Barsky AJ, Cleary PD, Sarnie MK, Ruskin JN. Panic disorder, palpitations, and the awareness of cardiac activity. J Nerv Ment Dis 1994; 182:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/7\">",
"      Zeldis SM, Levine BJ, Michelson EL, Morganroth J. Cardiovascular complaints. Correlation with cardiac arrhythmias on 24-hour electrocardiographic monitoring. Chest 1980; 78:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/8\">",
"      Barsky AJ, Cleary PD, Coeytaux RR, Ruskin JN. The clinical course of palpitations in medical outpatients. Arch Intern Med 1995; 155:1782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/9\">",
"      Lessmeier TJ, Gamperling D, Johnson-Liddon V, et al. Unrecognized paroxysmal supraventricular tachycardia. Potential for misdiagnosis as panic disorder. Arch Intern Med 1997; 157:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/10\">",
"      Kinlay S, Leitch JW, Neil A, et al. Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations. A controlled clinical trial. Ann Intern Med 1996; 124:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/11\">",
"      Zimetbaum PJ, Kim KY, Josephson ME, et al. Diagnostic yield and optimal duration of continuous-loop event monitoring for the diagnosis of palpitations. A cost-effectiveness analysis. Ann Intern Med 1998; 128:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/12\">",
"      Zimetbaum P, Kim KY, Ho KK, et al. Utility of patient-activated cardiac event recorders in general clinical practice. Am J Cardiol 1997; 79:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/13\">",
"      Kennedy HL, Whitlock JA, Sprague MK, et al. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 1985; 312:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/14\">",
"      Knudson MP. The natural history of palpitations in a family practice. J Fam Pract 1987; 24:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/15\">",
"      Varma N, Josephson ME. Therapy of \"idiopathic\" ventricular tachycardia. J Cardiovasc Electrophysiol 1997; 8:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/16\">",
"      Bunch TJ, Chandrasekaran K, Gersh BJ, et al. The prognostic significance of exercise-induced atrial arrhythmias. J Am Coll Cardiol 2004; 43:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/17\">",
"      Coumel P. Autonomic influences in atrial tachyarrhythmias. J Cardiovasc Electrophysiol 1996; 7:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/18\">",
"      Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001; 103:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/19\">",
"      Brugada P, G&uuml;rsoy S, Brugada J, Andries E. Investigation of palpitations. Lancet 1993; 341:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/20\">",
"      Josephson ME, Wellens HJ. Differential diagnosis of supraventricular tachycardia. Cardiol Clin 1990; 8:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/21\">",
"      Goldreyer BN, Kastor JA, Kershbaum KL. The hemodynamic effects of induced supraventricular tachycardia in man. Circulation 1976; 54:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/22\">",
"      Leitch JW, Klein GJ, Yee R, et al. Syncope associated with supraventricular tachycardia. An expression of tachycardia rate or vasomotor response? Circulation 1992; 85:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/23\">",
"      Barsky AJ, Delamater BA, Clancy SA, et al. Somatized psychiatric disorder presenting as palpitations. Arch Intern Med 1996; 156:1102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/24\">",
"      D&uuml;ren DR, Becker AE, Dunning AJ. Long-term follow-up of idiopathic mitral valve prolapse in 300 patients: a prospective study. J Am Coll Cardiol 1988; 11:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/25\">",
"      Wolfe RR, Driscoll DJ, Gersony WM, et al. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular septal defect. Results of 24-hour ECG monitoring. Circulation 1993; 87:I89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/26\">",
"      Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA guidelines for ambulatory electrocardiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the guidelines for ambulatory electrocardiography). Circulation 1999; 100:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/27\">",
"      Antman EM, Ludmer PL, McGowan N, et al. Transtelephonic electrocardiographic transmission for management of cardiac arrhythmias. Am J Cardiol 1986; 58:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/28\">",
"      Krahn AD, Klein GJ, Skanes AC, Yee R. Insertable loop recorder use for detection of intermittent arrhythmias. Pacing Clin Electrophysiol 2004; 27:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/29\">",
"      Lok NS, Lau CP. Prevalence of palpitations, cardiac arrhythmias and their associated risk factors in ambulant elderly. Int J Cardiol 1996; 54:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/30\">",
"      Zimetbaum PJ, Josephson ME. The evolving role of ambulatory arrhythmia monitoring in general clinical practice. Ann Intern Med 1999; 130:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/31\">",
"      Fogel RI, Evans JJ, Prystowsky EN. Utility and cost of event recorders in the diagnosis of palpitations, presyncope, and syncope. Am J Cardiol 1997; 79:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/32\">",
"      Reiffel JA, Schulhof E, Joseph B, et al. Optimum duration of transtelephonic ECG monitoring when used for transient symptomatic event detection. J Electrocardiol 1991; 24:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/33\">",
"      Zipes DP, DiMarco JP, Gillette PC, et al. Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 1995; 26:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/34\">",
"      Guidelines for Clinical Intracardiac Electrophysiological and Catheter Ablation Procedures. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures). Developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 1995; 92:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20665/abstract/35\">",
"      Krahn AD, Yee R, Klein GJ, Morillo C. Inappropriate sinus tachycardia: evaluation and therapy. J Cardiovasc Electrophysiol 1995; 6:1124.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6835 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.81.197.98-2E1E3D353B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_11_20665=[""].join("\n");
var outline_f20_11_20665=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Psychiatric disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Cardiac disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Arrhythmias during catecholamine excess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Age of onset",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Description",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Onset and offset",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Positional palpitations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Palpitations associated with syncope or presyncope",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Psychiatric illness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Medications and habits",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Other medical disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Twelve-lead ECG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Further diagnostic testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Ambulatory monitoring",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Electrophysiologic testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Diagnostic recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/6835\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6835|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/41/42652\" title=\"table 1\">",
"      Causes of palpitations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/9/38044\" title=\"table 2\">",
"      Dx criteria panic disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/54/29547\" title=\"table 3\">",
"      Dx criteria generalized anxiety",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6835|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?34/55/35706\" title=\"waveform 1\">",
"      ECG WPW tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?26/24/27008\" title=\"waveform 2\">",
"      Prolonged QT interval tutorial",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/32/36361?source=related_link\">",
"      Ambulatory monitoring in the assessment of cardiac arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/38/9832?source=related_link\">",
"      Approach to the child with tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/28/33223?source=related_link\">",
"      Arrhythmia management for the primary care clinician",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17719?source=related_link\">",
"      Arrhythmic complications of mitral valve prolapse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24793?source=related_link\">",
"      Atrioventricular nodal reentrant tachycardia (junctional reciprocating tachycardia)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24311?source=related_link\">",
"      Atrioventricular reentrant tachycardia (AVRT) associated with an accessory pathway",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/41/33431?source=related_link\">",
"      Catheter ablation of atrial tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/25/19866?source=related_link\">",
"      Catheter ablation of cardiac arrhythmias: Overview and technical aspects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/9/2202?source=related_link\">",
"      Clinical features of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=related_link\">",
"      Clinical manifestations and diagnosis of depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=related_link\">",
"      Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=related_link\">",
"      Clinical presentation and diagnosis of pheochromocytoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/36/36424?source=related_link\">",
"      Clinical significance and treatment of ventricular premature beats",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13705?source=related_link\">",
"      Definition and diagnosis of mitral valve prolapse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=related_link\">",
"      Evaluation of syncope in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/59/33719?source=related_link\">",
"      Examination of the jugular venous pulse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29129?source=related_link\">",
"      Exercise ECG testing to determine prognosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/0/32776?source=related_link\">",
"      Generalized anxiety disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/39/24184?source=related_link\">",
"      Hypoglycemia in adults without diabetes mellitus: Diagnostic approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3476?source=related_link\">",
"      Mitral valve prolapse syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/14/26858?source=related_link\">",
"      Monomorphic ventricular tachycardia in the absence of apparent structural heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/22/361?source=related_link\">",
"      Overview of atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/2/12326?source=related_link\">",
"      Overview of invasive cardiac electrophysiology studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/60/14279?source=related_link\">",
"      Overview of the clinical manifestations of hyperthyroidism in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/41/31384?source=related_link\">",
"      Paroxysmal atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/0/36868?source=related_link\">",
"      Pathogenesis and diagnosis of Q waves on the electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/9/5272?source=related_link\">",
"      Pathogenesis and etiology of syncope",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/17/14615?source=related_link\">",
"      Pathogenesis of ventricular arrhythmias in heart failure and cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/8/7305?source=related_link\">",
"      Pharmacotherapy for panic disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/6/9320?source=related_link\">",
"      Prevalence and evaluation of ventricular premature beats",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/25/14742?source=related_link\">",
"      Sinus tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14362?source=related_link\">",
"      Supraventricular arrhythmias during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/27/441?source=related_link\">",
"      Supraventricular premature beats",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/29/27097?source=related_link\">",
"      Tachycardia-mediated cardiomyopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_11_20666="Postpartum blues and depression";
var content_f20_11_20666=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Postpartum blues and depression",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/11/20666/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/11/20666/contributors\">",
"     Shari I Lusskin, MD, FAPA",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/11/20666/contributors\">",
"     Shaila Misri, MD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/11/20666/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/11/20666/contributors\">",
"     Peter P Roy-Byrne, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/11/20666/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?20/11/20666/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?20/11/20666/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?20/11/20666/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 15, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women and their friends, families, and clinicians expect the postpartum period to be a happy time, characterized by the joyful homecoming of the newborn. Unfortunately, many women will experience short- or long-term mood disturbances postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Postpartum depression and postpartum psychosis can transform this period into a nightmare. Panic disorder, generalized anxiety disorder (GAD), and obsessive compulsive disorder (OCD) can also arise or recur in the postpartum period. Obsessional thoughts may herald the new onset of OCD, or exacerbation of pre-existing but undiagnosed OCD. Both panic disorder and OCD are frequently comorbid with postpartum depression and may dramatically worsen the prognosis. GAD is often missed, as health care providers often do not recognize when worry experienced by new mothers is excessive and outside the normal range. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42582?source=see_link\">",
"     \"Obsessive-compulsive disorder in pregnant and postpartum women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Screening, diagnosis, and treatment of postpartum blues and depression will be reviewed here. Diagnosis and treatment of antepartum depression are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/2/29735?source=see_link\">",
"     \"Depression in pregnant women: Clinical features and consequences\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     POSTPARTUM BLUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postpartum blues refer to a transient condition characterized by mild, and often rapid, mood swings from elation to sadness, irritability, anxiety, decreased concentration, insomnia, tearfulness, and crying spells [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/4\">",
"     4",
"    </a>",
"    ]. Forty to 80 percent of postpartum women develop these mood changes, generally within two to three days of delivery. Symptoms typically peak on the fifth postpartum day and resolve within two weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/1\">",
"     1",
"    </a>",
"    ]. By comparison, a diagnosis of major and minor depression requires that depressed mood or loss of",
"    <span class=\"nowrap\">",
"     interests/pleasure",
"    </span>",
"    and other characteristic symptoms be present most of the day, nearly every day, for at least two weeks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link\">",
"     \"Clinical manifestations and diagnosis of depression\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Etiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there are no conclusive data regarding the etiology of postpartum blues, multiple factors are probably involved. The dramatic hormonal changes at parturition likely play a role, but studies have shown discordant results [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/4-7\">",
"     4-7",
"    </a>",
"    ]. Although all women experience hormonal fluctuations postpartum, some women may be more sensitive to these changes than others [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Women at high risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Major risk factors for postpartum blues include [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/4,9,10\">",
"     4,9,10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      History of depression",
"     </li>",
"     <li>",
"      Depressive symptoms during pregnancy",
"     </li>",
"     <li>",
"      Family history of depression",
"     </li>",
"     <li>",
"      Premenstrual or oral contraceptive associated mood changes",
"     </li>",
"     <li>",
"      Stress around child care",
"     </li>",
"     <li>",
"      Psychosocial impairment in the areas of work, relationships, and leisure activities.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Women with postpartum blues are at increased risk of developing postpartum depression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postpartum blues typically resolve over time and with conservative management. Useful interventions include providing support and reassurance to the woman and her family and insuring that she has adequate time for sleep and rest. Allowing someone else to care for the baby at night is often sufficient, but if not, then judicious use of minor tranquilizers is indicated. Low-dose benzodiazepines, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/45/26328?source=see_link\">",
"     clonazepam",
"    </a>",
"    (0.5 to 1 mg orally at bedtime) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"     lorazepam",
"    </a>",
"    (0.5 to 1 mg orally at bedtime) will help control insomnia. They have addictive potential so they should only be used for limited periods. Alcohol should be avoided as it may exacerbate mood swings.",
"   </p>",
"   <p>",
"    Women with postpartum blues must also be advised to seek evaluation promptly for postpartum depression if their symptoms do not resolve within two weeks or if they become worse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     POSTPARTUM DEPRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postpartum depression (PPD) affects many women from diverse cultures [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/11-16\">",
"     11-16",
"    </a>",
"    ]. It often goes unrecognized because many of the usual discomforts of the puerperium (eg, fatigue, difficulty sleeping, low libido) are similar to symptoms of depression. For this reason, and possibly because of perceived societal expectations of the new mother, postpartum women are often reluctant to complain about their mood. This was illustrated in a study in which only one-third of women with PPD believed they were suffering from this disorder and 80 percent had not reported their symptoms to a health professional. [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Prevalence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of postpartum depression appears to be close to that reported in nonpregnant women (point prevalence 5 to 9 percent, with a lifetime risk of 10 to 25 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/18\">",
"     18",
"    </a>",
"    ]) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/19\">",
"     19",
"    </a>",
"    ]. Prevalence estimates vary depending upon the study method used, diagnostic criteria, timing of evaluation, and location of the study. Probably the best estimate of PPD prevalence was determined by the Agency for Healthcare Research and Quality [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/20\">",
"     20",
"    </a>",
"    ]. The authors reported that the prevalence of major depression was 5.7 percent two months postpartum and 5.6 percent six months postpartum. The prevalence of minor depression was similar to that for major depression. However, the confidence intervals were wide and there was significant variation among the study designs.",
"   </p>",
"   <p>",
"    Although the prevalence of depression is similar for postpartum and nonpregnant women, the onset of new episodes of depression is higher in the first five weeks postpartum than in nonpregnant controls [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/21\">",
"     21",
"    </a>",
"    ]. Primiparous mothers are at particularly high risk of mental disorders (eg, unipolar depression, bipolar disorder, schizophrenia) in the first three months postpartum, and especially at 10 to 19 days postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/22\">",
"     22",
"    </a>",
"    ]. Thus, the postpartum period may represent a time of increased vulnerability to depression for some women.",
"   </p>",
"   <p>",
"    Studies of cultural and economic influences on PPD, although limited, have concluded that the prevalence of PPD in some groups is lower than in others [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. In contrast, our clinical experience in a multicultural setting suggests that the lower prevalence rates in these cultures are due to under-reporting. Others have also found that cultural group and socioeconomic station do not influence prevalence of PPD [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/11,25\">",
"     11,25",
"    </a>",
"    ]. Nevertheless, the course of the illness may be improved in cultures where support from extended family is available and where spousal support is encouraged [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H108630218\">",
"    <span class=\"h3\">",
"     Paternal postpartum depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depression also occurs in fathers after childbirth. A meta-analysis of 43 observational studies (28,004 participants) found that the prevalence of paternal birth-related depression from [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/27\">",
"     27",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Birth to 3 months postpartum was 8 percent (95% CI 6%-11%)",
"     </li>",
"     <li>",
"      3 to 6 months postpartum was 26 percent (95% CI 17%-36%)",
"     </li>",
"     <li>",
"      6 to 12 months postpartum was 9 percent (95% CI 5%-15%)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, the prevalence was significantly higher during the period three to six months postpartum. These rates of depression compare with a 12-month prevalence rate of depression in men of 5 percent (found in a large, nationally representative sample in the United States) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/28\">",
"     28",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The meta-analysis found a positive and moderate correlation between paternal and maternal depression. The same result was found in a systematic review of 26 studies [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;A personal history of depression (prior to pregnancy or postpartum) is the major risk factor for PPD; one-half of women with PPD have onset of symptoms before or during their pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/11,12,15,16,19,25,30-33\">",
"     11,12,15,16,19,25,30-33",
"    </a>",
"    ]. Many other risk factors for PPD have been reported:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Marital conflict [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Stressful life events in the previous 12 months [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/33,35\">",
"       33,35",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Lack of perceived social support from family and friends for the pregnancy [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/33,36\">",
"       33,36",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Lack of emotional and financial support from the partner [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/12\">",
"       12",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Living without a partner [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/25,36\">",
"       25,36",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Unplanned pregnancy [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/36,37\">",
"       36,37",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Having contemplated terminating the current pregnancy [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/34\">",
"       34",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Previous miscarriage [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/15\">",
"       15",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Family psychiatric history [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/36\">",
"       36",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A poor relationship with one's own mother [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/38\">",
"       38",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Not breastfeeding [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/25,37,39\">",
"       25,37,39",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Unemployment in the mother (no job to return to) or in the head of household [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/37\">",
"       37",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A lifetime history of depression in the husband or partner",
"     </li>",
"     <li>",
"      Child-care related stressors [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/40\">",
"       40",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Sick leave during pregnancy related to hyperemesis, uterine irritability, or psychiatric disorder [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/41\">",
"       41",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      High number of visits to prenatal clinic [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/41\">",
"       41",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A congenitally malformed infant [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/42\">",
"       42",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Personality factors (high neuroticism and high introversion) [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/43\">",
"       43",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Pregestational or gestational diabetes [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/44\">",
"       44",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Personal history of bipolar disorder",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    After pregnancy loss (miscarriage, stillbirth, or abortion for unplanned pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/45\">",
"     45",
"    </a>",
"    ]), the risk of PPD is higher among women with a prior history of depression than in those without this history [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/46\">",
"     46",
"    </a>",
"    ]. The elevated risk is highest within the first six months after the loss, thus indicating the need for prolonged postpartum follow-up of these women [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/47\">",
"     47",
"    </a>",
"    ]. Women who conceive less than 12 months after a stillbirth appear to be at higher risk for depression in the third trimester of the next pregnancy and at one year postpartum compared to women who conceived after 12 months [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no strong association between PPD and any mode of delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The interaction of genetic susceptibility [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/50\">",
"     50",
"    </a>",
"    ] with major life events [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/33\">",
"     33",
"    </a>",
"    ] and hormonal changes [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/8\">",
"     8",
"    </a>",
"    ] may explain why PPD affects some women and not others. No hormonal factor has emerged consistently as the causative agent. Estrogen [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/8,51-53\">",
"     8,51-53",
"    </a>",
"    ], progesterone [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/54,55\">",
"     54,55",
"    </a>",
"    ], thyroid hormone [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/56-59\">",
"     56-59",
"    </a>",
"    ], testosterone [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/60\">",
"     60",
"    </a>",
"    ], cholesterol [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/61\">",
"     61",
"    </a>",
"    ], corticotropin-releasing hormone [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/62\">",
"     62",
"    </a>",
"    ], and cortisol [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/55\">",
"     55",
"    </a>",
"    ] are some of the hormones that have been investigated [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A classic study designed to mimic the hormonal changes that occur at parturition compared eight women with a history of PPD to eight women without any history of major depression [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/8\">",
"     8",
"    </a>",
"    ]. All of the subjects were treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/41/4760?source=see_link\">",
"     leuprolide",
"    </a>",
"    to induce a hypogonadal state, followed by supraphysiological doses of estrogen and progesterone add-back therapy, which was then withdrawn. Five of the eight women in the former group, but none in the latter, developed a significant increase in depressive symptoms during the four week withdrawal phase, thereby suggesting that women with a history of PPD may be unusually sensitive to abrupt decreases in gonadal steroids. A few women also developed mood symptoms during the add-back phase. This is consistent with the theory that prolonged elevation of gonadal steroids in pregnancy may precipitate depression during gestation and that parturition incites a worsening of preexisting depression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Diagnosis and clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term postpartum depression is commonly used to describe depression that begins within the first month after delivery, using the same criteria as for nonpregnancy related depression. However, PPD is not considered a separate diagnosis in the DSM-IV; instead a \"postpartum onset specifier\" is used for episodes of mood disorders (eg, major depressive, manic, or mixed episode) that arise within four weeks postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/18\">",
"     18",
"    </a>",
"    ]. Episodes of PPD may present later than this, but there is no modifier available. In clinical practice, depression occurring within 12 months of delivery is accepted as PPD [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/64\">",
"     64",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link\">",
"     \"Clinical manifestations and diagnosis of depression\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinical manifestations of PPD include changes in somatic functions such as sleep, energy level, appetite, weight, gastrointestinal functioning, and libido. These symptoms should be evaluated in the context of normal expectations for the postpartum period [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. As an example, although insomnia is a common occurrence postpartum, a woman who is unable to sleep even when her baby sleeps may have PPD. Rapid weight loss",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a decrease in appetite accompanied by inability to enjoy the taste of food or having to force oneself to eat are other warning signs. Profound lack of energy to the point that the woman may not be able to get out of bed for hours is abnormal and must be distinguished from the normal lack of energy that results from sleep deprivation and caring for an infant. Disturbances in libido exceeding what would be expected normally can also be a sign of PPD.",
"   </p>",
"   <p>",
"    Additional symptoms include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Significant anxiety, often with panic attacks",
"     </li>",
"     <li>",
"      Intense irritability and anger",
"     </li>",
"     <li>",
"      Feelings of guilt",
"     </li>",
"     <li>",
"      A sense of being overwhelmed or unable to care for the baby",
"     </li>",
"     <li>",
"      Feelings of inadequacy, and of being a failure as a mother.",
"     </li>",
"     <li>",
"      Not bonding to the baby, which further exacerbates feelings of shame and guilt and leads women to suffer in silence",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Obsessional thoughts about harming oneself or the baby are common, but often concealed. These thoughts, which are described as \"scary thoughts,\" are usually not revealed unless the woman is questioned directly. They are generally recognized by the mother as illogical and intrusive and are not usually predictive of suicide or infanticide [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/67\">",
"     67",
"    </a>",
"    ]. However, these thoughts are occasionally indicative of psychosis and should alert the clinician to perform a careful evaluation for psychotic ideation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/39/17014?source=see_link\">",
"     \"Postpartum psychosis: Epidemiology, clinical manifestations, and assessment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/62/29670?source=see_link\">",
"     \"Treatment of postpartum psychosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;A screening tool permits formal evaluation of changes in somatic functioning (sleep, appetite, weight). The Edinburgh Postnatal Depression Scale (EPDS) is a 10 item self-report questionnaire designed specifically for the detection of depression in the postpartum period (",
"    <a class=\"graphic graphic_figure graphicRef67741 graphicRef81407 \" href=\"UTD.htm?33/20/34115\">",
"     figure 1A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/68\">",
"     68",
"    </a>",
"    ]. It has been validated [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/69,70\">",
"     69,70",
"    </a>",
"    ], computerized [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/71\">",
"     71",
"    </a>",
"    ], and translated into more than 12 languages. Responses are scored 0, 1, 2, or 3, with a maximum score of 30; scores &ge;12 or 13 identify most women with postpartum depression. Women who report depressive symptoms without suicidal ideation or major functional impairment (or score between 5 and 9 on the EPDS) are reevaluated within one month to determine the state of depression [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The value of the EPDS as a screening tool was illustrated in a prospective study that administered the EPDS or performed routine clinical evaluation in 391 outpatients at six weeks postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/73\">",
"     73",
"    </a>",
"    ]. The screening tool diagnosed significantly more women with PPD than routine clinical evaluation (35.4 versus 6.3 percent). Subsequent studies have shown that administration of the EPDS in the first few days postpartum can predict maternal mood four to eight weeks later [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. This suggests that health care professionals should consider screening all new mothers before discharge from the hospital so that secondary preventive interventions can be implemented when indicated. Surveillance for maternal depression is also warranted at pediatric visits, which provide frequent contact between the mother and health care providers in the first 12 months postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/76\">",
"     76",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Prevention'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Other screening tests include the Beck Depression Inventory, the Postpartum Depression Screening Scale,the Center for Epidemiological Studies Depression Scale, and the PRIME-MD Patient Health Questionnaire, but data on these tests are more limited than for the EPDS [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/20,77,78\">",
"     20,77,78",
"    </a>",
"    ]. All of the screening tests perform well for determining the absence of depression, but they are less reliable in identifying women with depression, especially minor depression. For the EPDS, in the populations used in research studies, the probability that a woman with a positive screen (score &ge;13) truly had major depressive disorder was 57 percent, while the probability that a woman with a negative screen did not have depressive illness was 99 percent. However, for major or minor depression, the probability that a woman with a positive screen (score &ge;10) had depressive illness was 30 percent, and the probability that a woman with a negative screen did not have depressive illness was 95 percent.",
"   </p>",
"   <p>",
"    There are several barriers to implementing a successful screening program (",
"    <a class=\"graphic graphic_table graphicRef78247 \" href=\"UTD.htm?4/40/4747\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/79\">",
"     79",
"    </a>",
"    ]. Furthermore, whether screening followed by intervention for screen positives ultimately leads to improved patient outcome is a key question that has not been addressed adequately [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/80\">",
"     80",
"    </a>",
"    ]. Instead, investigators have focused upon women who screen positive and compared the outcomes of those receiving a treatment intervention to those in control groups with no treatment intervention. Providing some form of psychosocial support to pregnant women who screen positive for depressive illness appears to decrease depressive symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/20,81,82\">",
"     20,81,82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We suggest that providers screen for depression at the first postpartum follow-up visit, and certainly by the six week postpartum visit. The EPDS is suggested, if available. At a minimum, the clinician should ask questions such as \"How is your mood?\" or \"How have you been feeling?\". If the answer is concerning, then follow-up questions such as \"Do you feel overwhelmed? Sad? Helpless? Are you able to sleep? How is your appetite? Do you enjoy the taste of food?\" can help to better define the patient's emotional state. It is also important to inquire whether the patient has intrusive thoughts regarding harming her baby or whether she is struggling with anxiety symptoms. If symptoms have been present for two weeks or are severe, the patient may have PPD. Further management of these patients is discussed below (see",
"    <a class=\"local\" href=\"#H14\">",
"     'Management'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Patients with obsessional thoughts or",
"    <span class=\"nowrap\">",
"     suicidal/homicidal",
"    </span>",
"    ideation should be co-managed by a psychiatrist and the obstetrical provider. If the obstetrical provider is informed and experienced in management of PPD,",
"    <span class=\"nowrap\">",
"     he/she",
"    </span>",
"    may consider initiating treatment. However, if the patient requests a psychiatric consultation, or the doctor isn't comfortable treating PPD, or is unfamiliar with treatment options, then the patient should be referred. In such cases, the obstetrical provider should contact the consulting psychiatrist to make sure the patient has followed through with the referral. Patients may not always follow-up if left to do it on their own due to fear, shame, embarrassment, and hopelessness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Adverse outcomes",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Paternal depression &mdash; A significant number of fathers become depressed postpartum, further exacerbating the effects of PPD on the mother, marriage, and child development [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/35,83\">",
"       35,83",
"      </a>",
"      ]. A large study that administered the EPDS to several thousand mothers and fathers eight weeks postpartum reported 10 percent of mothers and 4 percent of fathers scored &gt;12; there was a strong correlation of test scores between partners [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/83\">",
"       83",
"      </a>",
"      ]. In a another study of 54 first-time mothers and 42 fathers who were their husbands or partners, significant risk factors for development of postnatal depression in men were depression in the partner during or shortly after pregnancy (OR 42) and a personal history of depression (OR 21) [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/35\">",
"       35",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H108630218\">",
"       'Paternal postpartum depression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Interference with bonding and child development &mdash; Both antenatal and postpartum depression can interfere with maternal-infant bonding, thereby adversely influencing infant development and contributing to the mother's sense of shame and guilt [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/10,84-88\">",
"       10,84-88",
"      </a>",
"      ]. The negative interaction patterns formed during the early critical bonding period may impact on later child development, despite recovery from PPD [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/86,87\">",
"       86,87",
"      </a>",
"      ]. As an example, conduct disorders [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/89\">",
"       89",
"      </a>",
"      ], inappropriate aggression [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/90\">",
"       90",
"      </a>",
"      ], and cognitive and attention deficits [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/91,92\">",
"       91,92",
"      </a>",
"      ] have been described in children exposed to maternal psychiatric illnesses. However, maternal remission can have a positive effect on offspring [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/93\">",
"       93",
"      </a>",
"      ]. A study evaluating mothers with depression (although not specifically perinatal depression), and their children, noted that 35 percent of the children aged 7 to 17 years had a psychiatric disorder at baseline: the frequency of a psychiatric disorder fell to 24 percent if the mother had a remission over a three-month treatment period versus 43 percent if she did not. Thus, treatment of maternal depression can be therapeutic for both the mother and her children.",
"      <br/>",
"      <br/>",
"      Both paternal and maternal depression have been associated with behavioral problems in children evaluated at 42 months [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/83\">",
"       83",
"      </a>",
"      ]. In one of the few studies evaluating the effects of both maternal and paternal depression, paternal depression was more strongly correlated with behavioral problems in sons than in daughters; this was in contrast to maternal depression, which had a similar adverse effect on behavior for both sexes.",
"      <br/>",
"      <br/>",
"      Despite these findings, the relationship between maternal mood disorders and development disorders in offspring is difficult to characterize and quantify. This is due to variations in the design of these studies, including differences in patient selection, assessment tools, definitions of clinical entities, timing, length of follow-up, intervention, and adjustment of confounders.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Marital stress &mdash; Strain in the marital relationship is both a risk factor for and consequence of PPD [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/84\">",
"       84",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Suicide and infanticide &mdash; As discussed above, suicide and infanticide are more likely to occur with postpartum psychosis than with postpartum depression. However, there is an increased risk of suicide, particularly in the most severe cases [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/94\">",
"       94",
"      </a>",
"      ]. Fetal or infant death appears to be a strong risk factor for suicide [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/95\">",
"       95",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/39/17014?source=see_link\">",
"       \"Postpartum psychosis: Epidemiology, clinical manifestations, and assessment\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/62/29670?source=see_link\">",
"       \"Treatment of postpartum psychosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;PPD increases the risk for further episodes of major depression, both puerperal and nonpuerperal [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/66\">",
"     66",
"    </a>",
"    ]. Untreated PPD may resolve spontaneously, or develop into a chronic depressive disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Initial evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation of women with suspected PPD is similar to that of nonpregnant individuals. In particular, it is crucial to try to determine whether the woman is a threat to herself or any other individual; these women should be evaluated and managed by a specialist. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link&amp;anchor=H2#H2\">",
"     \"Initial treatment of depression in adults\", section on 'Initial evaluation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link&amp;anchor=H4#H4\">",
"     \"Initial treatment of depression in adults\", section on 'Suicidal ideation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link&amp;anchor=H5#H5\">",
"     \"Initial treatment of depression in adults\", section on 'Severe depression'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     General approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed above, psychosocial and biologic factors play a role in development of PPD. Therefore, a biopsychosocial approach to treatment is often utilized to maximize clinical response. The severity of symptoms will determine whether emphasis is placed on treating biological factors, psychological factors, or social factors. The best results are achieved when all three modalities are addressed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Biological factors are addressed directly by using somatic treatments such as promotion of adequate sleep, pharmacotherapy, light therapy, and electroconvulsive therapy (ECT).",
"     </li>",
"     <li>",
"      Psychological factors are addressed with individual",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      group psychotherapy aimed at reducing stress and depression. Marital therapy can be therapeutic, when indicated.",
"     </li>",
"     <li>",
"      Social factors, such as family discord, lack of education about postpartum mood disorders, and economic stressors, are addressed by psychotherapy and appropriate social services interventions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The value of a multicomponent intervention approach to treatment of major depression in postpartum women has been validated by a randomized trial [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We suggest psychosocial therapy for the initial approach to treatment of mild-to-moderate symptoms of PPD. In more severe illness, we suggest pharmacotherapy with psychosocial therapy as an adjunctive treatment.",
"   </p>",
"   <p>",
"    The psychosocial approaches described below may be the only treatment options for women who refuse pharmacotherapy. On the other hand, patient preference and insurance coverage may negatively influence the decision to undergo psychotherapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Psychosocial therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychosocial treatment of depression is discussed in detail separately. A brief synopsis of the use of these modalities in postpartum women is provided below. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link&amp;anchor=H13#H13\">",
"     \"Initial treatment of depression in adults\", section on 'Psychotherapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29751?source=see_link\">",
"     \"Overview of psychotherapies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Interpersonal psychotherapy &mdash; Interpersonal psychotherapy (IPT) has demonstrated efficacy in the treatment of mood and anxiety disorders in pregnant and postpartum women. As an example, a randomized trial in women with major postpartum depression found that 12 weeks of IPT was more effective in decreasing depressive symptoms and increasing social adjustment than no treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/97\">",
"       97",
"      </a>",
"      ]. Results were measured using the Hamilton Rating Scale for Depression, the Beck Depression Inventory, a Postpartum Adjustment Questionnaire, and a Social Adjustment Scale-Self-Report.",
"     </li>",
"     <li>",
"      Cognitive-behavioral therapy &mdash; A preliminary study examining short-term cognitive behavioral counseling for postpartum depression found that women who received six sessions of such counseling showed the same degree of improvement in functioning as a group of women receiving the antidepressant medication",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       fluoxetine",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/98\">",
"       98",
"      </a>",
"      ]. In addition, both groups had significant improvement in functioning when compared to a placebo medication group. The benefits of cognitive-behavioral therapy for",
"      <span class=\"nowrap\">",
"       prevention/treatment",
"      </span>",
"      of PPD were also demonstrated in a trial that randomly assigned 258 mothers at risk (EPDS &ge;9) to this therapy or no treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/99\">",
"       99",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Group therapy &mdash; A group therapy approach to treatment of PPD helps women who are feeling socially isolated increase their support networks. Different methods of psychosocial therapy, including interpersonal psychotherapy and supportive psychotherapy, may be adapted to a group model and appear to be effective [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/100-103\">",
"       100-103",
"      </a>",
"      ]. Components of the therapy include one or more of the following: social and emotional support from other women who are undergoing similar experiences; psychoeducation; cognitive-behavioral therapy to target irrational beliefs; exploration of resources within the community; a focus on communication, self-assertion, and problem-solving skills; involvement of the spouse; and homework tasks [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/102\">",
"       102",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      There are several lay groups that offer support and education to women with postpartum mood disorders. The best known is Postpartum Support International (",
"      <a class=\"external\" href=\"file://www.postpartum.net/\">",
"       www.postpartum.net/",
"      </a>",
"      or call 1-805-967-7636). These groups have done much to reduce the isolation experienced by many women and to counter the stigma of postpartum mood disorders. They offer educational opportunities for women, family members, and clinicians. Meetings are held at local, state, national, and international levels. Educational information is also available at the National Women's Health Information Center (",
"      <a class=\"external\" href=\"file://www.womenshealth.gov/\">",
"       www.womenshealth.gov",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Family and marital therapy &mdash; The roles of the partner and family are critical in the treatment of women with mood and anxiety disorders in pregnancy and the postpartum period. A stable marital relationship helps new parents adapt to the competing demands of marriage, the infant, and the family. Postpartum depressed women experience a more rapid recovery and are more appreciative of their partner's contribution to the relationship when the partner is supportive [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Light therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Light therapy is another, albeit less well-studied, alternative to pharmacotherapy. General research on the use of light therapy for major depression indicates that it is an effective form of treatment with a favorable side effect profile [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/104\">",
"     104",
"    </a>",
"    ]. However, the research literature on the efficacy of light therapy is limited by design problems, including small sample sizes, inadequate blinding and placebo groups, and inconsistencies in the timing and dose of therapy.",
"   </p>",
"   <p>",
"    Light therapy is widely used to treat seasonal affective disorder (SAD), as well as nonseasonal depression and premenstrual dysphoric disorder (PMDD). There is a paucity of data regarding its use in pregnant and postpartum women. One report of pregnant depressed women and another of postpartum depressed women treated with morning bright light therapy provided preliminary support for the hypothesis that light therapy may have an antidepressant effect in these populations [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/105,106\">",
"     105,106",
"    </a>",
"    ]. Additional research is needed with larger numbers of patients and longer follow-up before light therapy can be recommended for PPD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/25/22936?source=see_link&amp;anchor=H8#H8\">",
"     \"Seasonal affective disorder\", section on 'Light therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Pharmacologic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharmacotherapy has been proven to be an effective treatment of depression. There are virtually no data from randomized placebo controlled trials on the efficacy of this approach specifically in postpartum depression [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/107\">",
"     107",
"    </a>",
"    ]. Antidepressants are used in this setting based on extrapolation of results from studies in the general population and from observational series.",
"   </p>",
"   <p>",
"    The major issue in selecting a medication for treatment of PPD is whether or not the woman is breastfeeding. If she is not, then drug choices are based upon the same selection criteria used for nonpuerperal depression. In particular, if PPD is a relapse rather than a first episode, then the woman's prior history of therapeutic response should guide choice of pharmacotherapy. Women who have been successfully treated with a well tolerated drug in the past should resume that agent if depression recurs [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/108\">",
"     108",
"    </a>",
"    ]. In some cases, the choice of antidepressants can be guided by the family history of response to a particular medication. In other cases, the drug chosen depends upon physician familiarity and side effects. Lastly, the choice of drug should take into consideration",
"    <span class=\"nowrap\">",
"     fetal/neonatal",
"    </span>",
"    effects given the high rate of unplanned pregnancies in reproductive aged women.",
"   </p>",
"   <p>",
"    A number of clinical studies and systematic reviews have concluded that clinical outcomes, quality of life outcomes, and overall treatment costs provide no clear guidance on the choice between SSRIs and tricyclic or heterocyclic antidepressants. A single randomized controlled trial comparing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/21/30040?source=see_link\">",
"     nortriptyline",
"    </a>",
"    for treatment of PPD did not find significant differences in symptom reduction or improved functioning [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/109\">",
"     109",
"    </a>",
"    ]. The most compelling reason SSRIs are usually used as the agent of first choice in primary care is lower severity of side effects and markedly less danger with overdose. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link\">",
"     \"Initial treatment of depression in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pharmacologic issues in treatment of breast feeding women are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/53/38745?source=see_link\">",
"     \"Use of psychotropic medications in breastfeeding women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk for suicide may increase following the initiation of antidepressants. Therefore, all patients should be seen at one to two weeks after starting antidepressants. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43783?source=see_link\">",
"     \"Effect of antidepressants on suicide risk in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Women who were treated for depression during their pregnancy require careful follow-up in the postpartum period. Their medication dose requirements often change postpartum due to changes in pharmacodynamics after delivery. They may also experience an exacerbation or full-blown relapse of symptoms in the postpartum period. Medication doses and types may have to be adjusted accordingly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Expected response and duration of treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;A clinical response should be observed within two to six weeks of initiating effective therapy. There is little evidence to support extending a trial of a given antidepressant therapy beyond six weeks in patients who have shown no response at maximal dosage. However, for patients who have a partial response, extending the medication trial by two to four more weeks may result in an improvement in symptoms.",
"   </p>",
"   <p>",
"    If there is no response by six weeks at a maximum therapeutic dose, the patient should be given a second trial of another antidepressant (either of the same or different class) or should be referred to a psychiatrist. Augmenting the antidepressant with additional therapy is often needed when co-morbid illness is present.",
"   </p>",
"   <p>",
"    For a first episode of depression, treatment should be continued for at least 12 months after full remission to reduce the chance of relapse. A recurrent history of depression may warrant prolonged treatment with antidepressants. If and when medications are discontinued, a slow taper (reduce the antidepressant dose by 25 percent per week) is generally safer than a rapid taper. This facilitates early intervention should symptoms reemerge and minimizes the risk of antidepressant withdrawal syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If a patient with PPD in remission becomes pregnant while on medications, it is usually prudent to continue those medications; tapering can lead to relapse. Maintenance of euthymic mood during pregnancy is essential in reducing long-term morbidity and mortality. Psychiatric referral is indicated if there is a poor response, relapse, major functional impairment, or suicidal ideation.",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link&amp;anchor=H26#H26\">",
"     \"Initial treatment of depression in adults\", section on 'Timing of response and follow-up'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link&amp;anchor=H27#H27\">",
"     \"Initial treatment of depression in adults\", section on 'Duration of treatment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27609?source=see_link\">",
"     \"Treatment of resistant depression in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Electroconvulsive therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electroconvulsive therapy (ECT) in postpartum women is an effective line of treatment with few adverse effects for either the mother or infant [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/111,112\">",
"     111,112",
"    </a>",
"    ]. ECT is particularly useful:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When rapid treatment is imperative and where a comprehensive team of health care professionals (psychiatrist, obstetrician, anesthesiologist) is available [",
"      <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/113,114\">",
"       113,114",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      For severe depression where psychotic symptoms are present, or in acute mania",
"     </li>",
"     <li>",
"      In mothers who are at a risk for suicide or infanticide",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, it is a safe treatment option for the breastfeeding mother because there are no effects on breast milk [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/114\">",
"     114",
"    </a>",
"    ]. Exposure to the anesthetic medications administered during ECT treatment has not been shown to have a negative effect on nursing infants; however, this exposure can be minimized by delaying breastfeeding for a few hours after ECT therapy or by collection and storage of breast milk the day prior to ECT [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/115\">",
"     115",
"    </a>",
"    ]. Three to nine ECT treatments are typically required to produce an effective response in pregnant and postpartum women, paying special attention to individual responses. Treatments are usually administered three times per week. Some women will, however, require pharmacotherapy in addition to ECT to promote remission and prevent relapse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Hormonal therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data on use of hormones to prevent or treat PPD are limited. A Cochrane review concluded that there was no role for synthetic progestins in the prevention or treatment of postnatal depression [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/116\">",
"     116",
"    </a>",
"    ]. In fact, long-acting progestins given within 48 hours of delivery for contraception increased the risk of PPD in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, a double blind placebo controlled study including 36 women with severe and persistent PPD reported that administering estradiol transdermally was associated with greater improvement in depressive symptoms than in controls given placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/52\">",
"     52",
"    </a>",
"    ]. However, over half of the women in both groups were on antidepressants, which limits the conclusions that may be drawn about the role of estrogen. The dose and duration of estrogen therapy as either a primary or adjunctive treatment, or as a prophylactic strategy, remains to be elucidated. Estrogen cannot be recommended as standard therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of postpartum depression is high (25 percent) in women with a previous history of depression, particularly with a prior history of PPD (50 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/72,117,118\">",
"     72,117,118",
"    </a>",
"    ]. Such women should be closely monitored for signs of recurrence and therapy should be initiated promptly, if indicated. An early postpartum visit, at one to three weeks after delivery, is useful to screen for PPD in these women as well as in other women at high risk, such as those with a family history of mood disorder or concurrent stressful life events (see",
"    <a class=\"local\" href=\"#H11\">",
"     'Screening'",
"    </a>",
"    above) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/72\">",
"     72",
"    </a>",
"    ]. The optimal approach to prevention remains to be elucidated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Nonpharmacologic interventions",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systematic review attempted to determine the effectiveness of nonpharmacological interventions to reduce maternal depression after birth [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/119\">",
"     119",
"    </a>",
"    ]. The interventions included psychological, supportive, and educational strategies, implemented on an individual or group basis. The three major findings of this analysis were:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There was strong evidence that postnatal counseling interventions (all modalities tested), provided to women with depression or probable depression, by professionals from a variety of backgrounds after specific additional training, substantially reduced depressive symptoms and depression.",
"     </li>",
"     <li>",
"      Universal and selective antenatal interventions and universal postnatal interventions were generally not effective.",
"     </li>",
"     <li>",
"      Neither continuity of care, doula support in labor, nurse support in labor, nor postnatal debriefing by a midwife were effective strategies for reducing postnatal depression.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A Cochrane review of psychosocial and psychological interventions for preventing PPD also noted that intensive management by individuals with professional training in this area appeared to be an important component for success [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/120\">",
"     120",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, merely providing basic informational material to women at risk for PPD does not reduce the likelihood of developing the disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/121-123\">",
"     121-123",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Pharmacological interventions",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a paucity of data on pharmacotherapy to prevent relapse of PPD. The only randomized clinical trials evaluating antidepressants for prevention of PPD in nondepressed mothers with a past history of PPD yielded discordant results. One placebo controlled trial showed that prophylactic use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/21/30040?source=see_link\">",
"     nortriptyline",
"    </a>",
"    after delivery was not effective in preventing PPD [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/124\">",
"     124",
"    </a>",
"    ]. In contrast, the other trial found that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    administered immediately after birth reduced the recurrence of postnatal depression and the time to recurrence when compared with placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/125\">",
"     125",
"    </a>",
"    ]. After 20 weeks of follow-up, one of 14 women in the sertraline group suffered a recurrence versus four of eight women assigned to placebo.",
"   </p>",
"   <p>",
"    A randomized trial compared docosahexaenoic acid (DHA)-rich fish oil (800 mg per day of DHA) with vegetable oil in 2399 pregnant women, and found that the percentage of women with high levels of depressive symptoms during the first six months postpartum did not differ significantly between the DHA and control groups (9.7 versus 11.2 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/126\">",
"     126",
"    </a>",
"    ]. In addition, there was no significant difference in cognitive and language development in the offspring during early childhood.",
"   </p>",
"   <p>",
"    When the likelihood of relapse is high, it may be prudent to resume pharmacotherapy immediately after delivery with the agent to which the woman previously responded [",
"    <a class=\"abstract\" href=\"UTD.htm?20/11/20666/abstract/72\">",
"     72",
"    </a>",
"    ]. Some clinicians also recommend resuming medications in the third trimester to reduce the risk of postpartum relapse. A higher dose is often required in the third trimester due to increased plasma volume, changes in hormone levels, and other physiological factors leading to decreased levels of the drug in maternal serum.",
"   </p>",
"   <p>",
"    If a woman at risk for PPD develops even mild postpartum mood changes, one should consider that she is in the earliest phase of a relapse of depression rather than minimizing the severity of symptoms and attributing them to postpartum blues, especially if the symptoms continue beyond two weeks. Definitive treatment may then be started before her condition worsens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=see_link\">",
"       \"Patient information: Reducing the costs of medicines (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/9/41105?source=see_link\">",
"       \"Patient information: Postpartum depression (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=see_link\">",
"       \"Patient information: Reducing the costs of medicines (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Postpartum blues",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Forty to 80 percent of postpartum women develop mild mood changes. Symptoms typically peak on the fifth postpartum day and resolve within two weeks. By comparison, a diagnosis of major and minor depression requires that depressed mood or loss of",
"      <span class=\"nowrap\">",
"       interests/pleasure",
"      </span>",
"      and other characteristic symptoms be present most of the day, nearly every day, for at least two weeks. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Postpartum blues'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest providing support and encouraging adequate rest for women with postpartum blues (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We do not suggest pharmacotherapy unless the patient fails to improve. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Postpartum depression",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Postpartum depression is not considered a separate diagnosis in the Diagnostic and Statistical Manual of Mental Disorders; instead a \"postpartum onset specifier\" is used for episodes of mood disorders that arise within four weeks postpartum. Clinically, depression with onset within 12 months of delivery is considered postpartum depression. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis and clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Postpartum depression affects approximately 10 percent of women, which is similar to the prevalence in nonpregnant women. A personal history of depression (prior to pregnancy, antepartum or postpartum) is the major risk factor. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Prevalence'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      No hormonal factor has emerged consistently as the causative agent. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Postpartum depression can have adverse effects on the mother-child relationship, child development, marital relationship, and mental health of the woman's partner. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Adverse outcomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Postpartum depression increases the woman's risk for development of future episodes of major depression, both puerperal and nonpuerperal. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend asking postpartum women about their mood as a routine part of postpartum obstetrical care (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest psychosocial therapy as the initial approach to treatment of mild-to-moderate symptoms of postpartum depression (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). In more severe illness, we recommend pharmacotherapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). We suggest psychosocial therapy as an adjunctive treatment in these cases (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The major issue in selecting a medication for treatment of postpartum depression is whether or not the woman is breastfeeding. If she is not, then drug choices are based upon the same selection criteria used for nonpuerperal depression. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link\">",
"       \"Initial treatment of depression in adults\"",
"      </a>",
"      .) Treatment in breastfeeding women is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/53/38745?source=see_link\">",
"       \"Use of psychotropic medications in breastfeeding women\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In women with a history of postpartum depression, we suggest resuming pharmacotherapy immediately after delivery with the same agent that successfully treated her previous episode (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). In other woman at increased risk for postpartum depression, we suggest initiating treatment upon identifying even mild postpartum mood changes (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The safety of the medication in the event of unplanned pregnancy should also be considered when selecting an antidepressant. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/1\">",
"      Steiner M. Postpartum psychiatric disorders. Can J Psychiatry 1990; 35:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/2\">",
"      Brockington I. Postpartum psychiatric disorders. Lancet 2004; 363:303.",
"     </a>",
"    </li>",
"    <li>",
"     www.cdc.gov/PRAMS/PPD.htm (accessed June 5, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/4\">",
"      O'Hara MW, Schlechte JA, Lewis DA, Wright EJ. Prospective study of postpartum blues. Biologic and psychosocial factors. Arch Gen Psychiatry 1991; 48:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/5\">",
"      Harris B, Lovett L, Newcombe RG, et al. Maternity blues and major endocrine changes: Cardiff puerperal mood and hormone study II. BMJ 1994; 308:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/6\">",
"      Nappi RE, Petraglia F, Luisi S, et al. Serum allopregnanolone in women with postpartum \"blues\". Obstet Gynecol 2001; 97:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/7\">",
"      Heidrich A, Schleyer M, Spingler H, et al. Postpartum blues: relationship between not-protein bound steroid hormones in plasma and postpartum mood changes. J Affect Disord 1994; 30:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/8\">",
"      Bloch M, Schmidt PJ, Danaceau M, et al. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000; 157:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/9\">",
"      Bloch M, Rotenberg N, Koren D, Klein E. Risk factors associated with the development of postpartum mood disorders. J Affect Disord 2005; 88:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/10\">",
"      Halbreich U. The association between pregnancy processes, preterm delivery, low birth weight, and postpartum depressions--the need for interdisciplinary integration. Am J Obstet Gynecol 2005; 193:1312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/11\">",
"      Lee D, Yip A, Chiu H, et al. A psychiatric epidemiological study of postpartum Chinese women. Am J Psychiatry 2001; 158:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/12\">",
"      Cooper PJ, Tomlinson M, Swartz L, et al. Post-partum depression and the mother-infant relationship in a South African peri-urban settlement. Br J Psychiatry 1999; 175:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/13\">",
"      Wickberg B, Hwang CP. Screening for postnatal depression in a population-based Swedish sample. Acta Psychiatr Scand 1997; 95:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/14\">",
"      Glasser S, Barell V, Shoham A, et al. Prospective study of postpartum depression in an Israeli cohort: prevalence, incidence and demographic risk factors. J Psychosom Obstet Gynaecol 1998; 19:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/15\">",
"      Cryan, E, Keogh, F, Connolly, E, et al. Depression among postnatal women in an urban Irish community. Ir J Psychological Med 2001; 18:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/16\">",
"      Evans J, Heron J, Francomb H, et al. Cohort study of depressed mood during pregnancy and after childbirth. BMJ 2001; 323:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/17\">",
"      Whitton A, Warner R, Appleby L. The pathway to care in post-natal depression: women's attitudes to post-natal depression and its treatment. Br J Gen Pract 1996; 46:427.",
"     </a>",
"    </li>",
"    <li>",
"     Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/19\">",
"      O'Hara MW, Zekoski EM, Philipps LH, Wright EJ. Controlled prospective study of postpartum mood disorders: comparison of childbearing and nonchildbearing women. J Abnorm Psychol 1990; 99:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/20\">",
"      Gaynes BN, Gavin N, Meltzer-Brody S, et al. Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess (Summ) 2005; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/21\">",
"      Cox JL, Murray D, Chapman G. A controlled study of the onset, duration and prevalence of postnatal depression. Br J Psychiatry 1993; 163:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/22\">",
"      Munk-Olsen T, Laursen TM, Pedersen CB, et al. New parents and mental disorders: a population-based register study. JAMA 2006; 296:2582.",
"     </a>",
"    </li>",
"    <li>",
"     Wile, J, Arechiga, M. Sociocultural aspects of postpartum depression. In: Miller, LJ (Ed), Postpartum Mood Disorders, American Psychiatric Press, Washington, DC 1999. p. 83.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/24\">",
"      Howell EA, Mora PA, Horowitz CR, Leventhal H. Racial and ethnic differences in factors associated with early postpartum depressive symptoms. Obstet Gynecol 2005; 105:1442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/25\">",
"      Yonkers KA, Ramin SM, Rush AJ, et al. Onset and persistence of postpartum depression in an inner-city maternal health clinic system. Am J Psychiatry 2001; 158:1856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/26\">",
"      Misri S, Kostaras X, Fox D, Kostaras D. The impact of partner support in the treatment of postpartum depression. Can J Psychiatry 2000; 45:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/27\">",
"      Paulson JF, Bazemore SD. Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis. JAMA 2010; 303:1961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/28\">",
"      Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289:3095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/29\">",
"      Wee KY, Skouteris H, Pier C, et al. Correlates of ante- and postnatal depression in fathers: a systematic review. J Affect Disord 2011; 130:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/30\">",
"      Buesching DP, Glasser ML, Frate DA. Progression of depression in the prenatal and postpartum periods. Women Health 1986; 11:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/31\">",
"      Bernazzani O, Saucier JF, David H, Borgeat F. Psychosocial predictors of depressive symptomatology level in postpartum women. J Affect Disord 1997; 46:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/32\">",
"      Da Costa D, Larouche J, Dritsa M, Brender W. Psychosocial correlates of prepartum and postpartum depressed mood. J Affect Disord 2000; 59:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/33\">",
"      Wilson LM, Reid AJ, Midmer DK, et al. Antenatal psychosocial risk factors associated with adverse postpartum family outcomes. CMAJ 1996; 154:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/34\">",
"      Kumar R, Robson KM. A prospective study of emotional disorders in childbearing women. Br J Psychiatry 1984; 144:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/35\">",
"      Areias ME, Kumar R, Barros H, Figueiredo E. Correlates of postnatal depression in mothers and fathers. Br J Psychiatry 1996; 169:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/36\">",
"      Brugha TS, Sharp HM, Cooper SA, et al. The Leicester 500 Project. Social support and the development of postnatal depressive symptoms, a prospective cohort survey. Psychol Med 1998; 28:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/37\">",
"      Warner R, Appleby L, Whitton A, Faragher B. Demographic and obstetric risk factors for postnatal psychiatric morbidity. Br J Psychiatry 1996; 168:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/38\">",
"      Murray D, Cox JL, Chapman G, Jones P. Childbirth: life event or start of a long-term difficulty? Further data from the Stoke-on-Trent controlled study of postnatal depression. Br J Psychiatry 1995; 166:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/39\">",
"      Misri S, Sinclair DA, Kuan AJ. Breast-feeding and postpartum depression: is there a relationship? Can J Psychiatry 1997; 42:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/40\">",
"      Stowe ZN, Nemeroff CB. Women at risk for postpartum-onset major depression. Am J Obstet Gynecol 1995; 173:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/41\">",
"      Josefsson A, Angelsi&ouml;&ouml; L, Berg G, et al. Obstetric, somatic, and demographic risk factors for postpartum depressive symptoms. Obstet Gynecol 2002; 99:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/42\">",
"      Rona RJ, Smeeton NC, Beech R, et al. Anxiety and depression in mothers related to severe malformation of the heart of the child and foetus. Acta Paediatr 1998; 87:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/43\">",
"      Verkerk GJ, Denollet J, Van Heck GL, et al. Personality factors as determinants of depression in postpartum women: a prospective 1-year follow-up study. Psychosom Med 2005; 67:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/44\">",
"      Kozhimannil KB, Pereira MA, Harlow BL. Association between diabetes and perinatal depression among low-income mothers. JAMA 2009; 301:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/45\">",
"      Major B, Cozzarelli C, Cooper ML, et al. Psychological responses of women after first-trimester abortion. Arch Gen Psychiatry 2000; 57:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/46\">",
"      Neugebauer R, Kline J, Shrout P, et al. Major depressive disorder in the 6 months after miscarriage. JAMA 1997; 277:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/47\">",
"      Janssen HJ, Cuisinier MC, Hoogduin KA, de Graauw KP. Controlled prospective study on the mental health of women following pregnancy loss. Am J Psychiatry 1996; 153:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/48\">",
"      Hughes PM, Turton P, Evans CD. Stillbirth as risk factor for depression and anxiety in the subsequent pregnancy: cohort study. BMJ 1999; 318:1721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/49\">",
"      Patel RR, Murphy DJ, Peters TJ. Operative delivery and postnatal depression: a cohort study. BMJ 2005; 330:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/50\">",
"      Treloar SA, Martin NG, Bucholz KK, et al. Genetic influences on post-natal depressive symptoms: findings from an Australian twin sample. Psychol Med 1999; 29:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/51\">",
"      Hendrick V, Altshuler LL, Suri R. Hormonal changes in the postpartum and implications for postpartum depression. Psychosomatics 1998; 39:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/52\">",
"      Gregoire AJ, Kumar R, Everitt B, et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996; 347:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/53\">",
"      Ahokas A, Kaukoranta J, Wahlbeck K, Aito M. Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study. J Clin Psychiatry 2001; 62:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/54\">",
"      Lawrie TA, Hofmeyr GJ, De Jager M, et al. A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: the effect on postnatal depression and serum hormones. Br J Obstet Gynaecol 1998; 105:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/55\">",
"      Harris B, Lovett L, Smith J, et al. Cardiff puerperal mood and hormone study. III. Postnatal depression at 5 to 6 weeks postpartum, and its hormonal correlates across the peripartum period. Br J Psychiatry 1996; 168:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/56\">",
"      Harris B, Othman S, Davies JA, et al. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ 1992; 305:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/57\">",
"      Pedersen CA, Stern RA, Pate J, et al. Thyroid and adrenal measures during late pregnancy and the puerperium in women who have been major depressed or who become dysphoric postpartum. J Affect Disord 1993; 29:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/58\">",
"      Pedersen CA. Postpartum mood and anxiety disorders: a guide for the nonpsychiatric clinician with an aside on thyroid associations with postpartum mood. Thyroid 1999; 9:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/59\">",
"      Kent GN, Stuckey BG, Allen JR, et al. Postpartum thyroid dysfunction: clinical assessment and relationship to psychiatric affective morbidity. Clin Endocrinol (Oxf) 1999; 51:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/60\">",
"      Hohlagschwandtner M, Husslein P, Klier C, Ulm B. Correlation between serum testosterone levels and peripartal mood states. Acta Obstet Gynecol Scand 2001; 80:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/61\">",
"      van Dam RM, Schuit AJ, Schouten EG, et al. Serum cholesterol decline and depression in the postpartum period. J Psychosom Res 1999; 46:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/62\">",
"      Schmeelk KH, Granger DA, Susman EJ, Chrousos GP. Maternal depression and risk for postpartum complications: role of prenatal corticotropin-releasing hormone and interleukin-1 receptor antagonist. Behav Med 1999; 25:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/63\">",
"      McCoy SJ, Beal JM, Watson GH. Endocrine factors and postpartum depression. A selected review. J Reprod Med 2003; 48:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/64\">",
"      Lusskin SI, Pundiak TM, Habib SM. Perinatal depression: hiding in plain sight. Can J Psychiatry 2007; 52:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/65\">",
"      Misri, S, Duke, M. Depression during pregnancy and post-partum. J SOGC 1995; 17:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/66\">",
"      Nonacs R, Cohen LS. Postpartum mood disorders: diagnosis and treatment guidelines. J Clin Psychiatry 1998; 59 Suppl 2:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/67\">",
"      Brandes M, Soares CN, Cohen LS. Postpartum onset obsessive-compulsive disorder: diagnosis and management. Arch Womens Ment Health 2004; 7:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/68\">",
"      Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987; 150:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/69\">",
"      Murray L, Carothers AD. The validation of the Edinburgh Post-natal Depression Scale on a community sample. Br J Psychiatry 1990; 157:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/70\">",
"      Schaper AM, Rooney BL, Kay NR, Silva PD. Use of the Edinburgh Postnatal Depression Scale to identify postpartum depression in a clinical setting. J Reprod Med 1994; 39:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/71\">",
"      Glaze R, Cox JL. Validation of a computerised version of the 10-item (self-rating) Edinburgh Postnatal Depression Scale. J Affect Disord 1991; 22:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/72\">",
"      Wisner KL, Parry BL, Piontek CM. Clinical practice. Postpartum depression. N Engl J Med 2002; 347:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/73\">",
"      Evins GG, Theofrastous JP, Galvin SL. Postpartum depression: a comparison of screening and routine clinical evaluation. Am J Obstet Gynecol 2000; 182:1080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/74\">",
"      Dennis CL. Can we identify mothers at risk for postpartum depression in the immediate postpartum period using the Edinburgh Postnatal Depression Scale? J Affect Disord 2004; 78:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/75\">",
"      Teiss&egrave;dre F, Chabrol H. Detecting women at risk for postnatal depression using the Edinburgh Postnatal Depression Scale at 2 to 3 days postpartum. Can J Psychiatry 2004; 49:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/76\">",
"      Stowe ZN, Hostetter AL, Newport DJ. The onset of postpartum depression: Implications for clinical screening in obstetrical and primary care. Am J Obstet Gynecol 2005; 192:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/77\">",
"      Boyd RC, Le HN, Somberg R. Review of screening instruments for postpartum depression. Arch Womens Ment Health 2005; 8:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/78\">",
"      Spitzer RL, Williams JB, Kroenke K, et al. Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol 2000; 183:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/79\">",
"      Mitchell AJ, Coyne J. Screening for postnatal depression: barriers to success. BJOG 2009; 116:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/80\">",
"      Hewitt CE, Gilbody SM. Is it clinically and cost effective to screen for postnatal depression: a systematic review of controlled clinical trials and economic evidence. BJOG 2009; 116:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/81\">",
"      Dennis CL, Hodnett E, Kenton L, et al. Effect of peer support on prevention of postnatal depression among high risk women: multisite randomised controlled trial. BMJ 2009; 338:a3064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/82\">",
"      Morrell CJ, Slade P, Warner R, et al. Clinical effectiveness of health visitor training in psychologically informed approaches for depression in postnatal women: pragmatic cluster randomised trial in primary care. BMJ 2009; 338:a3045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/83\">",
"      Ramchandani P, Stein A, Evans J, et al. Paternal depression in the postnatal period and child development: a prospective population study. Lancet 2005; 365:2201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/84\">",
"      Weinberg MK, Tronick EZ. The impact of maternal psychiatric illness on infant development. J Clin Psychiatry 1998; 59 Suppl 2:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/85\">",
"      Murray L, Stein A. The effects of postnatal depression on the infant. Baillieres Clin Obstet Gynaecol 1989; 3:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/86\">",
"      Murray L, Fiori-Cowley A, Hooper R, Cooper P. The impact of postnatal depression and associated adversity on early mother-infant interactions and later infant outcome. Child Dev 1996; 67:2512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/87\">",
"      Stein A, Gath DH, Bucher J, et al. The relationship between post-natal depression and mother-child interaction. Br J Psychiatry 1991; 158:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/88\">",
"      Beck CT. A meta-analysis of the relationship between postpartum depression and infant temperament. Nurs Res 1996; 45:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/89\">",
"      Beardslee, W, Schultz, LH, Selman, RL. Level of social-cognitive development, adaptive functioning, and DSM-III diagnoses in adolescent offspring of parents with affective disorders: implications of the development of the capacity for mutuality. Dev Psychol 1987; 23:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/90\">",
"      Zahn-Waxler C, Cummings EM, McKnew DH, Radke-Yarrow M. Altruism, aggression, and social interactions in young children with a manic-depressive parent. Child Dev 1984; 55:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/91\">",
"      Zahn-Waxler C, Chapman M, Cummings EM. Cognitive and social development in infants and toddlers with a bipolar parent. Child Psychiatry Hum Dev 1984; 15:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/92\">",
"      Beck CT. The effects of postpartum depression on child development: a meta-analysis. Arch Psychiatr Nurs 1998; 12:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/93\">",
"      Weissman MM, Pilowsky DJ, Wickramaratne PJ, et al. Remissions in maternal depression and child psychopathology: a STAR*D-child report. JAMA 2006; 295:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/94\">",
"      Lindahl V, Pearson JL, Colpe L. Prevalence of suicidality during pregnancy and the postpartum. Arch Womens Ment Health 2005; 8:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/95\">",
"      Schiff MA, Grossman DC. Adverse perinatal outcomes and risk for postpartum suicide attempt in Washington state, 1987-2001. Pediatrics 2006; 118:e669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/96\">",
"      Rojas G, Fritsch R, Solis J, et al. Treatment of postnatal depression in low-income mothers in primary-care clinics in Santiago, Chile: a randomised controlled trial. Lancet 2007; 370:1629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/97\">",
"      O'Hara MW, Stuart S, Gorman LL, Wenzel A. Efficacy of interpersonal psychotherapy for postpartum depression. Arch Gen Psychiatry 2000; 57:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/98\">",
"      Appleby L, Warner R, Whitton A, Faragher B. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ 1997; 314:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/99\">",
"      Chabrol H, Teissedre F, Saint-Jean M, et al. Prevention and treatment of post-partum depression: a controlled randomized study on women at risk. Psychol Med 2002; 32:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/100\">",
"      Klier CM, Muzik M, Rosenblum KL, Lenz G. Interpersonal psychotherapy adapted for the group setting in the treatment of postpartum depression. J Psychother Pract Res 2001; 10:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/101\">",
"      Zlotnick C, Johnson SL, Miller IW, et al. Postpartum depression in women receiving public assistance: pilot study of an interpersonal-therapy-oriented group intervention. Am J Psychiatry 2001; 158:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/102\">",
"      Meager I, Milgrom J. Group treatment for postpartum depression: a pilot study. Aust N Z J Psychiatry 1996; 30:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/103\">",
"      Morgan M, Matthey S, Barnett B, Richardson C. A group programme for postnatally distressed women and their partners. J Adv Nurs 1997; 26:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/104\">",
"      Golden RN, Gaynes BN, Ekstrom RD, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry 2005; 162:656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/105\">",
"      Oren, D, Wisner, KL, Spinelli, M, et al. Morning light treatment for antepartum depression. Society Light Treatment Bio Rhythms Abstracts 1999; 11:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/106\">",
"      Corral M, Kuan A, Kostaras D. Bright light therapy's effect on postpartum depression. Am J Psychiatry 2000; 157:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/107\">",
"      Hoffbrand S, Howard L, Crawley H. Antidepressant drug treatment for postnatal depression. Cochrane Database Syst Rev 2001; :CD002018.",
"     </a>",
"    </li>",
"    <li>",
"     Depression Guideline Panel. Depression in Primary Care: Treatment of Major Depression: Clinical Practice Guideline. US Dept of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR publication 93-0551, Rockville, MD 1993.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/109\">",
"      Wisner KL, Hanusa BH, Perel JM, et al. Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol 2006; 26:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/110\">",
"      Einarson A, Selby P, Koren G. Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling. J Psychiatry Neurosci 2001; 26:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/111\">",
"      Miller LJ. Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry 1994; 45:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/112\">",
"      Reed P, Sermin N, Appleby L, Faragher B. A comparison of clinical response to electroconvulsive therapy in puerperal and non-puerperal psychoses. J Affect Disord 1999; 54:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/113\">",
"      Altshuler LL, Cohen L, Szuba MP, et al. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 1996; 153:592.",
"     </a>",
"    </li>",
"    <li>",
"     The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training and Privileging: A Task Force Report of the American Psychiatric Association. 2nd ed. Washington, DC: American Psychiatric Association; 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/115\">",
"      Rabheru K. The use of electroconvulsive therapy in special patient populations. Can J Psychiatry 2001; 46:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/116\">",
"      Lawrie TA, Herxheimer A, Dalton K. Oestrogens and progestogens for preventing and treating postnatal depression. Cochrane Database Syst Rev 2000; :CD001690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/117\">",
"      Viguera AC, Cohen LS. The course and management of bipolar disorder during pregnancy. Psychopharmacol Bull 1998; 34:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/118\">",
"      Yonkers KA, Wisner KL, Stowe Z, et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 2004; 161:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/119\">",
"      Lumley J, Austin MP, Mitchell C. Intervening to reduce depression after birth: a systematic review of the randomized trials. Int J Technol Assess Health Care 2004; 20:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/120\">",
"      Dennis CL, Creedy D. Psychosocial and psychological interventions for preventing postpartum depression. Cochrane Database Syst Rev 2004; :CD001134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/121\">",
"      Webster J, Linnane J, Roberts J, et al. IDentify, Educate and Alert (IDEA) trial: an intervention to reduce postnatal depression. BJOG 2003; 110:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/122\">",
"      Hayes BA, Muller R, Bradley BS. Perinatal depression: a randomized controlled trial of an antenatal education intervention for primiparas. Birth 2001; 28:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/123\">",
"      Brugha TS, Wheatley S, Taub NA, et al. Pragmatic randomized trial of antenatal intervention to prevent post-natal depression by reducing psychosocial risk factors. Psychol Med 2000; 30:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/124\">",
"      Wisner KL, Perel JM, Peindl KS, et al. Prevention of recurrent postpartum depression: a randomized clinical trial. J Clin Psychiatry 2001; 62:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/125\">",
"      Wisner KL, Perel JM, Peindl KS, et al. Prevention of postpartum depression: a pilot randomized clinical trial. Am J Psychiatry 2004; 161:1290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?20/11/20666/abstract/126\">",
"      Makrides M, Gibson RA, McPhee AJ, et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 2010; 304:1675.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1704 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.25.216.6-12D3B89698-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_11_20666=[""].join("\n");
var outline_f20_11_20666=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      POSTPARTUM BLUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Etiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Women at high risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      POSTPARTUM DEPRESSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Prevalence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H108630218\">",
"      - Paternal postpartum depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Diagnosis and clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Adverse outcomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Prognosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Initial evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - General approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Psychosocial therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Light therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Pharmacologic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Expected response and duration of treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Electroconvulsive therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Hormonal therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Nonpharmacologic interventions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Pharmacological interventions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Postpartum blues",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Postpartum depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/1704\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/1704|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/43/34495\" title=\"figure 1A\">",
"      Edinburgh depression scale 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/61/34783\" title=\"figure 1B\">",
"      Edinburgh depression scale 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/1704|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/40/4747\" title=\"table 1\">",
"      Barriers to dx PPD",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=related_link\">",
"      Clinical manifestations and diagnosis of depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/2/29735?source=related_link\">",
"      Depression in pregnant women: Clinical features and consequences",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43783?source=related_link\">",
"      Effect of antidepressants on suicide risk in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=related_link\">",
"      Initial treatment of depression in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42582?source=related_link\">",
"      Obsessive-compulsive disorder in pregnant and postpartum women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29751?source=related_link\">",
"      Overview of psychotherapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/9/41105?source=related_link\">",
"      Patient information: Postpartum depression (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=related_link\">",
"      Patient information: Reducing the costs of medicines (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/39/17014?source=related_link\">",
"      Postpartum psychosis: Epidemiology, clinical manifestations, and assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/25/22936?source=related_link\">",
"      Seasonal affective disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/62/29670?source=related_link\">",
"      Treatment of postpartum psychosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27609?source=related_link\">",
"      Treatment of resistant depression in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/53/38745?source=related_link\">",
"      Use of psychotropic medications in breastfeeding women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f20_11_20667="Salt suppl CF";
var content_f20_11_20667=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F50515&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F50515&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suggested salt supplementation for infants and children with cystic fibrosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Age",
"      </td>",
"      <td class=\"subtitle1\">",
"       <p>",
"        Usual conditions*",
"       </p>",
"       <p>",
"        Salt (teaspoons per day)",
"       </p>",
"      </td>",
"      <td class=\"subtitle1\">",
"       <p>",
"        Extreme conditions&bull;",
"       </p>",
"       <p>",
"        Salt (teaspoons per day)",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       0 to 6 months",
"      </td>",
"      <td>",
"       1/8 - 1/4",
"      </td>",
"      <td>",
"       1/4 - 1/2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       6 to 12 months",
"      </td>",
"      <td>",
"       1/4 - 1/2",
"      </td>",
"      <td>",
"       1/2 - 3/4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       1 to 5 years",
"      </td>",
"      <td>",
"       1/3 - 2/3",
"      </td>",
"      <td>",
"       2/3 - 1 1/3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Over 5 years",
"      </td>",
"      <td>",
"       3/4 - 1",
"      </td>",
"      <td>",
"       1 1/2 - 2",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    1/8 tsp salt provides approximately 300 mg or 11 mEq of sodium.",
"    <div class=\"footnotes\">",
"     * Moderate temperature and humidity, no excessive sweating, regular bowel movements, no vomiting or diarrhea.",
"     <br>",
"      &bull; High temperature and/or humidity; dry, desert climate; strenuous and/or prolonged exercise, especially in heat; excessive sweating; fever, diarrhea, or vomiting.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Chris Coburn-Miller, MSRD, CSP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_11_20667=[""].join("\n");
var outline_f20_11_20667=null;
var title_f20_11_20668="Personality disorders in DSM IV";
var content_f20_11_20668=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F51279&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F51279&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Personality disorders in DSM-IV",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Axis II personality disorders",
"      </td>",
"      <td class=\"subtitle1\">",
"       Key features",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"       Cluster A (odd, eccentric)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Paranoid",
"      </td>",
"      <td>",
"       Distrust and suspiciousness of others such that their motives are interpreted as malevolent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Schizotypal",
"      </td>",
"      <td>",
"       Social and interpersonal deficits marked by acute discomfort with, and reduced capacity for, close relationships as well as by cognitive or perceptual distortions and eccentric behavior",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Schizoid",
"      </td>",
"      <td>",
"       Detachment from social relationships and a restricted range of expression of emotions in interpersonal settings",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"       Cluster B (impulsive, emotional, dramatic)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Antisocial",
"      </td>",
"      <td>",
"       Disregard for and violating the rights of others, lying, stealing, defaulting on debts, neglect of children or other dependents",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Borderline",
"      </td>",
"      <td>",
"       Instability of interpersonal relationships, self-image, affects, and control over impulses",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Histrionic",
"      </td>",
"      <td>",
"       Excessive emotionality and attention seeking",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Narcissistic",
"      </td>",
"      <td>",
"       Grandiosity (in fantasy or behavior), need for admiration, and lack of empathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"       Cluster C (anxious, fearful)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Dependent",
"      </td>",
"      <td>",
"       Feels inadequate, cannot make own decisions, submissive, avoids confrontation for fear of losing source of support",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Avoidant",
"      </td>",
"      <td>",
"       Social inhibition, feelings of inadequacy, and hypersensitivity to negative evaluation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Obsessive-compulsive",
"      </td>",
"      <td>",
"       Preoccupation with perfectionism, mental and interpersonal control, and orderliness, at the expense of flexibility, openness, and efficiency",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text revision (DSM-IV-TR). American Psychiatric Association, Washington, DC, 2000.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_11_20668=[""].join("\n");
var outline_f20_11_20668=null;
var title_f20_11_20669="WAS disease severity scoring system";
var content_f20_11_20669=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F69089&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F69089&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Disease severity scoring system for disorders associated with WAS mutations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Disease",
"       </td>",
"       <td class=\"subtitle1\">",
"        XLN",
"       </td>",
"       <td class=\"subtitle1\">",
"        iXLT",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        XLT",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Classic WAS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Score",
"       </td>",
"       <td class=\"subtitle2\">",
"        0",
"       </td>",
"       <td class=\"subtitle2\">",
"        &lt;1",
"       </td>",
"       <td class=\"subtitle2\">",
"        1",
"       </td>",
"       <td class=\"subtitle2\">",
"        2",
"       </td>",
"       <td class=\"subtitle2\">",
"        3",
"       </td>",
"       <td class=\"subtitle2\">",
"        4",
"       </td>",
"       <td class=\"subtitle2\">",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombocytopenia",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -/+",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Small platelets",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eczema",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        (+)",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        ++",
"       </td>",
"       <td class=\"centered\">",
"        -/(+)/+/++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Immunodeficiency",
"       </td>",
"       <td class=\"centered\">",
"        -/(+)",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -/(+)",
"       </td>",
"       <td class=\"centered\">",
"        (+)",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        (+)/+",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infections",
"       </td>",
"       <td class=\"centered\">",
"        -/(+)",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        (+)",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +/++",
"       </td>",
"       <td class=\"centered\">",
"        -/(+)/+/++",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Autoimmunity and/or malignancy",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congenital neutropenia",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myelodysplasia",
"       </td>",
"       <td class=\"centered\">",
"        -/+",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     Scoring system:",
"    </strong>",
"    <ul>",
"     <li>",
"      -/(+): Absent or mild",
"     </li>",
"     <li>",
"      -/+: Intermittent thrombocytopenia, possible myelodysplasia",
"     </li>",
"     <li>",
"      (+): Mild, transient eczema or mild, infrequent infections not resulting in sequelae",
"     </li>",
"     <li>",
"      +: Thrombocytopenia, persistent but therapy-responsive eczema, and recurrent infections requiring antibiotics and often intravenous immunoglobulin prophylaxis",
"     </li>",
"     <li>",
"      ++: Eczema that is difficult to control and severe, life-threatening infections",
"     </li>",
"    </ul>",
"    <div class=\"footnotes\">",
"     WAS: Wiskott&ndash;Aldrich syndrome; XLN: X-linked neutropenia; XLT: X-linked thrombocytopenia.",
"    </div>",
"    <div class=\"reference\">",
"     Original table modified for this publication. From: Stiehm ER, Ochs HD, Winkelstein JA, Rich E (Eds). Immunologic disorders in infants and children, 5th ed. Philadelphia: Saunders, 2004. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_11_20669=[""].join("\n");
var outline_f20_11_20669=null;
var title_f20_11_20670="12-lead ECG left lateral WPW I";
var content_f20_11_20670=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F74370&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F74370&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 528px\">",
"   <div class=\"ttl\">",
"    12-lead electrocardiogram (ECG) of a left lateral accessory AV pathway",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 508px; height: 307px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram in sinus rhythm from a patient with the Wolff-Parkinson-White syndrome shows a maximally preexcited QRS. The PR is short, the QRS has a right bundle branch block morphology, there is a prominent RS complex in V1, the QRS is negative, and the delta wave is isoelectric in leads I and aVL, localizing the accessory pathway to the left lateral annulus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_11_20670=[""].join("\n");
var outline_f20_11_20670=null;
var title_f20_11_20671="USDA recommended average daily food intake";
var content_f20_11_20671=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F68730&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F68730&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    USDA recommended daily or weekly caloric intake of different food groups",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"12\">",
"        Calorie level",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        1000",
"       </td>",
"       <td class=\"subtitle2\">",
"        1200",
"       </td>",
"       <td class=\"subtitle2\">",
"        1400",
"       </td>",
"       <td class=\"subtitle2\">",
"        1600",
"       </td>",
"       <td class=\"subtitle2\">",
"        1800",
"       </td>",
"       <td class=\"subtitle2\">",
"        2000",
"       </td>",
"       <td class=\"subtitle2\">",
"        2200",
"       </td>",
"       <td class=\"subtitle2\">",
"        2400",
"       </td>",
"       <td class=\"subtitle2\">",
"        2600",
"       </td>",
"       <td class=\"subtitle2\">",
"        2800",
"       </td>",
"       <td class=\"subtitle2\">",
"        3000",
"       </td>",
"       <td class=\"subtitle2\">",
"        3200",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Fruits",
"        </strong>",
"        (c)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1&frac12;",
"       </td>",
"       <td>",
"        1&frac12;",
"       </td>",
"       <td>",
"        1&frac12;",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Vegetables",
"        </strong>",
"        * (c)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1&frac12;",
"       </td>",
"       <td>",
"        1&frac12;",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3&frac12;",
"       </td>",
"       <td>",
"        3&frac12;",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dark-green vegetables (c/wk)",
"       </td>",
"       <td>",
"        &frac12;",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1&frac12;",
"       </td>",
"       <td>",
"        1&frac12;",
"       </td>",
"       <td>",
"        1&frac12;",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Red and orange vegetables (c/wk)",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        5&frac12;",
"       </td>",
"       <td>",
"        5&frac12;",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        7&frac12;",
"       </td>",
"       <td>",
"        7&frac12;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Beans and peas (legumes) (c/wk)",
"       </td>",
"       <td>",
"        &frac12;",
"       </td>",
"       <td>",
"        &frac12;",
"       </td>",
"       <td>",
"        &frac12;",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1&frac12;",
"       </td>",
"       <td>",
"        1&frac12;",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Starchy vegetables (c/wk)",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        3&frac12;",
"       </td>",
"       <td>",
"        3&frac12;",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Other vegetables (c/wk)",
"       </td>",
"       <td>",
"        1&frac12;",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"       <td>",
"        3&frac12;",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5&frac12;",
"       </td>",
"       <td>",
"        5&frac12;",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Grains",
"        </strong>",
"        <sup>",
"         &bull;",
"        </sup>",
"        (oz-eq)",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        9",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Whole grains (oz-eq)",
"       </td>",
"       <td>",
"        1&frac12;",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3&frac12;",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        4&frac12;",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Enriched grains (oz-eq)",
"       </td>",
"       <td>",
"        1&frac12;",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3&frac12;",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        4&frac12;",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Protein foods",
"        </strong>",
"        <sup>",
"         &bull;",
"        </sup>",
"        (oz-eq)",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5&frac12;",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        6&frac12;",
"       </td>",
"       <td>",
"        6&frac12;",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Seafood (oz/wk)",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        9",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Meat, poultry, eggs (oz/wk)",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        19",
"       </td>",
"       <td>",
"        24",
"       </td>",
"       <td>",
"        24",
"       </td>",
"       <td>",
"        26",
"       </td>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        34",
"       </td>",
"       <td>",
"        34",
"       </td>",
"       <td>",
"        34",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nuts, seeds, soy products (oz/wk)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Dairy",
"        </strong>",
"        (c)",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"       <td>",
"        2&frac12;",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <strong>",
"         Oils",
"        </strong>",
"        <sup>",
"         &Delta;",
"        </sup>",
"        (g)",
"       </td>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        22",
"       </td>",
"       <td>",
"        24",
"       </td>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        34",
"       </td>",
"       <td>",
"        36",
"       </td>",
"       <td>",
"        44",
"       </td>",
"       <td>",
"        51",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"13\">",
"        Notes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"13\">",
"        All foods are assumed to be in nutrient-dense forms, lean or low-fat and prepared without added fats, sugars, or salt. Solid fats and added sugars may be included up to the daily maximum limit identified in the table. Food items in each group and subgroup are:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Fruits",
"        </strong>",
"       </td>",
"       <td colspan=\"12\">",
"        All fresh, frozen, canned, and dried fruits and fruit juices: for example, oranges and orange juice, apples and apple juice, bananas, grapes, melons, berries, raisins.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"13\">",
"        Vegetables",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dark-green vegetables",
"       </td>",
"       <td colspan=\"12\">",
"        All fresh, frozen, and canned dark-green leafy vegetables and broccoli, cooked or raw: for example, broccoli, spinach, romaine, collard, turnip, and mustard greens.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Red and orange vegetables",
"       </td>",
"       <td colspan=\"12\">",
"        All fresh, frozen, and canned red and orange vegetables, cooked or raw: for example, tomatoes, red peppers, carrots, sweet potatoes, winter squash, and pumpkin.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Beans and peas (legumes)",
"       </td>",
"       <td colspan=\"12\">",
"        All cooked beans and peas: for example, kidney beans, lentils, chickpeas, and pinto beans. Does not include green beans or green peas. (See additional comment under protein foods group.)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Starchy vegetables",
"       </td>",
"       <td colspan=\"12\">",
"        All fresh, frozen, and canned starchy vegetables: for example, white potatoes, corn, and green peas.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Other vegetables",
"       </td>",
"       <td colspan=\"12\">",
"        All fresh, frozen, and canned other vegetables, cooked or raw: for example, iceberg lettuce, green beans, and onions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"13\">",
"        Grains",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Whole grains",
"       </td>",
"       <td colspan=\"12\">",
"        All whole-grain products and whole grains used as ingredients: for example, whole-wheat bread, whole-grain cereals and crackers, oatmeal, and brown rice.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Enriched grains",
"       </td>",
"       <td colspan=\"12\">",
"        All enriched refined-grain products and enriched refined grains used as ingredients: for example, white breads, enriched grain cereals and crackers, enriched pasta, white rice.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Protein foods",
"        </strong>",
"       </td>",
"       <td colspan=\"12\">",
"        All meat, poultry, seafood, eggs, nuts, seeds, and processed soy products. Meat and poultry should be lean or low-fat and nuts should be unsalted. Beans and peas are considered part of this group as well as the vegetable group, but should be counted in one group only.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Dairy",
"        </strong>",
"       </td>",
"       <td colspan=\"12\">",
"        All milks, including lactose-free and lactose-reduced products and fortified soy beverages, yogurts, frozen yogurts, dairy desserts, and cheeses. Most choices should be fat-free or low-fat. Cream, sour cream, and cream cheese are not included due to their low calcium content.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Food group amounts are shown in cup (c) or ounce-equivalents (oz-eq). Oils are shown in grams (g). Quantity equivalents for each food group are:",
"    <br/>",
"    <strong>",
"     Grains",
"    </strong>",
"    , 1 ounce-equivalent is: 1 one-ounce slice bread; 1 ounce uncooked pasta or rice; &frac12; cup cooked rice, pasta, or cereal; 1 tortilla (6\" diameter); 1 pancake (5\" diameter); 1 ounce ready-to-eat cereal (about 1 cup cereal flakes).",
"    <br/>",
"    <strong>",
"     Vegetables and fruits",
"    </strong>",
"    , 1 cup equivalent is: 1 cup raw or cooked vegetable or fruit; &frac12; cup dried vegetable or fruit; 1 cup vegetable or fruit juice; 2 cups leafy salad greens.",
"    <br/>",
"    <strong>",
"     Protein foods",
"    </strong>",
"    , 1 ounce-equivalent is: 1 ounce lean meat, poultry, seafood; 1 egg; 1 Tbsp peanut butter; &frac12; ounce nuts or seeds. Also, &frac14; cup cooked beans or peas may also be counted as 1 ounce-equivalent.",
"    <br/>",
"    <strong>",
"     Dairy",
"    </strong>",
"    , 1 cup equivalent is: 1 cup milk, fortified soy beverage, or yogurt; 1&frac12; ounces natural cheese (eg, cheddar); 2 ounces of processed cheese (eg, American).",
"    <div class=\"footnotes\">",
"     * Vegetable and protein foods subgroup amounts are shown in this table as weekly amounts, because it would be difficult for consumers to select foods from all subgroups daily.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Whole-grain subgroup amounts shown in this table are minimums. More whole grains up to all of the grains recommended may be selected, with offsetting decreases in the amounts of enriched refined grains.",
"     <br/>",
"     &Delta; Oils and soft margarines include vegetable, nut, and fish oils and soft vegetable oil table spreads that have no trans fats.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: US Department of Agriculture and US Department of Health and Human Services. Dietary Guidelines for Americans 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, December 2010.",
"     <a href=\"file://www.dietaryguidelines.gov\" target=\"_blank\">",
"      file://www.dietaryguidelines.gov",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f20_11_20671=[""].join("\n");
var outline_f20_11_20671=null;
